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Supervisor: Carolyn M. Brown 
 
 The purpose of this study was to determine the factors related to young black 
men’s intention to screen for prostate cancer as well as their engagement in prostate 
cancer risk-reduction behaviors. The study tested the significance of the constructs – 
age, attitude (direct and indirect), social influence, comfortability, cues to action, health 
screening experiences and knowledge – in predicting young black men’s intention to 
screen for prostate cancer; as well as the significance of the constructs – age, cues to 
action, exercise and knowledge – in predicting engagement in prostate cancer risk-
reduction behaviors. Demographic/personal factors were also explored in related to the 
model predictors. 
 Web-based and paper-pencil surveys were administered to 279 black men aged 
between 18 – 40 years from the Austin area. Three focus groups were conducted to 
collect information regarding young black men’s behavioral beliefs toward prostate 
cancer screening as well as their comfortability with prostate examinations. The number 
of usable surveys was 267. Using direct and indirect measures, the combination of 




41.0 and 43.0 percent of the variance in intention to screen for prostate cancer, 
respectively; with social influence being the strongest predictor (β=0.41; p <0.01 for the 
direct model and β=0.47; p <0.01 for the indirect model). For the model with prostate 
cancer risk-reduction as the outcome variable, the model accounted for 10.0 percent of 
the variance in behavior with only knowledge (β=0.19; p=0.03) as significant predictor. 
 Interventions that address young black men’s attitude, social influence, 
comfortability, and knowledge may be necessary to increase young men’s intention to 
screen for prostate cancer when it is recommended by a physician. Additionally, factors 
surrounding exercise and knowledge may be important in increasing young men’s 
engagement in prostate cancer risk-reduction behaviors. Future studies using intention 
as a predictor of young men’s behavior are needed to assess the influence of intention 
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CHAPTER ONE: INTRODUCTION 
This chapter delineates the research problem, study significance, conceptual 
framework, definition of terms, assumptions, and delimitations of this study. 
 
1.1 THE RESEARCH PROBLEM 
 About one in six American men will be diagnosed with prostate cancer during 
their lifetime. Prostate cancer is the most commonly diagnosed cancer and the leading 
cause of cancer death among black men.
1,2
 Approximately 233,000 new cases of 
prostate cancer will be diagnosed and about 29,480 men (of all ethnic groups) will die 
of the disease in 2014. It is also estimated that 4,980 deaths from prostate cancer will 
occur in black men in 2014, making the death rate from prostate cancer 2.4 times higher 
in black men than in white men.
1
  Death rates among black men are among the highest 
in the world.
3
 In 2013 alone, an estimated 35,349 new cases of prostate cancer are 
expected to be diagnosed in black men. These new cases account for 37% of all cancers 
diagnosed in black men.
1
 Compared to Caucasian men, the average annual incidence of 
prostate cancer in black men during 2005-2009 was 228.8 cases per 100,000 men – an 
incidence rate 63% higher than the rate in white men.
4
 Compared to men of other racial 
and ethnic groups, black men are at least 56% more likely to develop prostate cancer, 
and mortality from prostate cancer is twice as likely in men of black origin.
5,6
 Survival 
rates comparing black men with Caucasian men show a clear disparity.
1
 
A major factor responsible for this disparity in morbidity and mortality is that 




screening when needed. Several studies reveal that even after adjusting for 
socioeconomic status, comorbidities, and access to care, black men are less likely to 
undergo prostate cancer screening.
1,7,8
 Other factors that have been associated with 
lower prostate cancer screening include lack of prostate cancer knowledge, lack of 
insurance and poor physician recommendation.
9-12
  Additionally, mixed messages in the 
media concerning screening and disease detection may affect prostate cancer screening 
among black men.
11,13
  A study conducted in 1998 to explore the impact of prostate 
cancer knowledge on prostate cancer screening showed that prostate cancer knowledge 
was a predictor of participation in prostate cancer screening.
14
 Results from this study 
showed that out of all the black men (N=319) participants, only about 14 percent had a 
high knowledge level about prostate cancer.
14
 About 82% of the men reported not to 
have heard of prostate specific antigen (PSA) and digital rectal examination (DRE) – 
both are diagnostic tests used in the early detection of prostate cancer. Although, the 
effectiveness of these diagnostic tests is yet to be proven, several screening guidelines 
have recommended physician communication of relevant information relating to the 
limitations, as well as the advantages of prostate cancer screening to male patients.
1,15,16
 
There are more debates surrounding the benefits of prostate cancer screening than there 
are for other types of cancer screening. While there is controversy associated with 
routine prostate cancer screening, there is overwhelming evidence to show that 
screening is beneficial in men with familial (high) risks or at least with one-first-degree 
relative with prostate cancer.
3




Results from the randomized prospective trial (Prostate, Lung, Colorectal, 
Ovarian Trial [PLCO]) conducted by the National Cancer Institute showed that -
concerning prostate cancer screening, many men (67%) were treated for prostate cancer 
that would not have been detected in their lifetime without screening; leading to 
unnecessary exposure to the potential harms of treatment.
17
 A second large trial 
(European Randomized Study of Screening for Prostate Cancer [ERSPC]) conducted in 
Europe compared prostate cancer deaths in men randomly assigned to screening vs. no 
screening. The results from this trial showed that death rates were lower in men who 
had screened for prostate cancer than in men who did not screen.
18
 Yet, the U.S. 
Preventive Services Task Force (USPSTF) no longer recommends prostate cancer 
screening in men in the general U.S. population, regardless of age.
19
 Despite these 
controversies, the American Cancer Society
1
 endorses prostate cancer screening 
annually only after the benefits and limitations of prostate cancer screening have been 
outlined to the patients. In addition, both the American Urologic Association (AUA) 
and the National Medical Association (NMA) support the use of screening in early 
detection of prostate cancer as a means to support health promotion especially in black 
men.
20
 It is therefore critical that decision aids be provided to assist men in making 
informed decisions consistent with their own preferences, as regards to prostate cancer 
screening.
21
 In addition, uncertain medical situations like prostate cancer screening 
warrants the need for patient knowledge and preferences to be held upfront during the 
decision-making process.
22
 However, since black men in general are less likely to 




decision-making processes, that could empower them with the choices of whether to get 
screened or not.  
One of the goals of Healthy People 2020
23
 is to reduce prostate cancer mortality 
to 21.2 deaths per 100,000 males, a 10% improvement from 2007. In order to ensure 
that the nation reaches this goal by the year 2020, there is a need to address the alarming 
incidence and mortality rates in black men. Future research needs to further examine 
factors that influence prostate cancer screening participation in black men as well as to 
develop interventions that integrate these factors. Interventions such as these may 
consequently lead to increased participation in screening activities, especially among 
this high risk group. 
It has been speculated that black men have higher genetic vulnerability and that 
compared to other racial groups, prostate cancer may be more biologically aggressive in 
black men.
24-26
 Additionally, black men have lower knowledge levels of prostate cancer 
screening, tend to be more burdened about the disease and have lower perceived risk of 
developing prostate cancer than Caucasian men.
27,28
 
Underrepresentation of black men in many major clinical studies of the disease 
may have resulted in the dearth of information available on the perspectives of black 
men on prostate screening. For example, black men constituted only seven percent of 
the total number of participants included in the American Cancer Society’s National 
Prostate Cancer Detection Project.
29
 The lack of adequate representation of black men, 







Adding to the disparity in mortality rates is that black men present with more 
aggressive forms of prostate cancer at the time of diagnosis and they also tend to have a 
higher prostate cancer incidence rate.
1,30
 Initially, the aggressiveness of the disease seen 
in black men was attributed to predisposing factors like genetic and biologic factors, or 
to poor screening and delayed presentation. However, there are studies which support 
the argument that prostate cancer is indeed more aggressive in black men, as a result of 
both genetic and biologic factors.
1,31
  
Discomfort associated with prostate examination has been identified as one of 
the most significant factors associated with screening participation, especially among 
black men.
32-35
 Little is known about the pain and discomfort experienced by patients 
during prostate examinations. While several patient-information guides report that there 
is little or no pain experienced during prostate examinations, studies have shown that 
physicians tend to give lower ratings of patients’ pain than the patients themselves.
34,36
 
Thus, the anticipated discomfort with prostate examination may be an important barrier 
to prostate cancer screening and may likely affect compliance with future examinations. 
 
1.2 STUDY SIGNIFICANCE AND IMPLICATIONS 
  This study is significant for several reasons. The economic burden of prostate 
cancer is substantial and likely to grow exponentially.
37,38
 Estimates of the total cost 
(direct and indirect) of prostate cancer (including screening, diagnosis, treatment, and 
monitoring) in the U.S. ranged from $5 billion to over $10 billion every year.
39
  Also, 




recommended that men at high risk, based on race and family history, should begin 
early detection.
40
 In addition, cancers that are detected at a younger age tend to be more 
aggressive, may be detected at a more advanced stage, and occasionally result in a less 
favorable outcome than cancers that arise later in life.
41,42
  A study by Karami, Young & 
Henson that examined earlier age at diagnosis and cancer disparity found that when 
compared to Caucasian men, black men are significantly more likely to be diagnosed at 
a younger age (<45 years), a factor that may result in poorer treatment outcomes and 
increased aggressiveness of the disease.
43
  
To our knowledge, this is the first study to examine prostate cancer screening 
intentions and current engagement in prostate cancer risk-reduction behaviors among 
young black men. Our rationale for including young black males aged 18 to 40 years is 
to examine their attitudes and intention toward prostate cancer screening to advise 
education initiatives for young black males so that informed decisions can be made in 
regards to screening at later ages. The information gathered from this study will 
increase our understanding of the factors influencing young black men's intentions to 
screen for prostate cancer, with an additional focus on issues surrounding their 
“comfortability” with prostate examinations. In addition, we plan to examine young 
black males’ current engagement in chemopreventive behaviors. Ultimately, we hope 
that this information will contribute to the development of targeted educational efforts 






1.3 CONCEPTUAL FRAMEWORK  
The Theory of Reasoned Action
44
 (TRA) developed by Fishbein and will be the 
conceptual framework utilized to guide this research. TRA has been used to test the 
relationship between behavioral beliefs, normative beliefs, and the intention to undergo 
certain behaviors. For this study, the attitudinal component (behavioral beliefs and the 
evaluations of these beliefs) and subjective norms will be assessed as two of the 
precursors to intentions to screen for prostate cancer. In addition, age, comfortability 
with prostate examination, cues to action, health screening experiences and knowledge 
regarding prostate cancer and will be examined. Based on the TRA, it is hypothesized 
that black men’s intention to screen for and prevent prostate cancer will be positively 
influenced by their favorable attitudes, positive social influences, increased knowledge, 
positive cues to actions, higher “comfortability” with prostate examinations, and 
positive health screening experience regarding prostate cancer and prostate cancer 
screening. 
Additionally, engagement in preventative behaviors such as diet and use of 
supplements will be examined. It is hypothesized that age, cues to action and 
knowledge regarding prostate cancer and screening will all be positive predictors of 
young black men’s engagement in such preventative behaviors. 
 
1.4 DEFINITIONS OF TERMS 





Black – (According to the U.S. Office of Management and Budget (OMB),
45
 “Black” 
refers to a person having origins in any of the black racial groups of Africa. The black 
racial category include blacks; those from Sub-Saharan Africa, such as Kenya and 
Nigeria; and Afro-Caribbean, such as Haiti and Jamaica. This will be used as a general 
term for U.S.-born, African-born and Caribbean-born black men. 
Prostate Specific Antigen – defined as a blood test that measures a protein produced 
by the prostate cells. High concentration of this protein could suggest prostate cancer.
46
 
Digital Rectal Examination (DRE) – palpation of the prostate gland through digital 
manipulation of the rectum.
47
 
Prostate Examination – will be used interchangeably with digital rectal examination 
(DRE). 
 
1.5 THE ASSUMPTIONS  
As with any scientific study, assumptions made will form the basis of the 
questions and choices of methods used in this study. These assumptions will guide and 
shape the execution and discussion of the study described herein; and they are important 
to useful interpretations from the data collected. 
 Primary data collection was utilized in this study because of its ease of 
implementation, cost effectiveness, and ability to obtain information in a limited time 
frame. Self-reports of behaviors and perceptions of the research participants will be 
relied on as opposed to direct observations and measurements of actual behavior. 




questions and will be able to accurately recall relevant information about events in the 
past. To encourage honest and accurate responses, no personal identifying information 
will be asked from the participants. 
The research herein describes the intentions of young black men to engage in 
preventative behaviors in the future. Since actual behaviors will not be measured, it is 
necessary to assume that intention to engage in prostate cancer screening is related to 
actual future behaviors. This assumption is supported by research based on examining 
general health behavior
48
 and has been particularly supported in research on screening 
behaviors among young adult males.
49,50
  
The effectiveness of engaging in preventative behaviors (e.g., prostate cancer 
screening, use of chemopreventive agents) is one of the assumptions made for this 
study. While there is no consensus as to if and when to screen, current evidence 
suggests that screening for prostate cancer is the most effective way to detect prostate 
cancer early. This study assumes that starting the conversation about preventative health 
behaviors in the early adult years can increase the likelihood of early detection of 
prostate cancer in later years. Furthermore, we assume that screening for prostate cancer 
will reduce mortality and morbidity rates. It is also assumed that when adequately 
informed about the risks they face, younger men can be proactive in reducing some of 
their risks and engaging in screening behaviors. Finally, we also assume that 
participants may have heard of prostate cancer or aware of it on some level and that 




necessary in order to limit the focus of this study to behaviors conformable to 
intervention cancer-related outcomes in black males. 
 
1.6 DELIMITATIONS 
 Choices were made specifically to limit and narrow the scope of this study; this 
is in addition to the various assumptions made for this study. The study was delimited to 
include only black men aged 18 to 40 years of age. This is not a study limitation given 
that there is a special interest in this age group. The lower limit of 18 years was chosen 
because it is the age of consent and the upper limit of 40 years was chosen because the 
American Cancer Society (ACS) recommends the discussion about prostate cancer 
should take place at age 40 for men considered high risk (those with more than one 
first-degree relative who had prostate cancer at an early age).
51
 It is therefore the goal of 
this research to examine and describe the current estimates of young black men’s 
attitude towards prostate cancer screening, comfortability with prostate examinations, 
cues to action, health screening experiences, social influence, knowledge regarding 
prostate cancer screening, and intentions to screen for prostate cancer when it is 
recommended by a physician. In addition, we aim to examine current engagement in 
prostate cancer risk-reduction behaviors (such as diet, use of supplements). 
  Knowledge regarding prostate cancer and prostate cancer screening will strictly 
comprise knowledge of limitations of screening, diet, screening controversy, side 
effects from treatment, symptoms, risk factors, and screening age guideline and these 




delimitation is permissible because the knowledge measure has been previously 
established from the literature, and it allows for an adequate knowledge base assessment 
for young adult males. 
 
1.7 SUMMARY  
 Currently, prostate cancer remains a significant burden among black men with 
research showing black men having a higher incidence and mortality rate for the 
disease. While prostate cancer screening alone may not be the “panacea” to prevent 
deaths from prostate cancer, screening still remains one of the ways to reduce the 
mortality rates from prostate cancer among black men. The goal of prostate cancer 
screening is to detect prostate cancer early in the localized stages rather than “watchful 
waiting” until the disease advances to a later stage. Therefore, the goal of this study is to 
gain a better understanding of the determinants of young black men’s intention to 
screen for prostate cancer when it is recommended by their doctors, as well as to assess 
young black men’s current engagement in prostate cancer risk-reduction behavior. The 
conceptual model for this research, based on the TRA, will be used to assess the factors 
that may influence prostate cancer screening among young black men. 





CHAPTER TWO: LITERATURE REVIEW AND THEORETICAL 
FRAMEWORK 
A review of the literature relevant to this study is presented. The major topics to 
be addressed are prostate cancer, prostate cancer screening, prostate cancer disparities, 
demographic/personal factors associated with prostate cancer screening, and theoretical 
models used in predicting intentions to screen for prostate cancer. 
 
2.1 PROSTATE CANCER  
 Prostate cancer is the most commonly diagnosed malignancy and the second-
leading cause of cancer-related deaths among men in the US.
51
 Black men have double 
the mortality rates of prostate cancer and are also more likely to be diagnosed at the 
advanced stages of prostate cancer compared to white men.
52
 Late-stage presentations at 
diagnosis have been attributed to the disparity gap in prostate cancer mortality between 
black and Caucasian men.
52
 Although there has been a general decline in mortality rate 
associated with prostate cancer mortality from 1993, this trend has not been observed 
among black men.
4,53
 While mortality figures are not yet available, there are 
exceptionally high incidence rates (72.8 per 100,000) of prostate cancer seen in 
immigrants from Jamaica and Trinidad and Tobago, with some available studies 
reporting even higher rates (257.3 per 100, 000) than those seen among U.S.-born 
blacks.
54,55
 A study by Glover et al.,
56
 exploring the epidemiology of prostate cancer in 




In general, black men with prostate cancer tend not to only present with higher-
risk disease characteristics but also have a higher likelihood of disease recurrence after 
treatment and a higher prostate cancer-specific mortality.
57-60
 A study by Latini et al.
59
 
used the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) 
database to examine the presenting characteristics in men with prostate cancer, and 
found that black men presented at a younger age with higher PSA (Prostate-Specific 
Antigen) levels and more aggressive forms of the cancer. These findings have been 
supported by other cohort studies.
61,62
 Race was found to be a significant predictor of 
presenting with advanced prostate cancer, even after controlling for socioeconomic 
status, pathologic factors, clinical factors, and demographics in the Population-based 
Cancer Outcomes Study (PCOS). The study enrolled 3,173 men diagnosed with prostate 
cancer between 1994 and 1995.
61
 Although the black race has been identified as a 
probable adverse cause for certain diseases, some researchers have refuted this claim 
especially regarding diseases associated with organs.
63-66
 Nonetheless, other studies 
have been able to show racial differences in outcomes after treatment. Cohen et al.
67
 
examined the data of over 25,000 men from the Surveillance, Epidemiology and End 
Results (SEER) -Medicare database who were diagnosed with prostate cancer between 
1986 and 1998. They found that compared to white men, black men had a lower 
disease-free survival time. A similar study by Godley et al.
68
 found that black men with 
prostate cancer had overall lower survival time, irrespective of treatment and even after 





2.1.1 SIGNS AND SYMPTOMS 
 There are usually no signs or symptoms in the early stages of prostate cancer. 
However, as the cancer becomes advanced, patients might begin to experience 
symptoms such as: decreased urine flow, urinary incontinence especially at night, 
inability to urinate, blood in the urine, pain or burning during urination, or continual 
pain in the lower back, upper thighs, or pelvis.
51
 Patients often perceive these symptoms 
as harmless, non-specific, or similar to symptoms associated with other less serious 
conditions. Therefore, it is important to engage in prostate cancer screening behavior 
early on, since prostate cancer is much more curable in the early stages. 
 
2.1.2 COMMONLY KNOWN RISK FACTORS 
The most common risk factors associated with prostate cancer are age, ethnicity, 
diet, and family history of prostate cancer.
51,58
 Globally, Jamaican men of African 
descent as well as African-American men are known to have the highest incidence of 
prostate cancer.
69,70
 Compared to Caucasian men, the risk of developing prostate cancer 
in black men based purely on ethnicity is estimated to be 40 – 80% higher.
71
  
A positive family history has also been found to be a significant risk factor for 
prostate cancer.
71,72
 The risk of developing prostate cancer is higher in families with a 
history of the disease than in the general population.
51,73
 Inherited susceptibility appears 
to play an additional independent role in the development of prostate cancer. Men 
diagnosed with prostate cancer are almost twice as likely to have a male blood relative 






addition, prostate cancer risk increases with an increasing number of affected family 
members, such that men with two or three first degree relatives affected have a five- and 
11-fold increased risk of developing prostate cancer, respectively.
75
 
Increased intake of dietary fat has been shown to contribute to the risk of 
developing prostate cancer.
51,76
 Cumulative exposure to androgens and high fat diets are 
also related to prostate cancer risk.
77-80
 This pattern of exposure has been established 






Treatment options available depend on stage of presentation, age and the 
presence of other diseases. Treatment for prostate cancer can be invasive and cause 
long-term complications such as incontinence or impotence.
86,87
 Surgery, such as radical 
prostatectomy (removal of the prostate gland), and radiation are the most common 
forms of treatment at the early stage of the disease.
87
 Hormone therapy, chemotherapy, 
and radiation are commonly used in combinations for metastatic or advanced stages of 
the disease. Nonetheless, chemotherapy and hormone therapy can be used in treating 
early stages of the disease as well. “Watchful waiting” is employed with much older 
individuals, those with less aggressive forms of the disease, or those with a shorter life 









Prostate cancer has a relatively higher survival rate when detected in its early 
phases. For those diagnosed early with prostate cancer, the five year survival rate is 
nearly 100 percent.
51
 The overall five year survival rate for prostate cancer among 
blacks is 96 percent (which is up from 67% just forty years ago), compared to nearly 
100 percent among whites, thus showing the importance of early detection on 
survival.
51
  Compared to 93 percent in whites, 91 percent of all prostate cancers among 
black men are diagnosed at a local or regional stage. However, in the distant stages, the 
overall five year survival rate drops to 29 percent.
88
 Not only is the risk of prostate 
cancer higher in black men than in any other racial groups, but the cancer itself is often 
more aggressive at the time of presentation, which is often late.
24-26
 Several studies have 






2.1.5 ECONOMIC BURDEN OF PROSTATE CANCER IN THE USA 
Prostate cancer is the most common malignancy in men.
90
 The economic burden 
of this disease keeps increasing due to more men being diagnosed at an earlier age.
38
 
The most recent annual cost data for prostate cancer has been published by the National 
Cancer Institute (NCI) based on incidence, survival, and cost of care data.
91
 The NCI 
estimate for expenditure on prostate cancer treatment in 2010 was $12 billion, and 
average Medicare payments per patient in the first year after diagnosis was $19,710. 
Roehnrborn, Albertsen, Stokes, Black & Benedict
92




Medicare database by tracking healthcare use and costs of prostate cancer from 
diagnosis to initial treatment in a cohort of 81,659 elderly patients with prostate cancer. 
After a 4-year follow-up, there was an increase in costs at all stages of prostate cancer. 
The diagnosis for each patient over four years for prostate cancer-related costs averaged 
about $18,200. The economic burden of prostate cancer is expected to increase in the 






 While modification of certain lifestyle behaviors may be an effective 
preventative measure, prostate cancer screening is still considered as the most effective 
mode of prevention. 
 
2.2.1 LIFESTYLE MODIFICATION 
 Modifications in lifestyle are the most likely means of primary prevention of 
prostate cancer. There are mixed or inconclusive findings from research concerning the 
relationship between lifestyle modification and prostate cancer, but given the known 
relationship between diet, exercise, smoking and other modifiable factors related to 
other common cancer, lifestyle can be an important prevention consideration.
88,91
 
 Diet remains the only known risk factor that may be modified to reduce a man’s 
chance of developing prostate cancer, thus an important element in primary 
prevention.
91,94






, however many men do not meet the recommended dietary 
guidelines and therefore appear to be at increased risk of developing prostate cancer. 




 Millon-Underwood and Sanders
97
 examined the factors responsible for health 
promotion behaviors in black men (N=177). This study was specifically focused on 
modifiable behaviors that reduce cancer risk or that can detect cancer early. Findings 
from the study showed that beliefs related to cancer risk, decreasing carcinogen 
exposures and beliefs related to influence of health care providers significantly 
contributed to explaining 72 percent of the variance in health-promoting behaviors. 
Further findings from the study indicated that black men did not consider themselves 
very health-conscious and more than half of the sample (56%) reported paying attention 
to their bodies and 42 percent stated that they were involved in one form of physical 
activity or the other. Twenty-three percent of the men in the survey reported that their 
diet consisted of an adequate amount of vitamins, minerals, fiber and dietary fat. 
 Some chemoprevention agents such as 5-α-reductase inhibitors, NSAIDs, 
selenium, allium vegetables, soy/isoflavones, green tea polyphenols, vitamins D and E, 
and statins, have been considered for reduction of prostate cancer and may reduce 
prostate cancer mortality.
98
 While there is no conclusive evidence for the 
chemopreventive benefit of nutrients or vitamins, it remains a significant part of 





2.2.2 PROSTATE CANCER SCREENING   
Detecting prostate cancer early is crucial to longer survival rates and significant 
reduction in mortality rates.
14,77
 Although prostate cancer screening is not without its 
controversies, it is currently the only method to control the disease through early 
detection. Recent data available show an increase in prostate cancer screening rates 
since 1995 in the U.S.,
99
 suggesting that more attention has been paid to either taking 
the prostate antigen (PSA) test and/or undergoing digital rectal examination (DRE).  
The PSA test and the DRE are the two primary modes of detecting and 
screening for prostate cancer. DRE is the oldest screening test and it requires that a 
physician insert an examining finger into the rectum to feel for lumps or irregularities. 
The PSA test is a blood test that can easily detect a protein made by the prostate cells. A 
high concentration of this protein indicates the presence of prostate cancer.
51
 Both PSA 
and DRE have a moderate sensitivity and high false positive rates. The DRE technique 
has been shown to have a moderate sensitivity of 55 – 68 percent of detecting prostate 
cancer in asymptomatic men,
100,101
 but the technique results in a high number of false 
positive results and has a low specificity. Studies have reported a positive predictive 
value of five to 30 percent.
100,102-106
 A meta-analysis study estimated an overall positive 
predictive value of the DRE as 28 percent.
107
 The sensitivity of the DRE is limited 
partly because the physician cannot palpate the posterior of the prostate gland, as well 
as the fact that palpation cannot detect the early stage of the tumors.
108
 The PSA test has 










 Both DRE and PSA screening tests remain controversial for several reasons. 
First, each test is more likely to detect cancers of unknown clinical significance. It is 
difficult to distinguish which tumors will be life-threatening and which will remain in a 
latent stage, making it difficult to comprehend the natural history of prostate 
cancer.
108,112
 Due to the slow growth of prostate cancer, many men may die of other 
causes before prostate cancer becomes evident clinically or life threatening.
113
 Second, 
treatment can result in a range of potentially fatal complications and unpleasant side 
effects including bowel injury, impotence, and incontinence.
105,112
 
Currently, there is no consensus on the use of screening tests to detect prostate 
cancer. The recent guideline for testing by the American Cancer Society (ACS) 
suggests that both tests (DRE and PSA) be offered generally to men after the age of 
fifty years. Furthermore, ACS suggests that black men or men with a first-degree 
relative who has been diagnosed with prostate cancer at the age of forty-five years be 
offered screening.
51
 Additionally, the American Urological Association recommends 
yearly screening after age fifty for men in the general population and after age forty for 




2.2.2.1 PROSTATE CANCER SCREENING IN BLACK MEN 
The high mortality rates from prostate cancer experienced by black men 




the literature on high-risk male patients and their participation in prostate cancer 
screening, some authors have suggested that less than 10 percent of black men 
participate in prostate cancer screening in the U.S.
13,14,114
 Lower prostate cancer 
screening rates have been attributed to the wide disparity in deaths from prostate cancer 
seen in black men.
115,116
 Black men are less likely than white men to participate in 
annual prostate cancer screening.
117,118
 In addition, black men with a positive family 




Several studies have shown than black men are less likely to undergo prostate 
cancer screening when compared with Caucasian men.
7,10,119
 A study conducted in 2001 
examined differences in PSA testing rates between black and white Medicare recipients 
from 1991 to 1998.
120
 The results revealed that annual testing rates were 20 percent 
higher for whites than for blacks, with the exception of men older than 80 years. This 
pattern of prostate cancer testing suggests a commonality between screening and higher 
rates of prostate cancer mortality experienced in black men and support the position that 
early detection and recognition are important factors in the outcome of prostate cancer 
management.  
 
2.2.3 POTENTIAL BENEFITS OF SCREENING 
 Epidemiological data have suggested an association between decline in prostate 
cancer mortality and PSA testing, though these findings are conflicting.
121-123
 An 




mortality rates for prostate cancer since 1994; a decree of 10.4 deaths per 100,000 
men.
124
 The 45 – 70 percent decline in prostate cancer mortality rates have been 
attributable to PSA screening and this decline has been estimated by mathematical 
models.
125
 Recent results of randomized trials conducted in seven European centers 
showed that screening resulted in a moderate reduction in prostate cancer mortality 
rates.
126,127
 A separate randomized screening trial conducted in Sweden showed a 
greater reduction in mortality among those who screened for prostate cancer than in 
those who did not screen. The participants in the study were men aged between 50 to 64 
years and were followed for a median of 14 years.
128
 Findings from this study 
correspond to a number needed to screen of 293 and a number needed to diagnose of 12 
to prevent one death from prostate cancer. Furthermore, studies have shown that 





2.2.4 POTENTIAL HARMS OF SCREENING 
Abnormal PSA tests can lead to biopsies, which can cause infection, pain, or 
bleeding.
130
 Despite negative biopsy results, some men experienced prolonged anxiety 
regarding the possibility of cancer when undergoing biopsies.
131
 Some mathematical 
models estimate that 23 to 42 percent of PSA-detected cancers are over-diagnosed. If 
such cancers have been left undiagnosed, it would not be expected to cause clinical 
problems during the natural history of the patient’s lifetime.
129




therapy on such cancers is associated with unnecessary risks of urinary, sexual and 




2.2.5 BARRIERS TO PROSTATE CANCER SCREENING 
Several studies have identified barriers to prostate cancer screening; they 
include: embarrassment,
133,134











 sexual and urinary 
complications of surgery,
138,141
 lack of transportation,
142,143
 and concerns about the 
accuracy of the test results.
133,137,144,145
 Discomfort of the DRE has also been reported to 





 surveyed a convenience sample of 100 black and Caribbean men 
aged 37 to 89 years from three churches in South Miami Dade counties. Eighty percent 
of the men surveyed stated that a dislike of prostate examinations and sexual and 
urinary complications of prostate cancer prevented them from regular screenings. On 
the contrary, Gelfand, Parzuchowdki, Cort & Powell surveyed 613 black men between 
the ages of 40 and 70 on their willingness to undergo DREs.
147
 The findings indicated 
that negative beliefs toward DRE were not a barrier to participating in prostate cancer 
screenings. Another study conducted in 2003, which included black and Caucasian men, 
examined factors that predicted screening practices of Department of Defense (DoD) 
health care beneficiaries.
148
 The findings indicated that participants in the study had 
higher levels of self-efficacy and perceived benefits of prostate cancer screening. There 




men; black men were less likely to screen regularly for prostate cancer. Similar findings 
were identified by Weinrich, Reynold, Tingen & Starr
16
 who designed a cohort study to 
measure barriers to prostate cancer screening. Barriers identified in the study included: 
embarrassment, mistrust, fear of post-operative complications, access to health care, 
limited knowledge about the disease and abnormal test results. 
In a qualitative study by Jones, Steeves, and Williams,
149
 17 black men were 
interviewed to determine whether or not they intend to screen for prostate cancer. The 
following themes emerged from the study: physician trust; family and friend input; and 
familial history of prostate cancer. These were all regarded as important factors that 
determined whether to screen for prostate cancer or not. Barriers to screening were 
health literacy, limited knowledge, and fear. Carter, Tippett, Anderson & Tameru
150
 
conducted a study to evaluate the impact of prostate cancer education on screening rates 
among 239 black men in rural Black Belt counties in Alabama. The main barrier to 
screening participation was fear of cancer death. Fifty percent of the 239 men reported 
participating in prostate cancer screening, with only 33 percent participating within the 
previous 12 months. Other themes identified as barriers to prostate cancer screening 
included: lack of communication with others concerning their health and the fear of 
death associated with prostate cancer. 
Using several focus groups, a 2001 study assessed psychosocial factors that 
influence screening behaviors with black men and women.
151
 The sample size consisted 
of 19 males and 26 females. Findings from this study indicated that increasing age was 




distrust of the health care system, perceiving cancer as a death sentence, and attributing 
the presence of symptoms as an initial reason for screening for cancer. Compared to 
women, men were also less likely to initiate screening for cancers on their own and 
depended on close females for encouragement. These findings support the impact of 
beliefs and customs on decision-making of black men to partake in cancer screening.  
In a recent qualitative study with 20 men between the ages of 40 and older, 
Conde et al.
152
 reported similar findings. Results suggested that the following factors 
have an impact on participating in prostate cancer screening: reluctance to seek medical 
care, fear of cancer diagnosis, financial issues, time constraints, lack of awareness of the 
need to screen and embarrassment. Both patient and physician barriers to prostate 
cancer screening were studied from the physicians’ perspective 
153
 This in-depth 
qualitative study was conducted in 18 purposively-sampled primary care physicians. 
Barriers of prostate cancer screening were identified using both interviews and patient 
charts in a bid to aid physician recall. Patient comorbidities, prior refusal of care and 
limited education/health literacy were identified as patient barriers. However, 
forgetfulness, lack of time and negative attitude toward prostate cancer screening were 
identified as physician barriers. Other barriers included lack of regular physician and a 
reduced appreciation for the value of preventative care, due to tradition and 
culture.
151,154,155







2.2.5.1 DISCOMFORT OF DIGITAL RECTAL EXAMINATIONS (DREs) 
Discomfort associated with the DRE has been identified as one of the most 
significant factors associated with screening participation, especially among black men. 
The digital rectal examination involves a procedure whereby a doctor puts a gloved 
finger into the rectum to examine the prostate gland, which lies directly in front of the 
rectal wall. This procedure is done to determine if there are growths present in the rectal 
cavity. It usually lasts up to 15 seconds.
156
 One study indicated that the procedure is 
probably no more painful than the extraction of a blood sample for PSA testing but it is 






 examined the beliefs of black men regarding prostate cancer and found 
that while there was a high perceived seriousness of the disease among the participants, 
the discomfort of rectal examinations and concerns about sexual problems were listed as 
important barriers to screening. A cross-sectional study by Woods et al.
52
 to investigate 
what social ecological factors are predictive of PSA and DRE revealed that one of the 
major self-reported barriers to screening was comfort level. About 75.4 percent of the 
black men in the study (N=276) indicated that they were uncomfortable having a rectal 
exam, even though they were aware that “the finger” was how the physician checked 
for prostate cancer during DREs. Similar findings were reported in a focus group study 
conducted in 2006.
134
 The findings revealed that black men did not participate in 
prostate cancer screening for several reasons such as fear of invasion of their privacy 




Masculinity has been linked to issues such as discomfort, embarrassment, or beliefs that 
the exam is related to homosexuality.
1,35,141,158
 These findings suggests that something 
about black men in particular is associated with their reluctance to undergo DREs, 
however, there is some evidence that these beliefs about DREs are not held by black 
men alone.
159
 The fear and embarrassment of having a DRE among black men has been 
largely documented as a significant barrier to participating in screenings.
1,35,141,160
 A 
study by Consedine et al.
159
 found that even after controlling for age, income, and 
education, black men reported more fear and anxiety of DREs compared to their white 
participants, which impacts their lower rates of screening. This finding is consistent 
with reports showing that men who were more afraid and anxious were more likely to 
drop out of screening programs.
40,161
 
Another study revealed that younger, less-educated, and low-income men were 
more likely to have a more unfavorable attitude towards DRE than older, well-educated, 
and high-income men.
147
 This study was designed to explore the relationship (N=613) 
between black men’s attitude towards DRE and their participation in screening for 
prostate cancer. The study also found that black men were not opposed to DRE when it 
is considered a routine part of physical examinations.  
To better aid in counseling and patient information for prostate cancer screening, 
Ramalho and collegeaues
34
 assessed 200 patients’ perception of pain and discomfort 
during DREs. The study also assessed the impact of discomfort on potential future 
screening, and if the discomfort patients undergo can be alleviated by emptying the 




participants’ intention to have a prostate exam in the future. The incidence of pain, 
urinary or bowel urgency during DRE was not significantly reduced by urinating 
immediately before the examination. 
Conversely, Nagler et al.
162
 surveyed 12,580 health men undergoing PSA-only 
population-based screening whether they would still undergo screening if a DRE was 
involved. The survey responses were modeled to examine whether undergoing a DRE 
would reduce screening participation, detection rates, or both. Results from the study 
showed that only 78 percent of men would participate in the screening if it included 
both a DRE and PSA. By inference, 7,800 men of a theoretical population of 10,000 
would participate in a screening that included both DRE and PSA. Using these figures, 
the positive screening rate (PSA ≥ 4.0 ng/mL or abnormal DRE) would have been 
2,013, with 473 prostate cancer cases and 1,540 negative biopsies. All 10,000 men 
would have undergone PSA-only screenings and the positive screening rate (PSA ≥ 4.0 
ng/mL) would have been 1,480, with 499 prostate cancer cases and 980 negative 
biopsies. Thus, twenty-seven more cancers would have been detected via PSA-only 
screenings and 560 fewer numbers of negative biopsies would have been performed. 
Programs using both DRE and PSA produce more numbers of negative biopsies and 
detect fewer cases of prostate cancer. As a result, Nagler et al. suggested that DREs be 
omitted and only PSA tests be included during future mass screening efforts. 
 Much on the research on prostate cancer beliefs, knowledge and screening finds 
that black men perceive DREs as embarrassing, uncomfortable, inconvenient and 
emasculating,
32-34,52,87,163






 Findings from the literature warrant the need for culturally-
sensitive education and tailored resources to address the growing prostate cancer 
epidemic in black males and much more importantly, a need to address these barriers 
through targeted efforts that will increase black men’s participation in prostate cancer 
screening. 
 
2.2.6 DEMOGRAPHIC/PERSONAL FACTORS AND PROSTATE CANCER 
SCREENING 
 Several demographic factors have been shown to influence intention to screen 
for prostate cancer. The factors include age, marital status, family history, access to 




2.2.6.1 AGE  
Age is a known risk factor for prostate cancer as well as for other hereditary 
cancers.
43,165
 It has also been found to be positively correlated with intention to screen 
for prostate cancer.
165-167
 For example, in a study of at-risk relatives for prostate cancer, 
intention to undergo screening positively correlated with younger age and perceived 
risk.
158
 This inverse relationship between age and intention could be potentially 
explained by older men being more skeptical due to cultural factors or fatalism 
associated with developing prostate cancer.
165
 In addition, older patients have been 
shown to prefer to leave their medical decisions to their physicians and as such play a 
less active role in medical decision-making.
168








According to the American Cancer Society
51
 the risk of developing prostate 
cancer for African men with no family history of diseases begins at 40, while the risk 
for Caucasian males begins at 50. Studies have shown that prostate cancer is more 
aggressive in younger men and that these men who present with metastatic forms of the 
disease are likely to be black.
170,171
 Assessing the association between age at diagnosis, 
treatment and survival outcomes in men diagnosed with prostate cancer was the basis of 
a study by Lin, Porter & Montgomery.
171
 The NCI SEER database was used to identify 
men who were diagnosed with prostate cancer between 1988 and 2003, and who were 
aged between 35 – 74 years. Younger men (aged 35 – 44) were found to be at the 
highest risk of all cause and cancer-specific death and were most likely to present with 
aggressive forms of the cancer. 
 
2.2.6.2 ETHNICITY  
The racial/ethnic group categorized as “blacks” are blacks of African origin. 
Africans from the Caribbean and West Africa were imported as slaves, although some 
arrived as slaves bound in contracts to whites. While some blacks later became free to 
settle, the term “slavery” became nearly synonymous to the African culture.
172
  Blacks 
have since had a more heterogeneous pool than their source population in Africa as a 
result of interbreeding and intermarriage with Europeans and Native Americans of 
diverse ethnic backgrounds.
173




U.S. black population as a result of Africans brought in from the slave era.
76
 Data 
collected in 2005 showed that majority of the U.S. foreign-born blacks were born in the 
Caribbean, Africa, South America and Europe, with a small number from Canada.
174
 
Between 1960 and 1980, the population of foreign-born blacks rose nearly seven fold, 
and more than tripled between 1980 and 2005.
174
 As a result, foreign-born blacks 
continue to change the ethnic composition of the black population in the U.S.
76
 
Ethnicity has been cited as one of the major risk factors of prostate cancer in 
black men.
76,158,175
 According to the U.S. Department of Health and Human Services 
report and evidence-based recommendations,
176
 “Black men have the highest relative 
risk of dying from prostate cancer.” The Prostate Cancer Outcomes Study (PCOS) by 
the National Cancer Institute showed that black men were at higher risk of developing 
prostate cancer than Hispanic or Caucasian men.
91
 According to the result summary 
findings from the Behavioral Risk Factor Surveillance System Survey (a nationally-
representative database of preventative and health risk behaviors), black men have 
much higher prevalence rates of prostate cancer compared to Caucasian or Hispanic 
men.
177
 These findings are evidence of a prolonged trend of prostate cancer disparity 
among black men.  
Research has shown that while prostate cancer screening rates may vary among 
the major ethnic group, black men are less likely to undergo prostate cancer 
screening.
116,158,178
 A study conducted in 2006 examined the differences in prostate 
cancer screening rates among samples of 44 men from each of the seven ethnic groups 




English-speaking Caribbean, Haitians, Dominicans, Puerto Ricans, and Eastern 
Europeans).
116
 Findings from the study show that prostate cancer screening rates, 
especially DREs are lower among African Americans. Similar findings have been 





Income level is associated with numerous health related behaviors. Having a 
higher income has been linked to increased participation in prostate cancer 
screening.
164,181,182
 A cross-sectional study conducted in 2002 found that participants 
with lower income were more concerned about insurance coverage and were therefore 
less likely to engage in prostate cancer screening.
183
 In another study conducted in 2010 
to examine demographic and lifestyle factors that influenced black men’s intention to 
screen for prostate cancer, income level was a positive predictor of screening.
164
 The 
tendency for higher income level persons to engage in more health-promoting lifestyle 





Research has shown a positive correlation between level of education and 
intention to screen for cancers in various populations.
13,164,185
 For example, a 
randomized trial conducted by Lerman et al.
185
 to investigate racial differences on 
BRCA1 genetic testing, women with more than a high school education were more 




another related study, Lerman et al.
186
 found that women who underwent genetic testing 
were more likely to have both health insurance and more education that those who 
declined. Lower level of education can therefore be considered as a barrier to screening. 
This may be partly due to the limited ability of some individuals to understand the 
information presented to them about screening.
185
 Additionally, research has shown that 
highly educated people tend to be more proactive about medical decisions than those 
with low education levels.
168
 
Intention to screen for prostate cancer was the outcome measure in a Canadian 
study examining current and future use of DRE and PSA testing.
187
 The study reported 
that education was positively correlated with intention to be screened by DRE while 
testing with PSA did not increase with education. However, Edwards, Johnson, Mason 
& Boyle
188
 found education to be positively correlated with intention to screen for 
prostate cancer, regardless of which mode of screening was used, among African 
American men. Other studies have suggested positive correlations and have indicated 





2.2.6.5 FAMILY HISTORY 
 A positive family history of prostate cancer has been shown to be the strongest 
risk factor of its eventual development.
190
 In fact, it appears to correlate with perceived 
risk as well. Evidence from twin studies suggests that at least some of this increased risk 
is due to a shared genetic predisposition.
71




prostate cancer rates were greater among monozygotic/identical (27.1%) twins than 
among dizygotic/fraternal (7.1%) twins.
71
 Furthermore, genetic influences were 
estimated to account for 57 percent of the variance in twin liability. Similar results from 
studies using twin registries from Denmark, Sweden, and Finland calculated the 
heritability of prostate cancer to be 42 percent.
191
 
 The term “heritable” refers to predispositions or characteristics that can be 
passed down from parents to their children. The family history of a particular disease 
can thus be used to estimate heritable risk. Since many relatives of prostate cancer do 
not develop the disease nor carry the genetic predisposition, it is sometimes inaccurate 
to estimate the risk of prostate cancer via familial history.
192
 In some families, the 
inheritance trait is similar to a dominant one. This is referred to as ‘hereditary prostate 
cancer’ and it is defined as: two or more first- or second-degree relatives with prostate 
cancer under the age of fifty-five years; a group of three or more first-degree relatives 
with prostate cancer, as well as prostate cancer in each of the three generations in either 
maternal or paternal relatives.
73
 The increase in number of affected relatives has been 
shown to increase the risk level of prostate cancer. For example, Nieder et al.
71
 
observed that the chances of developing prostate cancer is twice as likely in an 
individual with one first-degree relative than in a man in the general population.
71
 In 
addition, a Utah Population Database study found that first-degree relatives of persons 
with prostate cancer were more likely to develop prostate cancer.
193
 
 Known family history has been found to be predictive of intention to undergo 
prostate cancer screening. For example, Lerman et al.
194




likely to undergo genetic testing for breast cancer as the number of first-degree relatives 
known to have breast cancer increases. Another study on attitude toward prostate cancer 
genetic testing found that family history of prostate cancer was an essential factor 
associated with interest in testing.
166
 Jacobsen et al.
195
 also found this to be true in a 
study of prostate cancer screening behavior and family history, where family history 
correlated with perceived susceptibility.  
 
2.2.6.6 ACCESS TO HEALTH CARE PROVIDERS 
 Participation in prostate cancer screening can be improved by access to and 
utilization of the health care system. In a study by Talcott et al.,
196
 207 North Carolinian 
black men and 348 Caucasian men who had been recently diagnosed with prostate 
cancer were surveyed to better understand the impact of factors such as attitudes and 
beliefs regarding prostate cancer screening and diagnosis, socioeconomic status, 
demographic factors, and health care access on racial disparity. The findings from the 
study showed that black men had limited access to healthcare resources (including 
primary care physicians) and when they did have access to care, it resulted in distrustful 
and irregular interactions with health care providers. The authors reported that 
compared to Caucasian participants, black participants were more distrustful of 
physicians and less likely to accept conventional medical treatments. Barriers to timely 
diagnosis and quality care, including physician mistrust, appear to arise from limited 
access to and continuity of medical care as a result of lack of insurance and regular 




cancer screening tests than whites, although their (black males) physicians were less 
likely to honor those requests. 
 McDougall, Adams & Voelmeck
197
 conducted a study on black men who 
participated in a screening initiative and completed the 22-item Barriers to Prostate 
Cancer Checklist. A total of 43 men received a DRE and PSA. The average age of the 
participants was 56.4 (range = 45 – 76) years; 47 percent were compliant with the ACS 
annual screening guidelines for high-risk individuals. Based on their results, participants 
ranked “takes time to get an appointment” as one of the problematic issues encountered. 
 
2.2.6.7 INSURANCE AND INCOME CONCERNS 
 Health insurance status has been shown to be one of the most significant barriers 
to screening.
183
 In the study conducted in 2002 to examine concerns about 
discrimination in the BRCA1/2 testing population, 62 percent of people who declined 
screening did so because of health insurance concerns.
183
 There was also a significant 
difference between income level and the decision-making process associated with 
screening. Steele et al.
10
 examined prostate cancer screening practices of older black 
men. In their study, income was found to be statistically significant with intention to 
screen for prostate cancer, as men who had income levels above $25,000 per year were 







2.3 PROSTATE CANCER DISPARITIES IN BLACK MEN 
A review of the literature indicates that, despite attempts to increase awareness 
of and access to prostate cancer screening, there have been delays among black men to 
utilize primary health care services. Black men often forgo preventative services, 
choosing instead to delay treatment, or avoid health care altogether.
198
 According to the 
American Cancer Society,
1
 while all men are presumed to be at risk for prostate cancer, 
race has been a nagging factor in predicting the likelihood for developing the disease.  
Several studies have shown that black men are less likely to get screened for prostate 
cancer
10,119
 when compared with Caucasian men. This disparity has partly been due to 
prostate cancer being diagnosed in its latter stages in black men, which suggests delays 
in screening for this group.
89
 
Racial disparities in health in the U.S. are well known, and federal initiatives 
have been undertaken to reduce these disparities. In 1985, the Report of the Secretary’s 
Task Force on black and Minority Health was released. The report was generated to 
create an awareness of racial disparities and health. The findings from the report 




The disparities between blacks and Caucasians in cancer mortality has widened 
over the years for all cancers combined and for major cancers.
184
 Generally, men have 
less than a one in two lifetime risk of developing cancer, but this risk increases 
dramatically for black men.
51
 Cancer is the first or second leading cause of death in 
black men aged 45 and older.
46




a higher incidence and mortality rate, have a lower five-year survival rate, are less likely 
to undergo screening tests, are less likely cancer diagnosed at early or localized stages, 
and have less access to appropriate and timely care.
200
 Prostate cancer is the most 
commonly diagnosed cancer and the leading cause of cancer death among black men.
51
  
In general, black men with prostate cancer tend not to only present with higher-
risk disease characteristics but also have a higher likelihood of disease recurrence after 
treatment and a higher prostate cancer-specific mortality.
57-60
 Another study using the 
Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) database to 
examine the presenting characteristics in men with prostate cancer, found that black 
men presented at a younger age with a higher PSA (Prostate-Specific Antigen) and 
more aggressive forms of the cancer.,
59
 These findings have been supported by other 
cohort studies. The population-based Cancer Outcomes Study (PCOS) enrolled 3,173 
men diagnosed with prostate cancer between 1994 and 1995. Race was found to be a 
significant predictor of presenting with advanced prostate cancer, even after controlling 
for socioeconomic status, pathologic factors, clinical factors, and demographics.
61
 
Although the black race has been identified as a probable adverse cause for certain 




Other studies have been carried out to examine racial differences in outcomes 
after treatment. Cohen et al.
67
 examined data of over 25,000 from the SEER-Medicare 
database that were diagnosed with prostate cancer between 1986 and 1998. They found 




similar study by Godley et al.
68
 found that black men with prostate cancer had overall 
lower survival time, irrespective of treatment and even after controlling for several 
factors. 
Racism, as a type of stressor, has been linked to prostate cancer. For example, 
Ellison et al.
201
 have suggested that environmental stressors such as racism may have a 
deleterious impact on prostate cancer. This conceptual framework has been supported 
by several researchers. One study
202
 found that perceived stress was significantly 
associated with abnormal PSA results. In addition, both perceived and actual racial 
discrimination had similar associations with PSA levels in black men. Thus, while 
environmental stressors and perceptions of stress can contribute to poor health 
outcomes in black men, perceived racism is more likely to negatively impact the quality 
of life among black men.
203,204
 However, there is a dearth of research on comparing the 
effect of socio-environmental stressors on quality of life between black and Caucasian 
men diagnosed with prostate cancer. 
One theory posited by researchers as the cause of the mortality gap seen in black 
men is the genetic predisposition theory. It has been speculated that black men have 
higher genetic vulnerability and that, compared to other racial groups; prostate cancer 
may be more biologically aggressive in black men.
24-26
 A study conducted in 2010 to 
examine autopsy data of men who had died of prostate cancer from 3 specific age 
groups (20-29, 30-39, and 40-49 years) showed that there was no difference in the age 
of onset of the disease between black and white men.
205
 Findings from The SEER 




metastatic form of the disease.
205
 A follow–up done 10 years later confirmed that 
advanced or metastatic forms of the disease occurred up to four times more in black 
men.
206
 A separate study
31
 found that tumors from prostate biopsies in black men 
expressed higher levels of biomarkers, indicating the aggressiveness of the disease. 
Epidemiologic studies of men with similar genetic backgrounds have linked this genetic 
component to the high incidence and mortality rate seen in black men.
77
 For example, 
several studies
207-209
 have associated the chromosome 8q24 variants with prostate 
cancer which are more expressed in black men. These findings suggest that genetic 
predisposition may contribute to the higher incidence and mortality rates seen in black 
men. 
Generally, minority groups and those with low socioeconomic status (SES) are 
less likely to have access to preventive services. They are also less likely to receive 
cancer screening services, and present with cancer at later stages than other groups. 
210,211
 Racial disparities in health – in this case racial disparities in prostate cancer – can 
be characterized as an outcome of racism.  
Poor access to care or lower quality care is another theory that has been used to 
explain disparity gaps seen in black men with prostate cancer. For example, the 2002 
Institute of Medicine report, Unequal Treatment: Confronting Racial and Ethnic 
Disparities in Health Care, found that after controlling for factors such as patients’ 
insurance status and income, racial minorities receive lower-quality health care than 
whites. Several studies have documented the fact that in addition to having lower SES 






 Several studies have shown that black men are less likely to 
get screened for prostate cancer
10,119
 when compared with Caucasian men. The 
American Cancer Society (ACS) recommends annual prostate cancer screening in high-
risk patients, after informed consent has been provided to the male patients.
1
 Despite 
these recommendations, a National Health Interview Survey in 2012 demonstrated that 
only one in three men over 50 years of age had had a PSA test done in the prior year.
215
 




There are studies that have shown the association between economic status and 
disease processes.
217,218
 Minorities, especially black men, often receive “watchful 
waiting” instead of definitive treatment, such as surgery.
219
 Several studies have shown 
that when compared to white men, black men were more likely to receive no treatment, 
and less likely to receive definite prostate cancer treatment.
220-222
 Researchers also 
compared the use of radical prostatectomy versus conservative treatments (androgen 
deprivation or watchful waiting) among black men and non-Hispanic white men. The 
results from this study showed that black men with more aggressive cancers were more 
likely to be treated conservatively than with radical prostatectomy.
61
 Thus, there is 
evidence showing that black men may not be receiving the same level of treatment for 
their prostate cancer as their white counterparts. Lack of access to specific treatment 





There have been implications found between literacy levels and health seeking 
behaviors among black men. The U.S. has been plagued with a low level of health 
literacy for a long time. In 1993, nearly one-quarter of adults in the U.S. (between 40 
and 44 million people) lack adequate basic reading skills.
223
 About 50 million had 
marginal literacy skills, meaning they could read uncomplicated text but found it hard to 
read or comprehend lengthy and more difficult documents. There were no significant 
changes seen in the average literacy levels of Americans when a follow-up study was 
carried out a decade later in 2003 by Kunter et al.
224
  
 Eighty percent of blacks have been reported to have difficulty reading and 
comprehending health-related materials, a term known as health literacy.
225
 Low 





 found that black men who presented with advanced prostate cancer had literacy 
levels below sixth grade. The authors concluded that low levels of literacy were a 
barrier to early prostate cancer screening. Therefore, interventions in the form of written 
materials and instruments aimed at promoting health behaviors should be developed at a 
level that is both readable and comprehensible by the targeted population. 
 
2.3.1 ENVIRONMENT 
 Approximately 28.8 percent of Americans live in rural communities, with 34 
states having more than half their populations living in rural areas or in towns under a 
population of 50,000.
227
 Regardless of what indicator (per capita income, educational 




counterparts. Inhabitants of rural areas are often limited by geographical, economic and 
cultural barriers which in turn limits access to health care.
228
 People living in rural areas 
experience wide health disparity gaps compared to urban populations.
229
 Health care 
resources in most rural areas in the U.S have long been considered limited.
230,231
 
Previous research has shown that cancer tends to be diagnosed at more advanced stages 
among rural residents, indicating that this population is less likely to receive timely 
cancer screening tests.
232,233
 Indeed, there are differences in cancer staging among rural 
populations. In a study by Higginbotham, Moulder & Currier,
234
 blacks residing in rural 
areas presented cancers at late stages. Similar findings were found in a study by Liff, 
Chow & Greenberg
233
 who documented that rural dwellers were likely to have less 
access to, or utilization of, early cancer detection programs and quality medical care. 
Reding et al.
230
 suggested that factors such as geography and distance act as 
socioeconomic and cultural barriers that could eventually lead to wider health disparity 
gaps.  
Currently, the PLCO Screening Trial and the Prostate Cancer Intervention 
Versus Observation Trial is ongoing and the results will not be made available until 
2015. The expected results from this study will provide information on the efficacy of 
prostate cancer screening.
235
 The present health care policy issues and controversies 
surrounding screening could have a major impact on prostate cancer screening and 
screening behaviors of men, especially those residing within rural communities. As 
succinctly stated by Smedley et al.,
236
 “Health status disparities observed between many 




interplay of social, economic, biologic and environmental factors.”
236
 Because poverty 
is considered a regional problem as it interacts with health care at the rural level, it is 
important that awareness of health issues such as prostate cancer screening is evaluated 
in men, especially black men who reside in rural areas. 
 
2.3.2 SOCIOCULTURAL BARRIERS  
 Although there has been an increase in literature addressing informed decision 
making for cancer screening, few studies have concentrated on understanding 
sociocultural factors that impact the perceptions of black men about prostate 
cancer.
27,237,238
 Sociocultural barriers in black men have been attributed to 
underutilization of prostate cancer screening tests. The effect of culture on attitudes and 
behaviors as it pertains to health is well known and has been recognized for many 
years.
239,240
 According to the sociocultural perspectives, our behaviors are not only 
shaped by prior learning experiences, but also by the social or cultural context of the 
behavior. 
A study conducted to identify personal factors related to black men's prostate 
cancer screening behavior revealed that attitudes, social influences, instrumental beliefs, 
and behavioral intentions were high among black men while perceived susceptibility, 
perceived severity, and knowledge about prostate cancer were low.
117
 There are several 
beliefs and attitudes, both accurate and erroneous, about prostate cancer screening that 
can hinder screening participation in black men. In order to significantly increase 




attitudes, beliefs, and knowledge levels of young black men regarding prostate cancer 
and screening. 
 
2.3.2.1 PROSTATE CANCER SCREENING BELIEFS 
 Studies have shown that cultural beliefs, customary practices, and experiences of 
black men are possible barriers to participating in screening.
160
 For example, studies 
suggest that black men are more likely to hold fatalistic beliefs.
241,242
 Fatalism refers to 
the beliefs held by an individual when they regard certain events as beyond their 
control.
242
 Studies have shown that less educated participants are more likely to 
embrace fatalistic beliefs concerning cancer.
243
 Fatalism in African Americans is 
regarded as one of the major reason for decreased participation in health-promoting 
activities. It is believed that these fatalistic beliefs change over time as African 
Americans face the challenges of the disparity gaps in health care. Fatalism has also 
been shown to be more common among African American men.
244
  
Cancer fatalism, on the other hand, refers to the perception that cancer is 
inevitable regardless of a person’s preventive actions against it.
245
 Poverty has been 
considered as the primary reason for fatalistic beliefs among African Americans,
246
 
while other  factors such as inferior health care and perceived discrimination may also 
be contributory factors to cancer fatalism among African Americans.
136
 A study by 
Underwood
244
 examined the degree to which learned helplessness impacted cancer risk-
reduction and early detection behaviors in African American men. A total of 236 




five-part instrument assessing perceptions of learned helplessness as it relates to 
participation in early cancer detection practices. Thirty-six percent of the participants 
perceived themselves to be helpless regarding control of their health. Three out of four 
participants believed that even if screening recommendations were routinely followed, 
deaths from cancer would not be reduced. Also, men who perceived themselves as 
helpless in regard to their health status were less likely to participate in early detection 
practices or cancer risk-reduction. Overall, men within the group expressed that good 
health was a matter of chance and that they had little or no control over their health 
status.  
 Another study conducted in 2006 compared beliefs concerning prostate cancer 
etiology and risk, screening routines, and shared decision-making among black, 
Hispanic, and non-Hispanic white men and women.
247
 The participants were recruited 
from primary care settings and included 33 black, 35 Hispanic, and 22 non-Hispanic 
white men and women. Risk factors identified from the study included hereditary, age, 
race, sexual activity, and other lifestyle influences. Unlike the Hispanic and non-
Hispanic male participants, black men were acutely aware of the health risks of prostate 
cancer. Another important finding was that, in addition to expressing collective risk of 
prostate cancer, black participants’ approach to health protection was more community 
focused to improving screening rates in their immediate environment.  
 Contrary to other study designs, Richardson, Webster & Fields
248
 not only 
assessed knowledge and beliefs of prostate cancer among a cohort of low-SES black 




health decisions and behaviors. Both sociocultural and psychological barriers such as 
myths and lack of adequate knowledge about prostate health and cancer, fear, apathy 
and denial were identified by participants. These barriers were listed as validated 
reasons for not participating in prostate cancer screening services. In addition, 
knowledge gaps and attitudinal barriers to early detection of prostate cancer were 
believed to be widened by socioeconomic disadvantages. 
 The studies identified from the literature assessing prostate cancer screening 
beliefs among black men employed methodologies that allowed for discussion of these 
factors. Culturally relevant educational interventions are needed to address these 
barriers that affect participation in preventive behaviors, like prostate cancer screening.  
 
2.3.2.2 PROSTATE CANCER KNOWLEDGE 
 Research examining prostate cancer knowledge among black men has shown a 
deficit of knowledge in this very high-risk group.
119,215,249
 This is not unexpected given 
the lack of agreement within the medical community about the benefits of screening, 
lack of trust of physicians and access to screening.
114,250
 These factors have been 
associated with the reluctance of black men to participate in cancer control and 
screening programs.
250
 Lack of uniform guidelines and the controversy surrounding 
prostate cancer screening has spurred researchers into exploring informed decision-





 assessed prostate cancer knowledge among low-income men. 




factors and possible signs of prostate cancer. Nearly 48 percent of the respondents could 
not correctly identify signs of prostate cancer and about 39 percent incorrectly identified 
any risk factor. A comparison of levels of prostate cancer knowledge between black 
men and Caucasian men was also studied by Demark-Wahnefried et al.
119
 The 
participants were selected from a sample of men participating in a nationwide prostate 
cancer awareness screening campaign. The study revealed that 68 percent of men 
reported their risk of prostate cancer as equal to that of other men. The same responses 
were recorded for both black men and Caucasian men. Weinrich et al.
14
 attributed the 
lack of knowledge regarding prostate cancer screening to racial differences in incidence 
and mortality of prostate cancer. The findings from this study showed that only 14 
percent of the black men showed a high level of knowledge about prostate cancer. The 
knowledge gap existing among black and Caucasian men has also been documented by 
Barber et al.
28
 Black men showed significantly lower levels of knowledge than 
Caucasian men. In addition, black men were less likely than Caucasian men to correctly 
distinguish race and family history as risk factors of prostate cancer.  
Agho and Lewis
253
 assessed actual and perceived knowledge of prostate cancer 
in blacks. The aim of the study was to explore the association between age, income, and 
education on perceived and actual knowledge of prostate cancer. A secondary aim was 
to examine the correlation between knowledge of prostate cancer screening and 
participation in prostate cancer screening activities. The participants consisted of a 
nonrandom sample of 108 black men recruited from local churches, barbershops, and 




approximately 56 percent reported earning a yearly income lower than $40,000 and 39 
percent had more than a high school education. Participants scored less than 70 percent 
on 15 of the 21 items. A statistically significant difference was found between younger 
respondents (those less than 40 years of age) and those who older than 40 years in terms 
of actual knowledge of prostate cancer (p=.047). There was no difference in perceived 
knowledge of prostate cancer. Overall, actual knowledge of prostate cancer was 
negatively correlated with age, income and education. A moderately strong positive 
correlation was observed between the use of prostate cancer screening services and 
actual knowledge of prostate cancer (r= 0.47, p < .001) as well as between the use of 
prostate cancer screening services and perceived knowledge of prostate cancer (r=0.55, 
p<0.001).  
 
 In contrast, a cross sectional study by Ashford et al.
254
 did not identify a 
significant correlation between knowledge of prostate cancer risk factors and self-
reported utilization of prostate cancer screening. This prevalence survey was conducted 
using two samples of black men (N=404), aged 50 – 74 years from clinics drawn from 
Harlem, New York City. In another study, Weinrich et al.
15
 assessed the knowledge 
level of 81 low income Caucasian and black men aged between 40 and 70 years. The 
mean household income of the respondents ranged between $17,668 and $33,333. The 
findings revealed a correlation between total knowledge scores and income. Men who 
reported lower incomes had significantly lower knowledge scores than men with higher 




men attending prostate cancer education seminars were surveyed.
11
 The outcome 
measures were whether a 1-hour educational seminar could cause a change in awareness 
and knowledge of prostate cancer. The results from this study showed that prostate 
cancer awareness and knowledge improved after the 1-hour seminar. 
 Taylor, Shelby, Kerner, Redd & Lynch
21
 conducted telephone interviews with a 
group of 136 men to determine the impact of screening on psychological distress and 
their knowledge of prostate cancer screening. About 34 percent of the participants were 
black, 71.3 percent were married, and more than half of the participants reported having 
a college degree or more education. Participants were administered an 11-item 
knowledge questionnaire prior to screening. The items on the questionnaires were 
aimed at assessing how participants rated the degree to which risk factors such as older 
age, black descent and a family history of prostate cancer were related to developing 
prostate cancer. The questionnaire was re-administered at the end of each screening. 
Results from this study showed that while men had an understanding of the risk factors 
for prostate cancer (M = 3.3, SD = 0.64), knowledge levels did not increase 
significantly after prostate cancer screening and psychological distress associated with 
prostate cancer screening decreased upon receipt of a negative test result. 
The knowledge, attitudes, and screening practices of older men (≥ 50 years) 
regarding prostate cancer were assessed in a study conducted in 2009.
10
 The following 
items were measured: self-perceived risk of developing prostate cancer, knowledge of 
existing screening test for prostate cancer, whether participants had received a 




The survey consisted of a random-digit-dialed monthly statewide telephone survey 
which employed the use of a complex multistage design. Of the 721 black men 
surveyed, 42 percent perceived themselves to have a “medium to low” risk, and 18 
percent as having “no” risk, while about 31 percent responded as “don’t know/not 
sure.” Also, men aged 70 years and older, with less education and who earned less than 
$25000 yearly were significantly more likely to perceive themselves as “medium to 
low” risk. Finally, lower knowledge levels of prostate cancer screening were found in 
men who indicated that they were “medium to low” risk. Findings such as these are 
indicative of the work that still needs to be done among black males, especially those 
with lower incomes, to make them aware of their risk and the importance of prostate 
cancer screening, when necessary. 
Magnus
255
 conducted a study in 528 multiethnic black men in the metropolitan 
area of Miami and Fort Lauderdale, FL. to assess prostate cancer knowledge. The men 
included in the study were recruited via barbershops as they waited to be seen by their 
barbers. Approximately 19.1 percent of respondents answered 80 percent of questions 
correctly, and 7.1 percent answered all the questions correctly. While there was no 
significant difference in knowledge levels among the ethnic groups, the findings from 
the study show that certain groups will benefit from more information regarding the 
benefits and risk of prostate cancer prevention. 
A correlation design to test the impact of prostate cancer knowledge on cancer 
screening was the main focus of a study by Weinrich et al.
14
 The sample used in the 




prostate cancer. Prostate cancer knowledge was measured with a questionnaire prior to 
a community-based educational program. After the intervention, men were given 
referrals to their primary physicians for a free prostate cancer screening. Men who had 
high knowledge scores were twice more likely to undergo free prostate cancer screening 
that than those with lower knowledge scores. The positive predictors of participation 
were ethnicity, income, urinary symptoms, and educational intervention. Using a North 
Carolina cancer registry to identify participants, 207 black and Caucasian men who 
were recently diagnosed with prostate cancer were enrolled in a study.
196
 This study was 
designed to explore patient factors that account for some of the disparities seen in 
cancer outcomes. The findings showed that while African men in North Carolina were 
aware of their increased susceptibility to prostate cancer, they had less access to 
healthcare and report lower socioeconomic status compared to their Caucasian 
counterparts.  
Most studies have consistently shown a low level of knowledge among black 
men regarding prostate cancer and prostate cancer screening.
15,118,137,253
 A majority of 
these studies focused on several knowledge areas such as: incidence, prevalence, risk 
factors, signs and symptoms, relative risk, anatomy and function of the prostate gland, 
screening and early detection options, treatment availability, and side effects associated 
with treatment. Regardless of the various methods used, a commonality exists between 
these studies of assessing prostate cancer knowledge in black men: black men are more 




however, that while most of these studies assessed knowledge levels in men over 40 
years of age, little is known about knowledge in younger black adult males. 
Thus, findings from the literature suggest that income, age, positive family 
history, education, access to care may significantly affect an individual’s knowledge 
about prostate cancer screening.
11,15,164,196,256
 Knowledge of prostate cancer and prostate 





2.4 THEORETICAL MODELS USED TO EXPLAIN PROSTATE CANCER 
SCREENING BEHAVIORS 
 There are several theories, grounded in social psychology, that have been used 
to explain and understand behavioral responses to health-related issues. Researchers 
have been able to predict individual behavior by examining a set of commonly-held 
beliefs. This is based on the assumption that cultural elements, such as beliefs and value 
systems, are shared across generations and have been shown to have strong influence on 
the cultural practices of an individual.
258
 
Despite the burden of disease and increased mortality in black men, there have 
been few attempts made to explain their health-related behaviors, with respect to 
prostate cancer, using health behavioral theories. Examples of frameworks that have 
been used include: the Health Belief Model
146,259,260
, Preventive Health Model
133,165,261
, 







2.4.1 HEALTH BELIEF MODEL 
 The Health Belief Model (HBM) is a psychological model that attempts to 
explain and predict health behaviors. Developed in 1950s by social psychologists 
Hochbaum, Rosenstock and Kegels, the model was first used in response to the failure 
of a free tuberculosis (TB) health screening program.
265
 HBM is one of the most widely 
used explanatory models in preventative health behaviors.
266
 It has been viewed as one 
of the leading cognitive-based theories in predicting health behaviors.
146,259
 As with 
other theories of health protective behavior, the HBM assumes that motivation for self-
protection comes from the anticipation of a negative health outcome; a positive 
expectation that by taking a recommended action, the individual avoids a negative 
health outcome and that by taking the recommended health action the individual 
prevents or reduces the impact of the outcome.
267,268
 This model focuses on “conscious 
decisions about the utility of specific actions and distinguishes five factors that are 
assumed to determine the adoption of protective action.”
268
 These factors are perceived 
susceptibility to developing a specific health problem, perceived severity of that 
problem, perceived benefits of behavioral actions, perceived barriers and/or possible 
negative consequences of the actions, and specific cues to action such as symptoms, 
media publicity, bodily events, or a health education campaign.
266
 The model assumes 
the preventive action or health protective behavior is most likely to occur when 
perceived severity, susceptibility, and perceived benefits are high, and costs of the 
behavior are low.
266
 The HBM has been used to assess a broad range of health 










 and risky sexual behaviors.
273,274
 Conner and Norman
267
 have identified 
the areas in which the HBM has been used: preventive health behaviors, which include: 
health-promoting (e.g., exercise and diet) and health-risk (e.g., smoking) behaviors as 
well as vaccination and contraceptive practices; sick role behaviors, which refers to 
adherence with recommended medical regimens; and, clinic use, which indicates 
hospital visits for several reasons. This model of self-protective behavior has been well 
supported by research.
266,273,275
 On the other hand, Weinstein
268
 argues that the HBM is 
not a theoretical model, but rather a group of unconnected variables employed to predict 
behavior because the model itself does allow for interaction between its constructs. 
However, the HBM still remains an expectancy-value approach used in health-related 
decision-making.
276
 There is still a spate in the use of HBM in the literature to predict 
health behaviors.  
Goldring, Taylor, Kemeny & Anton
276
 reported that health beliefs account for 
up to 40% of the variance in health protective behavior. In their study, which was 
designed to measure the intentions of inflammatory bowel disease patients to take their 
medications using the HBM, the model accounted for 57.8 percent of the variance in 
medication-taking intention and nearly 32 percent of this variance was accounted for by 
health beliefs. Additionally, higher intention to take medications was predicted by 
higher perception of risk of disease flare-up.
276
 The HBM was also used to assess the 
factors that contribute to a person’s likelihood to obtain genetic testing for cancer.
189
 
Study variables included: perceive disease susceptibility, perceived barriers, medical 




demographic variables. The authors hypothesized that likelihood to undergo testing will 
be closely related to the belief and perception variables and distally related to the 
demographic factors. These hypotheses were supported by the model. 
In a study assessing the intention of 147 black men, who were military health 
care beneficiaries, to undergo prostate cancer screening, age, education and perceived 
benefits all correlated positively with intention.
188
 One study of patients’ intention to 
screen for colon cancer showed that perceived benefits, such as the belief that screening 
will prevent cancer in family members or will outweigh costs were associated with the 
likelihood of an individual engaging in genetic testing for colon cancer.
277
 Another 
focus group study of patients with colorectal cancer found that themes such as 
improving health-related decisions, informing relatives about risk potential and 
providing guidance to physicians for recommendations, were perceived benefits of 
screening. Lerman, Schwartz, Narod & Lynch
278
 found that intention to undergo genetic 
testing for breast cancer correlated positively with perceived benefits of testing and 
increased belief in the importance of benefits. 
With respect to prostate cancer screening, Bloom et al.
158
 applied the HBM to 
describe the extent to which African men are aware of their susceptibility to prostate 
cancer and their perceived risk of the disease based on their race and family history. 
They hypothesized that men with a family history of prostate cancer will have higher 
perceived risk and as a result would be more likely to undergo screening. However, 




increased perceived risk. Similarly, research has shown that black men with positive 




2.4.2 PREVENTIVE HEALTH MODEL 
 The Preventive Health Model (PHM)
133,165
 is a theory-based explanatory 
framework based on Antonovsky’s work on the sense of coherence as a determinant of 
health,
279
 Theory of Reasoned Action,
280
 the Health Belief Model,
281
 and Social 
Cognitive Theory.
282
 The PHM has been useful in explaining intention and adherence to 
screening.
133,283-286
 Preventive health behavior theories postulate that people are highly 
rational in decision-making about health behaviors as long as people consider the 
likelihood that certain health-related events will or will not occur as well as personal 
events associated with the occurrence of the event.
287
 The PHM particularly theorizes 
that both the intention to engage in a preventive health behavior and taking preventive 
action are associated with background factors, psychological representation, social 
support and influence, and program factors.
133
 
 Myers et al.
133
 applied the PHM to assess the receptivity of black men in 
Philadelphia to annual prostate cancer screening. The study found that 69 percent of the 
participants intended to undergo annual prostate cancer screening. In addition, the 
findings showed that most men tended to view prostate cancer screening as reasonable 
and effective for prevention and early detection of prostate cancer. Furthermore, the 
authors reported that almost two-thirds (64%) of the participants did not perceive their 




cancer screening were discomfort and embarrassment, cost and abnormal screening 
results. 
 In another study, Myers et al.
165
 applied the PHM to identify factors associated 
with intention to be tested for prostate cancer risk among black men. Contrary to 
findings from their previous study, 
133
 they found that receptivity to prostate cancer 
screening was related to previous screening history, perceived susceptibility, and 
beliefs. Other studies utilizing the PHM
133,165
 for assessing prostate cancer screening 
behaviors of black men found that socio-demographic and cognitive factors were the 
most significant predictors of intention to screen for prostate cancer. In contrast, 
affective factors such as social support and influence did not significantly predict 
prostate cancer screening among this population. 
 Researchers have theorized that when an individual is aware of the benefits and 
risks of cancer screening, affective behavior may become significant in predicting 
behavior. While Ajzen and Fishbein
288
 emphasized the importance of affect, they placed 
more emphasis on the use of attitude measures that include both instrumental and 
affective behavioral components, such as disease-specific anxiety or apprehension 
related to the actual screening processes. 
 
2.4.3 LIMITATIONS OF PREVIOUS RESEARCH USING HBM AND PHM 
A general limitation of the HBM
265
 and PHM 
133,165
 is that other factors, such as 
cultural, environmental and economic factors, that may influence health behaviors are 








The role of cultural influences on health-related attitudes, beliefs, and practices 
has been well emphasized in the literature. Yet, there has been a shortage of empirical 
research that examines how cultural-related beliefs may impact health related outcomes 
of black men.
290
 In addition, there is a limitation in research based on theoretically 
driven approaches in explaining and predicting the role of cultural beliefs in health-
related behaviors of racial and ethnic minorities, especially black men. 
 Culture is central to specific behaviors and has a relationship on health.
291
 
Lifestyles and behaviors associated with health disparities are often portrayed by 
socioeconomic disadvantage and cultural influences that often occur in tandem.
292
 The 
environment one lives in has also been acknowledged as a factor that contributes to 
health.
293
 Being in an environment determines an individual’s access to goods and 
services, social norms and other factors related to health. While the relationship 
between socioeconomic variables and health-related practices have been examined, 
there is a call for an integrative approach that provides a better interpretation to the way 
culture interferes with social environments. 
 
2.5 THEORY OF REASONED ACTION 
 The theory of reasoned behavior (TRA) is an expectancy-value theory. 
Expectancy-value theories assume that human behavior is rationally guided by logical 
thought processes.
294




subjective norms. According to the TRA (see Figure 2.1), a person’s behavior is 
determined by their attitude towards the behavior, the opinions of important others and 
the level of control they have over the outcome. The attitude toward the behavior can be 
described as the individual’s evaluation, either positive or negative, toward performing 
the behavior. In other words, does the individual believe that performing the behavior is 
good or bad? While this factor relates to the person’s individual beliefs regarding the 
performance of the behavior, the subjective norm relates to the social influences that 
affect the intention to perform the behavior. The advantage of the TRA model is that 
situation-specific, salient, belief-based attitudes (i.e., the perceived consequences of the 




Figure 2.1: Theory of Reasoned Action
44
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According to the TRA, people are likely to have strong intentions to engage in a 
behavior if they have positive attitudes, and strong subjective norms, regarding the 
behavior. However, the relative strength of each of the components of the TRA varies 
across behaviors. Self-report questionnaires are designed to capture people’s beliefs in 




In this study, we will focus on the attitude, subjective norm and intention 
components of TRA model. 
 
2.5.1 ATTITUDE 
 Attitude is described as a ‘learned predisposition’ to respond in a consistently 
favorable or unfavorable manner with respect to a given object.
296
 The applicability of 
the TRA to prostate cancer screening was examined by Berglund, Nilsson & Nordin
179
 
who found that intention to screen for prostate cancer was predicted strongly by the 
attitude component. The aim of the study was to examine intention among men to 
screen for prostate cancer. A total of 1000 men, aged between 40 to 70 years, were 
randomly selected from a population database. Attitude toward prostate cancer 
screening was assessed in two ways: general and belief-based attitude. Attitude was 
found to be the most important predictor, explaining 42 percent of the variance in 
intention to undergo prostate cancer screening. Another study was conducted by Talcott 
et al.
196
 to identify factors associated with increased death rates from prostate cancer 




risk of prostate cancer, the fear and fatalism associated with prostate cancer screening 
delayed participation in screening. In contrast, a quasi-measure of attitude – perceived 
benefits of prostate cancer screening – was statistically significantly associated with 
intention to screen in a study by Kenerson.
262
 These finding were consistent in a 
separate study where black men were found to be more likely to undergo prostate 
cancer screening when they perceived the benefits of prostate cancer screening 
outweighed the barriers to screening. 
297
 Both Tingen et al.
297
 and Price, Colvin & 
Smith
139
 operationally defined perceived benefits as the following categories: peace of 
mind, detection, and early treatment. Theoretically, perceived benefits has been 
included in several health behavior models as an attitudinal construct of expected 




 Cullati, Charvet-Bérard & Perneger
300
 assessed the general attitudes toward and 
factors associated with prostate cancer in a Swiss population. The study found that 
regardless of what type of cancer (be it breast, cervical or prostate), most participants 
had positive attitudes toward screening when it was recommended by a physician. 
Participants with negative attitudes were more likely to be men, rural residents, those 
without a primary physician, and those with no personal history of cancer. Respondents 
who had a doctor visit within the past six months and those who had a history of cancer 
had favorable attitudes toward screening. Findings from this study show that attitudes 








 In a study by Parchment
6
 to examine prostate cancer screening behaviors among 
black men in a Miami county, attitude toward screening was hypothesized to be 
influenced by access to health care, health beliefs about screenings and fear of 
screening. Results from the study revealed that a majority (80%) of the participants 
disliked the idea of screening and feared the consequences of prostate cancer therapy. 
Furthermore, participants who had been diagnosed with prostate cancer purposely 
delayed treatments in order to avoid experiencing the feared effects of treatment. 
 
2.5.2 SUBJECTIVE NORM 
             Subjective norm (SN) is a person’s own estimate of the societal pressure to 
perform or not perform a target behavior.
280
  Subjective norm differs from attitude as it 
is determined by normative beliefs (n), and unlike attitude which is determined by 
behavioral beliefs. Normative beliefs are defined as beliefs that are brought about by 
how other people, who may be in some way important to the person, would like them to 
behave. 
303
 Subjective norm could thus be regarded as the how a person engages in a 
behavior in question as a result of social pressure.
303
 Similar to attitudes, once the 
important individuals have been identified, there must be some evaluations done to 
determine the strength of the normative belief. A person’s motivation to comply (m) 
with each identified individual is measured by asking. “How much do you want to do 




 A qualitative study by Jones, Underwood and Rivers
304
 entailed the impact that 
friends and family have in assisting in decision making regarding prostate cancer 
screening. Results from the study showed that black male participants regarded friends 
and family as credible informal sources of health information; and reported these 
significant referents as sources of encouragement to adopt health lifestyles and engage 
in preventative behaviors, such as health screenings.
304
 
Using the Theory of Reasoned Action, Brubaker and Wickersham 
305
 examined 
factors that are associated with testicular self-examination (TSE). A total of 232 male 
college students completed a questionnaire operationalizing the components of the 
theoretical model. Results from the study showed that attitude and subjective norm 
accounted for 39 percent of the variance in intention to undergo TSE. In this study, 
social influence (SI) will be used as a proxy for subjective norms (SN). 
 
2.5.3 INTENTION  
 Most studies on prostate cancer screening have relied on the actual observed or 
reported behavior, although a handful of studies have measured intention to screen. 
Sometimes referred to as behavioral intention, intention can be an accurate precursor of 
actual behavior. Behavioral intention is conceptualized in the Theory of Reasoned 
Action as an individual’s perception of his or her likelihood of performing a behavior of 
interest.
280
 Given that behavior is under volitional control, intention can be considered 




 Studies of testicular screening behaviors have shown the accuracy and 
usefulness of intention as an alternative to assessing actual behavior. In a survey of 101 
Australian university students aged 18-25 years, intention to undergo testicular self-
examination (TSE) was highly and positively correlated with regular use of TSE 
(r=0.86, p<0.01).
50
 Similar findings were reported in a survey of 116 men aged 17-65 
years, where intention to perform TSE moderately correlated with intention to screen 




2.5.4 STRENGTHS AND LIMITATIONS OF LITERATURE REVIEW 
 Several studies have shown that low participation in prostate cancer screening 
remains a significant burden in the black male population despite decades of research 
showing the importance of screening in preventing morbidity and mortality from 
prostate cancer.
52,306,307
 In comparison, the literature has not identified the factors that 
influence young black men’s attitudes about and intentions to participate in future 
prostate cancer screening.
114
 Furthermore, few studies have specifically addressed 
health disparities in prostate cancer among black men. The application of TRA and 
related measures will not only contribute to understanding the complex concept of 
belief systems from a cultural standpoint, but will also serve to understand the factors 
that drive the intentions of young black men to screen for prostate cancer when it is 






2.5.5 SUMMARY  
This chapter provides a comprehensive review of the literature that supports this 
study. Compared to other ethnic groups in the U.S., the incidence and mortality rates of 
prostate cancer remain higher in black males. Additionally, prostate cancer is detected 
often at more advanced stages in black men. The findings from the literature suggest 
that social, personal, environmental, and cultural factors, such as access to care, 
restricted community exposure, lack of knowledge, fear, income, threat to manhood, 
perceived benefits, knowledge of the disease, perceived barriers, and customary beliefs 
may also affect the ability and willingness of black men to participate in screening 
behaviors.
5,154,160,259,308
 Yet, few studies examine the reasons for the low levels of 
participation of black men in prostate cancer screenings within a theoretically-based 
context. 
 Since the goal of prostate cancer screening is to reduce morbidity and mortality 
associated with prostate cancer, it is therefore critical that strategies are needed to 
increase participation especially in black men. Improving providers’ understanding of 
the factors that predict intention to screen for prostate may facilitate the development of 
educational programs that focus on early detection. The literature review is consistent 
with the attitudinal construct of the TRA model in that a person feels that there are 
benefits to prostate cancer screening or negative consequences associated with 
participating in prostate cancer screening. In addition, knowledge of prostate cancer and 
prostate cancer screening is also believed to be related to prostate cancer screening 




men’s intentions to screen for prostate cancer, 
1,133,164,167
 to our knowledge, these factors 
have not been adequately addressed in the younger black male population. Based on the 
review of the literature, the study model in Figure 2.2 is proposed below to address the 
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2.6 STUDY OBJECTIVES AND HYPOTHESES 
Objectives and Hypotheses 
The specific objectives and hypotheses of this study are: 
 
 
For Dependent Variable “Intention to screen for prostate cancer (I)” 
 
Objective 1A: To determine participants' age, attitude towards prostate cancer 
screening (A), social influence (SI), comfortability with prostate examinations (C), cues 
to action (CA), health screening experience (HS), knowledge regarding prostate cancer 
and prostate cancer screening (K), intention to screen for prostate cancer (I) and other 
demographic/personal factors. 
 
Objective 2A: To explore the predictive ability of age, attitude towards prostate cancer 
screening (A), social influence (SI), comfortability with prostate examinations (C), cues 
to action (CA), health screening experience (HS), and knowledge regarding prostate 
cancer and prostate cancer screening (K), in explaining intention to screen for prostate 
cancer (I) while controlling for demographic/personal factors; 
H1A: Age, A, SI, C, CA, HS, and K will explain a significant amount of variance in I 
while controlling for demographic/personal factors. 
H2A: Age will be a positive and significant predictor of I while controlling for A, SI, 
C, CA, HS, K, and demographic/personal factors. 
H3A: A towards screening for prostate cancer will be a positive and significant 





H4A: SI will be a positive and significant predictor of I while controlling for Age, A, 
C, CA, HS, K, and demographic/personal factors. 
H5A: CA will be a positive and significant predictor of I while controlling for Age, 
A, SI, C, HS, K, and demographic/personal factors. 
H6A: HS will be a positive and significant predictor of I while controlling for Age, 
A, SI, C, CA, K, and demographic/personal factors. 
H7A: SI will be a positive and significant predictor of I while controlling for  Age, A, 
C, CA, HS, K and demographic/personal factors. 
H8A: K will be a positive and significant predictor of I while controlling for Age, A, 
SI, C, CA, HS, and demographic/personal factors. 
 
 
Objective 3A: To determine if participants’ attitude towards screening for prostate 
cancer (A)  is related to age, comfortability with prostate examinations (C), cues to 
action (CA), health screening experience (HS) and knowledge regarding prostate cancer 
and prostate cancer screening (K). 
H9A: There is no difference between A and age. 
H10A: There is no difference between A and C. 
H11A: There is no difference between A and CA. 
H12A: There is no difference between A and HS. 






Objective 4A: To determine if participants’ social influence (SI) is related to age and 
comfortability with prostate examinations (C). 
H14A: There is no difference between SI and age. 
H15A: There is no difference between SI and C. 
 
Objective 5A: To determine if participants’ comfortability with prostate examinations 
(C) is related to age and health screening experience (HS). 
H16A: There is no difference between C and age. 
H17A: There is no difference between C and HS. 
 
Objective 6A: To determine if participants’ cue to action (CA) is related to age. 
H18A: There is no difference between CA and age. 
 
Objective 7A: To determine if participants’ health screening experience (HS) is related 
to age. 
H19A: There is no difference between HS and age. 
 
Objective 8A: To determine if participants’ knowledge regarding prostate cancer and 
screening (K) is related to age, cues to action (CA), health screening experience (HS). 
H20A: There is no difference between K and age. 
H21A: There is no difference between K and CA. 




For Dependent Variable “Prostate cancer risk-reduction behavior (PCB)” 
Objective 1B: To determine participants' age, cues to action (CA), exercise, knowledge 
regarding prostate cancer and prostate cancer screening (K), prostate cancer risk-
reduction behavior (PCB) and other demographic/personal factors. 
 
 
Objective 2B: To explore the predictive ability of age, cues to action (CA), exercise, 
and knowledge regarding prostate cancer and prostate cancer screening (K), in 
explaining prostate cancer risk-reduction behavior (PCB) while controlling for 
demographic/personal factors; 
H1B: Age, CA, Exercise, and K will explain a significant amount of variance in PCB 
while controlling for demographic/personal factors. 
H2B: Age will be a positive and significant predictor of PCB while controlling for 
exercise, K, CA, and demographic/personal factors. 
H3B: CA will be a positive and significant predictor of PCB while controlling for 
age, exercise, K, and demographic/personal factors. 
H4B: Exercise will be a positive and significant predictor of PCB while controlling 
for age, CA, K, and demographic/personal factors. 
H5B: K will be a positive and significant predictor of PCB while controlling for age, 
CA, exercise, and demographic/personal factors 
 
For demographic/personal factors 
Objective 1C: To explore the relationship between A (direct and indirect), SI, C, CA, 






CHAPTER THREE: METHODOLOGY 
The goals of this study were to examine young black men’s intentions to screen 
for prostate cancer when it is recommended by a physician and to examine their 
engagement in prostate cancer risk-reduction behaviors. Constructs from the theory of 
reasoned action (TRA) as well as the additional constructs of comfortability with 
prostate examinations (C), cues to action (CA), health screening experience (HS), 
knowledge regarding prostate cancer and screening (K), age, and demographic/personal 
factors, as described in Chapter Two, were used to address the study objectives. This 
chapter is divided into ten major sections: Study Design, Sample Size Determination, 
Sample Selection, Instrument Development, Study Variables, Survey Pretest, 
Instrument Distribution, Data Analyses, Objectives and Hypotheses Tests, and 
Limitations. 
 
3.1  STUDY DESIGN 
This study employed a cross sectional, non-experimental design. Self-report 
web-survey and paper-pencil instruments were used to measure how behavioral 
intention of young black men is affected by attitude (A), comfortability with prostate 
examinations (C), cues to action (CA), health screening experience (HS), knowledge 
regarding prostate cancer and screening (K), social influence (SI), age and 
demographic/personal factors. In addition, these two modes of data collection were used 
to assess how engagement in prostate cancer risk-reduction behavior is influenced by 











3.2     SAMPLE SIZE DETERMINATION  
To ensure adequate power to decrease the probability of accepting an incorrect 
null hypothesis, sample size estimations were performed a priori.
299
 This is also 
important in ensuring that the statistical analyses to be conducted will be capable of 
supporting the stated hypotheses under investigation.
311
 For multiple regression, a ratio 
of 20 cases per predictor variable is recommended.
312
 Based on this calculation, 360 
respondents were required for adequate power for the study. 
Furthermore, the software program, G*Power 3.1.6 was employed to validate the 
desired a priori sample size. Based on conservative estimates of moderate effect size of 
0.3
313
 [It is reasonable to assume at least a moderate effect size (i.e., multiple R of 
around 0.3)
313
 for TRA studies using a multiple regression approach], α = 0.05, β=0.80, 
the needed sample size was estimated to be 83.
314
 There are several other rules-of-
thumbs for determining the minimum number of subjects required for a study using 
regression. These include: 1) a minimum of 200 subjects for any regression analysis; 2) 
a minimum subject to predictor ratio of between 15: 1 to 25:1; 3) N ≥ 104 + m (for the 
partial correlation) and 4) N≥ 50 + 8m (where m is the number of independent 
variables) – [with a medium effect size, α = 0.05, and β = 0.20 assumed for #3 and 
#4].
312,315
 Cohen stated that sample size is depended on effect size, alpha level, and 
power.
313






size: the larger the ES posited, other things (significance criterion, desired power) being 
equal, the smaller the sample size necessary to detect it.”
313
 The importance of effect 
size in determining the minimum sample size has also been emphasized by Green.
315
 
Recalling that one estimate in determining sample size was to have a minimum 
subject to predictor ratio of between 15:1 and 25:1. This would indicate that the 
minimum sample size required to power this study would be between 270 and 450. 
Another method estimated at least 10 to 20 participants per predictor variable; this 
resulted in 180 – 360 participants. Yet another method suggested N≥ 50 + 8m (where m 
= 18); for this example, N ≥194. It is imperative to ensure that the most powerful 
statistical test is used for the question and data at hand, as suggested by Kraemer and 
Thiemann.
311
 Therefore, an approximate average of all methods described [(360+ 83 
+360+ 270 + 194) / 5 = 252.4 ~ 260], was found to provide adequate power for the 
proposed study.  Using the mixed mode of survey distribution (paper-pencil and online-
based), we targeted 130 participants from colleges and universities surrounding in 
Austin. The remainder of the participants (N=130) was targeted using a combination of 
community liaisons, churches and local organizations in the Austin area. 
 
3.3    SAMPLE SELECTION  
The study population sampled in this research project consisted of young black 
men from three universities (University of Texas at Austin, Huston-Tillotson 
University, and Austin Community College), local organizations (e.g., 100 black men of 






3.3.1 INCLUSION AND EXCLUSION CRITERIA 
The inclusion criteria in this study were as follows: 
 Black males 
 Ability to understand written and spoken English 
 Aged between 18 – 40 years 
The exclusion criteria were as follows: 
 Non-black males 
 Non-English speakers 
 Aged under 18 or over 40 years 
 
3.3.2  IRB PROCEDURES 
 This study was conducted within accordance of the guidelines set forth by The 
University of Texas Institutional Review Board (IRB). Because this study involved 
human subjects, two applications – one for the focus groups and a separate submission 
for the web-based/paper-pencil surveys – were sent to and approved by the Institutional 
Review Board (IRB) at the University of Texas at Austin [focus group: IRB Protocol 
#2013-02-0134, and web/paper-pencil survey: IRB Protocol #2013-02-0134]. 
 
3.4      INSTRUMENT DEVELOPMENT  
            The instrument employed in this survey was constructed based on three 
constructs from the (TRA) – attitude towards prostate cancer screening (A), social 






additional constructs of comfortability with prostate examinations (C), cues to action 
(CA), health screening experience (HS), knowledge regarding prostate cancer and 
screening (K), age and demographic/personal factors. The behavioral beliefs (attitude) 
toward prostate cancer screening and comfortability with prostate examinations of the 
target population (i.e., black males, aged 18 – 40 years) were elicited from the focus 
group interviews. A pilot testing of the questionnaire was conducted to assess the 
readability and content validity of the instrument. Following the results from the pilot 
testing, corrections and modifications were made, as necessary. The final questionnaire 
was then administered to the target population. 
 
3.4.1   FOCUS GROUPS 
             Three focus groups (FGs) were conducted to elicit the salient behavioral beliefs 
associated with screening for prostate cancer, as well as issues surrounding 
comfortability with prostate examinations. Approximately six to ten black men were 
recruited [See Appendix A] for each group and were compensated with a $20 VISA gift 
card for their participation in a 1-hour FG session. The men were aged between 18 and 
40 years, majorly enrolled in school (70%),  most of them were single (65%), mostly 
aged between 18 and 30 (60%), and were mostly men of  African-American of 
American origin (born and grew up in America) (45%). 
             At the beginning of the FG sessions, informed consent was obtained from FG 
participants [See Appendix B]. Using the focus group moderator guide [See Appendix 






prostate cancer screening when it is recommended by their physician. These questions 
were to assess their behavioral beliefs regarding prostate cancer screening. The 
behavioral beliefs and outcome evaluations of performing a behavior have universally 
been related to the underlying determinants of attitude towards a behavior.
296,298
 The 
following open ended questions adapted from Ajzen
316
 were used to elicit information 
on black men’s behavioral beliefs:  
1. What do you believe are the advantages of screening for prostate cancer when it 
is recommended by a physician? 
2. What do you believe are the disadvantages of screening for prostate cancer when 
it is recommended by a physician? 
3. Are there any other factors that come to mind when you think about screening 
for prostate cancer when it is recommended by a physician? 
                In addition, they were asked questions about issues that would make 
examinations comfortable or uncomfortable to identify comfortability factors. The 
following open-ended questions were used to elicit information on black men’s 
comfortability with prostate examinations: 
1. What issues would make prostate examinations comfortable or uncomfortable? 
a. Probe: Take a moment to jot down your experience with any physicals 
that included being touched in places where you were not comfortable 






b. Probe: Do you think that being exposed early to these kinds of 
“physicals” might make it easier for Black men to be more comfortable 
with prostate examination when the time comes? 
The total sets of beliefs were listed, following the focus groups, and the responses were 
categorized “by grouping together beliefs that refer to similar outcomes and counting 
the frequency with which each outcome in a group was elicited.”
280
 These frequently-
held beliefs are called modal salient beliefs. The formulation of the survey 
questionnaire was directed by five to nine of the most salient beliefs, as described by 
Ajzen and Fishbein.
280
 Similarly, salient items regarding comfortability with prostate 
examinations were derived from the focus group discussions. 
 
3.5      STUDY VARIABLES 
              The dependent and independent variables included in this study are detailed in 
this section. The included variables were based on three constructs from the TRA as 
outlined by Fishbein:
44,317
 attitude (A), social influence (SI) and behavioral intention 
(I); additional constructs are comfortability with prostate examinations (C), cues to 
action (CA), exercise, health screening experience (HS), knowledge regarding prostate 
cancer and screening (K), prostate cancer risk-reduction behavior (PCB), age and other 
demographic/personal factors (e.g., ethnicity, income, educational level). Figure 2.2 








3.5.1 DEPENDENT VARIABLES 
            The two dependent variables in this study were: (1) behavioral intention of 
young black men to screen for prostate cancer when it is recommended by their 
physician and (2) engagement in prostate cancer risk-reduction behavior.  
 
Intention 
Intention is the most proximal determinant of behavior and it represents the 
motivation to perform a behavior.
316
 As described by Ajzen,
318
 the first dependent 
variable - behavioral intention was assessed with three items: 1) I intend to get screened 
for prostate cancer when my doctor recommends it (Extremely Unlikely to Extremely 
Likely), 2) I will try to get screened for prostate cancer when my doctor recommends it 
(Definitely True to Definitely False), and, 3) I plan to get screened for prostate cancer 
when my doctor recommends it (Strongly Disagree to Strongly Agree). Ajzen
319
 
recommends using three questions that have a high internal consistency with each other. 
The format for the questionnaire below was adapted from a previous study that assessed 
pharmacists’ intention to report serious adverse drug events to the FDA. The 












1. I intend to get screened for prostate cancer when it is recommended by my 
physician. 
 
2. I will try to get screened for prostate cancer when it is recommended by my 
physician. 
 
3. I plan to get screened for prostate cancer when it is recommended by my physician. 
Intention (I) score from these items would be = +6 
  
         These items were measured using the unipolar 7-point semantic differential scales 
ranging from 1 – 7 with 3 sets of anchors (extremely unlikely to extremely likely; 
definitely false to definitely true, and strongly disagree to strongly agree). The items 
were then summed to create a composite intention score ranging from -9 to +9 with 
higher scores indicating a higher likelihood to screen for prostate cancer. 
 
Prostate Cancer Reduction Behavior  
The second dependent variable assessed participants’ engagement in prostate 
cancer risk-reduction behavior. The construct was derived from the Personal 
Integrative Model of Prostate Cancer Disparity (PIPCaD model) by Odedina et al.
321
 
The construct was composed of 10 items that assessed participants’ engagement in 
lifestyle activities to reduce prostate cancer risk factors, including low-fat diet 
consisting mainly of fruits and vegetables, and the use of supplements within the last 
week.
321
  Items were measured on a 5-point scale ranging from never (0) to 2 or more 
extremely 
unlikely 
-3 -2 -1 0 1 2 3 extremely 
likely 
definitely false -3 -2 -1 0 1 2 3 definitely true 






times a day (4), with higher scores indicating higher levels of engagement in prostate 
cancer risk-reduction behaviors. 
Participants were asked to indicate: 1) how often they consumed fruits, 
vegetables, meat products, dairy products, and butter/oil within the last week, and 2) if 
they have taken the following supplements - selenium, lycopene, Vitamin A and other 
retinoids, Vitamin D and soy – to prevent prostate cancer within the last week. 
 
3.5.2 INDEPENDENT VARIABLES  
Age 
Age was measured by asking respondents in what year they were born. The year 
provided from participants was then subtracted from the current year (2014) to calculate 
participants’ ages. 
 
Attitude   
Attitude refers to an individual’s overall subjective evaluation of performing or 
not performing a behavior. In other words, “an attitude is an index of the degree to 
which a person likes or dislikes an object, where ‘object’ is used in the generic sense to 
refer to any aspect of the individual’s world.”
280
 Attitude was measured directly and 
indirectly and can either be positive or negative (favorable or unfavorable) toward the 
performance of the behavior. 
Direct attitude questions assessed the personal evaluation of screening for 






differential scale ranging from -3 to +3 was used. A summary score was created 
by calculating an average of the five attitude items based on the total from each 
participant.
322
 The summary score represent the overall direct attitude measure, 
with a total score range from -15 to +15, with higher scores representing a more 
favorable attitude toward the behavior. Below is a model question used in the 
study to assess direct attitude: 
Overall, I think that getting screened for prostate cancer when my physician 
recommends it is… 
                         very bad    -3    -2    -1    0    1     2     3          very good 
 
  very inconvenient   -3    -2    -1    0    1     2     3          very convenient  
 
               very harmful       -3    -2    -1    0    1     2     3          very beneficial 
 
               very worthless     -3    -2    -1    0    1     2     3          very valuable 
 
                very useless        -3    -2    -1    0    1     2     3          very useful 
Direct attitude (A) score from these items would be = +2 
 
Indirect attitude measure was assessed from the beliefs elicited from the focus 
group discussions (9 items). As discussed in the previous chapter, the behavioral  
beliefs (b) and the corresponding outcome evaluations (e), were assessed for 
each set of salient beliefs identified from the focus groups.
317
  A 7-point 
semantic differential scale with +3 to -3 anchors was used. Each behavioral 
belief (bi) was multiplied by the relevant outcome evaluation (ei) and summed to 
obtain a score for attitude A = ∑ bi ei.
296,323,324
 Below is a set of sample questions 
to assess attitude, as recommended by Ajzen 
325









Behavioral belief (bi) 
Screening for prostate cancer opens me up to knowing whether or not I have 
prostate cancer. 
b. strongly disagree     -3     -2     -1     0     1     2     3     strongly agree 
Outcome evaluation (ei)  
 Opening me up to knowing whether or not I have prostate cancer is   
e.                very bad   -3     -2     -1     0     1     2     3     very good 
 
Indirect attitude (A) score from these items would be -3: A = (b x e); from above A = (+3 x -1) = -3. 
 
Social Influence (SI) 
Social influence (SI) in this study was a proxy for subjective norms (SI). Social 
influence assessed the extent that intent to participate in prostate cancer screening when 
it is recommended by a physician was influenced by the perceived social pressure of 
significant referent(s) and/or family member(s).  
Four items were measured using the unipolar 7-point semantic differential scales 
ranging from 1 – 7 with 3 sets of anchors (extremely unlikely to extremely likely; 
definitely false to definitely true, and strongly disagree to strongly agree). The items 
were then summed to create a composite social influence score ranging from -12 to 12, 











 Below is a model question used in the study to assess social influence: 
When it is recommended by my physician. . . 
1. many of my peers will screen for prostate cancer. 
 
2. the people in my life whose opinion I value would approve of my screening for 
prostate cancer. 
 
3. it is expected of me that I should screen for prostate cancer. 
 
4. most people who are important to me would want me to screen for prostate 
cancer. 
Social influence (SI) score from these items would be = +1 
 
Comfortability (C) 
Comfortability with prostate examinations (C) was assessed by asking 
respondents to respond to a 9-item scale which was elicited from the three previously-
held focus groups. The questions assessed what factors might make prostate 
examinations comfortable (positive contributors; questions 1 – 3, and 7) or 
uncomfortable (negative contributors; questions 4 – 6 and 8 – 9) when it is 
recommended by a physician.  Items were measured on a unipolar 5-point response 
scale ranging from very uncomfortable (1) to very comfortable (5). The items were 
summed to create a composite score for comfortability ranging from 9 to 45, with 
higher scores indicating higher levels of comfortability.  
 
extremely unlikely -3 -2 -1 0 1 2 3         extremely likely 
definitely false  -3 -2 -1 0  1 2 3         definitely true 
strongly disagree -3 -2 -1 0 1 2 3         strongly agree 






Cues to Action (CA) 
 Two items were used to measure participants’ cues to action on a Yes (1) /No or 
Don’t Know (0) response scale. The items included prostate cancer histories from 
participants and those close to them. The items were collapsed into two categories: “0” 
represents those with negative prostate cancer history and those who answered “No” to 
knowing someone with prostate cancer and “1” representing those who answered “Yes” 
to having had prostate cancer or knowing someone close to them with prostate cancer. 
 
Exercise 
  Three items were used to measure exercise. The items included participants’ 
exercise level, frequency and duration. The construct was derived from the Personal 
Integrative Model of Prostate Cancer Disparity (PIPCaD model) by Odedina et al.
321
 
The three items were summed up to create a composite score for exercise with higher 
scores indicating higher exercise time/intensity/level. Scores ranged from 0 to 10. 
 
Health Screening Experience (HS) 
  Two items were used to measure participants’ health screening experience on a 
unipolar 5-point response scale ranging from very negative (1) to very positive (5). The 
items included participants’ experience with prostate cancer screening and sport 
physicals. The items were summed to create a composite score for HS ranging from 2 to 








 Knowledge regarding prostate cancer and screening (K) was measured using a 
14-item scale with six domains (1-limitations, 2-side effects from treatment, 3-
symptoms, 4-risk factors, 5-screening age guideline and 6-screening controversy). 
Twelve items from this scale was developed by Weinrich et al. 
15
 and two more items 
were added to assess dietary knowledge
321
 and screening controversy. The initial 12-
item questionnaire has been used in previous studies to assess knowledge levels of 
prostate cancer and prostate cancer screening among low-income men. The response 
scales for each item are: true, false, or don’t know. The authors reported an internal 
consistency (Cronbach’s α, KR- 20) of 0.77. Construct validity analysis of the scale 
revealed that the 12 items clustered on one factor as their factor loadings were 0.35 or 
greater, suggesting a unidimensional scale.
15
 In addition, content validity was 
established with five cancer health professionals who provided suggestions for the 
questionnaire.
15
 Since it was developed, the questionnaire has been revised and 
administered 12 additional times to 56 men.
15
 Test-retest reliability, performed with a 
different group of 27 men, yielded an overall K reliability of 0.55.
15
 
 Sample items include: “Frequent pain often in your lower back could be 
a sign of prostate cancer;” “Some treatments for prostate cancer can cause problems 
with a man’s ability to have sex;” and “prostate cancer may grow slowly in some 
men.” The 14-items on the Knowledge scale were scored according to whether or not 
the participants responded correctly to each question, and the total number of correct 






knowledge levels. Domains measured include risk factors (questions 1, 3), symptoms 
(questions 2, 4), screening age guidelines (question 5), side effects from treatment 
(questions 6–8), limitations (questions 9–12), diet (question 13) and screening 
controversy (question 14). Responses were scored as true (yes), false (no), and don’t 
know. Don’t know responses were coded as incorrect. True is the correct answer for 9 
of the questions (questions 1, 2, 4, 5, 6, 7, 11, 12 and 14). False is the correct answer for 
5 of the questions (questions 3, 8, 9, 10 and 13). 
 
 
Demographic or Personal Factors 
The covariates in the study were based on characteristics of young black men 
(aged between 18 and 40 years) participating in the study that may impact their 
perception of prostate cancer and prostate cancer screening. These covariates were to 
differentiate factors that are related to young black men’s intention to screen for 
prostate cancer and their engagement in prostate cancer risk-reduction behaviors. These 
demographics variables include: 
 Academic classification was coded into nine categories [Less than High School, 
High School Graduate or GED, Freshman (College), Sophomore (College), Junior 
(College), Senior (College), Graduate Student, Postgraduate (e.g., MS, JD, MD, 
PhD) or Other]. 
 Annual 2012 household income was originally coded into 11 categories ($0 - 
$10,000, $10,001 - $20,000, $20,001 - $30,000, $30,001 - $40,000, $40,001 - 






$90,000, $90, 001 - $100,000 and, $100,001 or more). Annual income was recoded 
into two categories: ≤30,000 (coded as “1”) and ≥ 30,001 (coded as “2”). 
 Ethnicity was coded into six categories [African-American of American origin (born 
and grew up in America), African-American of African origin (born in Africa but 
now American citizen), African-American of Caribbean origin (born in one of the 
Caribbean Islands but now American citizen), African, Caribbean  or Other]. 
 Family history of prostate cancer was measured by asking participants if any of their 
male blood relatives ever had prostate cancer (yes/no/don’t know) and if yes, which 
blood relative has had prostate cancer [count], this was combined and used as a 
continuous scale; with 0 representing negative family history of prostate cancer, 1 
representing positive family history of prostate cancer with one family member and 
2 representing positive family history of prostate cancer with two family members. 
Dues to low responses, family history was recoded into two categories: “Yes 
(reflecting a positive family history)” (coded as “1”) and “No (reflecting a negative 
family history)” (coded as “0”).  
 Health insurance status was originally coded into seven categories (Private 
insurance [e.g., BlueCross/Blue Shield, Humana], CHIP, Medicare, Medicaid, Not 
insured/self-pay, Not sure, or Other). Health insurance was recoded from seven 
categories into the four categories – those with a private health insurance, public 
health insurance, without health insurance or who self-pay and who were not sure. 
 Major field of study was originally coded into 15 categories (Architecture, Business, 






Natural Sciences, Nursing, Pharmacy, Public Affairs, Social Work, or Other). Major 
field of study was recoded into three categories: professional and applied sciences 
(e.g., architecture, business, communication, education, engineering and law), 
humanities (e.g., fine arts, liberal arts and public affairs) and natural/healthcare 
sciences (e.g., natural sciences, nursing, pharmacy, social work and medicine); 
 Marital status was coded into six categories (Single, in a relationship; Single, not in 
a relationship; Married, Partner/Living together; Divorced/Separated; or Widowed). 
 Parents’ (mother’s and father’s) educational achievement was originally coded into 
nine categories (Less than High School, High School Graduate or GED, Freshman 
(College), Sophomore (College), Junior (College), Senior (College), Graduate 
Student, Postgraduate (e.g., MS, JD, MD, PhD) or Other). This measure was 
collapsed to a single measure by choosing the higher of the father’s or the mother’s 
education to represent the parents’ educational achievement. 
 Perception of health status was coded into four categories (Poor, Fair, Good, and 
Excellent). 
 Regular source of care was measured by asking participants if they have a regular 
primary care physician (yes/no) and if yes, how long they have been seeing their 
primary care physician [Less than 6 months (coded as 1), 6 months to less than 1 
year (coded as 2), 1 – 5 years (coded as 3), 6 – 10 years (coded as 4), 11 – 15 years 
(coded as 5) and more than 15 years (coded as 6)]. This was combined to one 
ordinal scale. 






Table 3.1 below summarizes the sources of construct measurements in this study. 
 
  
Table 3.1: Sources of Construct Measurements 
CONSTRUCT OPERATIONAL DEFINITION DATA 
SOURCE 
ITEM(S) 
Intention to engage 
in prostate cancer 
screening (I) 
This assessed the participants’ willingness to participate 
in prostate cancer screening when it is recommended by 
a physician. Intention was measured using a7-point 
bipolar semantic differential scales ranging from -3 to +3 
with 3 sets of anchors (extremely unlikely to extremely 
likely; definitely false to definitely true, and strongly 









This assessed participants’ engagement in lifestyle 
activities to reduce prostate cancer risk factors, including 
low-fat diet consisting mainly of fruits and vegetables, 










Direct attitude assessed the personal evaluation of 
screening for prostate cancer when it is recommended by 
a physician. 
 
Indirect attitude  assessed behavioral beliefs (b) and the 

















Proxy for direct measure of subjective norms. It assessed 
participants’ own estimate of the social pressure to 
screen or not screen for prostate cancer when it is 
recommended by a physician. SI using a 7-point bipolar 
semantic differential scales ranging from 1 – 7 with 3 
sets of anchors (extremely unlikely to extremely likely; 











Nine items assessed factors that make prostate 
examinations comfortable or uncomfortable. 
Comfortability will be measured on a five point scale 





Cues to Action Two items measured participants’ cues to actions on a 
“yes,” “no” response scale. The items include questions 
about whether participants or someone close to them 












Table 3.1: Sources of Construct Measurements (Cont’d) 
Exercise  Three items from the personal integrative 
model of prostate cancer disparity (PIPCaD) 







Health screening experience Two items measured participants’ health 
screening experience on a “very positive,” 
“positive,” “neither positive nor negative,” 
“negative,” “very negative” response scale. The 
items include questions about whether 
participants’ experiences with prostate cancer 
and sports physicals. 
- 2 
Prostate cancer knowledge (K) Fourteen items assessed knowledge about 
prostate cancer and prostate cancer screening 
using a “true,” “false,” and “don’t know” 
scale.  
Domains include:  
Limitations  
Side effects from treatment   
Symptoms  
Screening age guidelines  






Demographic/Personal Factors These are factors that may or may not directly or 
indirectly influence the intention to participate in 
prostate cancer screening tests. 
 
 Academic classification 
 Annual 2012 household income  
 Ethnicity 
 Family history of prostate cancer 
 Health insurance status 
 Major/field of study 
 Marital status  
 Parents’ educational achievement  
 Perception of health status 
 Regular source of care 











3.6   SURVEY PRETEST 
The questionnaire was pretested by 15 black men (aged 18 to 40 years) to ensure 
content validity and readability of all questions and responses. Participants were asked 
to identify problematic issues such as: format/layout, length, instructions, unclear or 
confusing questions, unclear or confusing answer choices, and face validity (e.g., 
omission of important topic/response choice).
326,327
 The 15 “pretesters” were a mix of 
male university students and men from the local community and churches in Austin. 
Following the suggestions and comments, corrections and modifications were made, as 
necessary. Since several changes were made to the survey, those who participated in the 
pilot survey were allowed to participate in the larger study. Participants were 
compensated with $15 HEB gift cards in appreciation of their time. 
 
3.7   INSTRUMENT DISTRIBUTION 
The survey instrument was distributed using a mixed mode of both web-based 
and paper-pencil approaches so as to increase the response rate. Potential respondents 
were invited to participate via emails, phone calls and face-to-face conversation. In 
addition to face-to-face recruitment, male participants in University of Texas (UT) at 
Austin were recruited via a web-link distributed to their email addresses [See Appendix 
D for survey recruitment detail]. Emails were sent to black fraternities and 
organizations on campus for distribution to their members.  
Using the mixed mode of survey distribution (paper-pencil and online-based), we 






Texas at Austin. The remainder of the participants was targeted using a combination of 
community liaisons, churches and local organizations in the Austin area. At the end of 
survey completion, participants were compensated with a $10 HEB gift card and 
provided educational materials on prostate cancer screening obtained from the National 
Cancer Institute (NCI). 
 
Internet survey 
For all web-based surveys, a pre-notification email was sent to all participants in 
February 2014. The survey introduction email was sent a week prior to the initial survey 
distribution, informing the participants that a questionnaire will be sent in a week’s 
time. Participants who wished to opt-out at the time of initial contact were able to do so 
by emailing the researcher. Those who did not opt-out were sent an email cover letter 
that included a web-link to the web-based survey [See Appendix E]. A follow-up email 
[See Appendix F], including the survey link was sent one week later, thanking those 
who had completed the survey and encouraging those who had not to please do so. The 
web-based survey was constructed and distributed via www.qualtrics.com.  
 
Paper/pencil survey 
Participants for the paper-pencil surveys [See Appendix G] were recruited via 
established contacts in neighboring colleges (e.g., Austin Community College and 
Huston-Tillotson University), local churches, and local organizations. Completed 






A cover letter [See Appendix H] was included with all the surveys (web-based or 
paper-pencil) which consisted of: the purpose of the study, the voluntary nature of study 
participation, the importance of the respondents’ participations, the approximate time to 
complete the study, assurance of anonymity, as well as the investigator’s contact 
information. 
 
3.8   DATA ANALYSES  
Data from the questionnaire were coded and analyzed using SAS version 9.3 
(SAS Institute, Cary, N.C.). The significance level for this study was based on alpha of 
0.05. 
Descriptive Statistics 
 Descriptive statistics (frequencies, means, and standard deviations) were 
performed on all study variables.  
 
T-Test Analyses 
 An independent sample t-test was used to determine mean differences in 










Analysis of Variance (ANOVA) 
 ANOVA was used to assess the mean differences in Age, A, SI, C, CA, 
Exercise, HS, and K for categorical variables which are polytomous (e.g., annual 
household income, ethnicity, parent’ educational achievement). 
 
Multiple Regression Analyses 
 The statistical objective of this proposed study was to develop two regression 
models: 1) to predict black men’s intention to screen for prostate cancer using age, A, 
SI, C, CA, HS, and K, and demographic/personal factors as predictor variables, and 2) 
to predict black men’s engagement in prostate cancer risk-reduction behaviors using 
age, CA, K, and demographic/personal factors as predictor variables. Multiple linear 
regressions were used to assess: 1) the relationships between the constructs (age, A, SI, 
C, CA, HS, and K), and demographic/personal factors with intention serving as the 
dependent variable, and 2) the relationships between the constructs (age, CA, exercise, 
and K), and demographic/personal factors with engagement in prostate cancer risk-
reduction behavior serving as the dependent variable. The constructs will be entered 
simultaneously: 
Y1 = B0 + B1X1 + B2X2 + B3X3 + B4X4 + B5X5 + B6X6 + B7X7 + B8X8 + B9X9 + 
B10X10 + B11X11 + B12X12 + B13X13 + B14X14 + B15X15 + B16X16 + B18X18 + B19X19ei 
 
Y2 = B0 + B1X1 + B2X2 + B3X3 + B4X4 + B5X5 + B6X6 + B7X7 + B8X8 + B9X9 + 






Y1= black men’s intention to screen for prostate cancer 
Y2= black men’s engagement in prostate cancer risk-reduction behavior 
B0= intercept 
X1= academic classification 
X2= annual 2012 household income 
X3= ethnicity 
X4= family history of prostate cancer 
X5= health insurance status 
X6= major field of study 
X7= marital status 
X8= parents’ educational achievement  
X9= perception of health status 
X10= regular source of care  
X11= residency 
X12= age 
X13= attitude toward prostate cancer screening 
X14= social influence  
X15= comfortability with prostate examinations 
X16= cues to action 
X17= exercise 
X18= health screening experience 
X19= knowledge regarding prostate cancer and prostate cancer screening 
ei = error term 
 
The Bs are the regression coefficients for the respective IVs. The dependent 







The use of multiple linear regression comes with several assumptions: 
normality, homoscedasticity and linearity.
312
 Normality describes the condition in 
which all variables and all possible linear combinations of variables are normally 
distributed. If this assumption is met, the residuals (differences between the observed 
and predicted values of the variables) will be normally and independently distributed 
about the predicted values of the dependent variable (DV) and proportionately 
distributed across the center of the scatterplot. The test for this assumption is not readily 
tested as it is almost impossible to test multiple numbers of linear combinations of 
variables. Furthermore, the tests available are too sensitive to detect violations of the 
normality condition.
312
 Normality can be assessed by statistical analysis or graphical 
techniques. Normality has two essential components: skewness and kurtosis. Skewness 
refers to the degree to which a distribution is asymmetric while kurtosis addresses the 
degree to which a distribution deviates from the “peakedness” of a distribution.
328
 In 
this study, normality was assessed by using frequency histograms, residual scatterplots, 
probability plots, and statistics for skewness and kurtosis provided via proc univariate. 
Curran, West & Finch
329
 recommend that skewness > |2| and kurtosis > |7| is a cause of 
concern for multivariate data.  
 The assumptions of homoscedasticity (equal variance) was assessed by visually 
inspecting the residual scatterplot;
312
 homoscedasticity can be said to be present when 
the residuals have equal band widths at all values of the predicted DV. 
Heteroscedasticity, on the other hand, occurs when the residuals are not evenly scattered 






 The assumption of linearity is that a straight-line relationship exists between 
two variables. This assumption can be evaluated by producing bivariate scatterplots of 
each independent variable and the dependent variable. A visual examination of the 
scatterplots is recommended for detecting linearity and homoscedasticity. Violating the 
assumptions of linearity or homoscedasticity does not compromise data analyses, but 
rather weakens them.
312
 Nonetheless, transformation of the variable may be warranted 
in cases of serious heteroscedasticity. Serious cases of heteroscedasticity occurs “when 
the spread in standard deviations of residuals around predicted values is three times 
higher for the widest spread as for the most narrow spread.”
312
  
Multicollinearity is often another problem encountered in multiple regression 
analysis. Multicollinearity occurs when two predictor variables are highly correlated 
with one another, which if left undetected can prevent a predictor variable from 
reaching its statistical significance. Multicollinearity between independent variables 
will be assessed in order to determine whether predictors are correlated among 
themselves. Presence of multicollinearity could greatly affect the results of the study by 
inflating the standard deviation of a regression weight and decreasing power. Statistics 
will be done to determine the degree of multicollinearity between independent 




 represents the proportion of variance in the first 
variable shared with the second variable. A rule of thumb to detect multicollinearity is a 
tolerance of less than 0.10 or a variance inflation factor (1 divided by tolerance) greater 
than 10.
312
 If significant collinearity exists between variables, only one variable will be 







Reliability was assessed using an index of internal consistency (e.g., Cronbach’s 
alpha).
318,322
 The reliability of multi-item scales (A, C, K, SI, I and PCB) was assessed 





3.9    HYPOTHESES STATISTICAL TESTS 
The goal of this study was to examine the predictive utility of age, A, SI, C, CA, 
HS, K, and demographic/personal factors to predict young black men’s intentions to 
screen for prostate cancer when it is recommended by their physician and the predictive 
utility of age, CA exercise, and K to predict young black men’s engagement in prostate 
cancer risk-reduction behavior. Table 3.1 provides an outline of the objectives, 







Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests 
Variables Measurement Level Statistical Test 
Dependent Variables 
Prostate cancer risk reduction behavior (PCB)* Interval Descriptive Statistics 
 








Intention to engage in prostate cancer screening (I)* Interval 
Primary Independent Variables 
Age Interval 
Attitude (A)* Interval 
Social influence (SI)* Interval 
Cues to action (CA) Nominal 
Comfortability  with prostate examination (C)* Interval 
Exercise* Interval 
Health screening experience (HS) Interval 
Knowledge (K)* Interval 
 
Covariates  
Academic Classification Ordinal 
Annual 2012 Household Income Ordinal 
Ethnicity Nominal 
Family history of prostate cancer  Nominal  
Health Insurance Status Nominal 
Major field of study Nominal 
Marital Status Nominal 
Parents’ educational achievement Ordinal 
Perception of health status Ordinal 
Regular source of care  Ordinal 
Residency Nominal 
 A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social 














Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 
Objectives/Hypotheses Dependent Variable Independent Variable Statistical 
Test 
Objective 1A: To determine participants' age, attitude towards prostate cancer screening (A), social influence (SI), comfortability 
with prostate examinations (C), cues to action (CA), health screening experience (HS), knowledge regarding prostate cancer and 
prostate cancer screening (K), intention to screen for prostate cancer (I) and other demographic/personal factors. 
Objective 2A:  To explore the predictive ability of age, attitude towards prostate cancer screening (A), social influence (SI), 
comfortability with prostate examinations (C), cues to action (CA), health screening experience (HS), and knowledge regarding 
prostate cancer and prostate cancer screening (K), in explaining intention to screen for prostate cancer (I) while controlling for 
demographic/personal factors. 
H1A:  Age, A, SI, C, CA, HS, and K will explain a significant 




Age, A (direct and 





Annual 2012 Household 
Income 
Ethnicity 
Family history of prostate 
cancer 
Health Insurance Status 




Perception of health status 


















H2A: Age will be a positive and significant predictor of I while 
controlling for A, SI, C, CA, HS, K, and demographic/personal 
factors. 
Intention 
H3A: A towards screening for prostate cancer will be a positive 
and significant predictor of I while controlling for Age, SI, C, 
CA, HS, K, and demographic/personal factors. 
Intention 
H4A: SI will be a positive and significant predictor of I while 
controlling for Age, A, C, CA, HS, K and demographic/personal 
factors. 
Intention 
H5A: C will be a positive and significant predictor of I while 
controlling for Age, A, SI, CA, HS, K, and demographic/personal 
factors. 
Intention 
H6A: CA will be a positive and significant predictor of I while 




H7A: HS will be a positive and significant predictor of I while 




H8A: K will be a positive and significant predictor of I while 
controlling for Age, A, SI, C, CA, HS, and demographic/personal 
factors. 
Intention 
 A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, 





Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 
Objectives/Hypotheses Dependent Variable Independent Variable Statistical Test 
Objective 3A: To determine if participants’ attitude towards screening for prostate cancer (A)  is related to  age, comfortability with 
prostate examinations (C), cues to action (CA), health screening experience (HS) and knowledge regarding prostate cancer and prostate 
cancer screening (K). 
H9A: There is no difference between A and age.  
 
Direct and Indirect 







H10A: There is no difference between A and C. Comfortability 
H11A: There is no difference between A and CA. Cues to Action 
H12A: There is no difference between A and HS. Health Screening Experience 
H13A: There is no difference between A and K. Knowledge  
Objective 4A:  To determine if participants’ social influence (SI) is related to age and comfortability 
H14A: There is no difference between SI and age. Measure of SI Age Correlation 
H15A: There is no difference between SI and C. Measure of SI Comfortability Correlation 
Objective 5A: To determine if participants’ comfortability with prostate examinations (C) is related to age and health screening 
experience (HS). 
H16A: There is no difference between C and age. Measure of C Age Correlation 
H17A: There is no difference between C and HS. Measure of C Health Screening Experience Correlation 
Objective 6A: To determine if participants’ cues to action (CA) is related to age. 
H18A: There is no difference between CA and age. Measure of CA Age t-test 
Objective 7A: To determine if participants’ health screening experience (HS) is related to age. 
H19A: There is no difference between HS and age. Measure of HS Age Correlation 
Objective 8A: To determine if participants’ knowledge regarding prostate cancer and screening (K) is related to age, cues to action 
(CA), health screening experience (HS). 
H20A: There is no difference between K and age. 
Measure of K 
Age Correlation  
H21A: There is no difference between K and CA. Cues to Action Correlation  
H22A: There is no difference between K and HS. Health Screening Experience Correlation  
 A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, b 










Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d)- 
Objectives/Hypotheses Dependent Variable Independent Variable Statistical Test 
Objective 1B: To determine participants' age, cues to action (CA), exercise, knowledge regarding prostate cancer and prostate cancer 
screening (K), prostate cancer risk-reduction behavior (PCB) and other demographic/personal factors. 
Objective 2B:    To explore the predictive ability of age, cues to action (CA), exercise, and knowledge regarding prostate cancer and 
prostate cancer screening (K), in explaining prostate cancer risk reduction behavior (PCB) while controlling for demographic/personal 
factors. 
H1B: Age, CA, Exercise, and K 
will explain a significant amount 






Prostate Cancer Risk Reduction 
Behavior (PCB) 
 Primary Variables 




Annual 2012 Household 
Income 
Ethnicity 
Family history of prostate cancer 
Health Insurance Status 
Major field of study 
Marital Status 
Parents’ educational achievement  
Perception of health status 












H2B: Age will be a positive and 
significant predictor of PCB 
while controlling for CA, 
Exercise, K, and 
demographic/personal factors. 
H3B: CA will be a positive and 
significant predictor of PCB 
while controlling for age, 
exercise, K, and 
demographic/personal factors. 
H4B: Exercise will be a positive 
and significant predictor of PCB 
while controlling for age, CA, K 
and demographic/personal 
factors. 
H5B: K will be a positive and 
significant predictor of PCB 
while controlling for age, CA, 
exercise, and 
demographic/personal factors. 
 A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, b 
= Behavioral beliefs, e = Outcome evaluation, FH = Family history of prostate cancer, RS = Regular source of care, PCB= Prostate 







Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 
Objective 1C:  To explore the relationship between attitude (direct and indirect) towards screening for prostate cancer (A), social 
influence (SI), comfortability with prostate examinations (C),   cues to action (CA) , exercise, health screening experience (HS), 
knowledge regarding prostate cancer and screening (K),  with demographic/personal factors. 




Direct and Indirect measures of: A Annual 2012 Household Income 
Direct and Indirect measures of: A Ethnicity 
Direct and Indirect measures of: A Family history of prostate cancer 
Direct and Indirect measures of: A Health Insurance Status 
Direct and Indirect measures of: A Major field of study 
Direct and Indirect measures of: A Marital Status 
Direct and Indirect measures of: A Parents’ educational achievement  
Direct and Indirect measures of: A Perception of health status 
Direct and Indirect measures of: A Regular source of care 
Direct and Indirect measures of: A Residency  
 




Measure of SI Annual 2012 Household Income 
Measure of SI Ethnicity 
Measure of SI Family history of prostate cancer 
Measure of SI Health Insurance Status 
Measure of SI Major field of study 
Measure of SI Marital Status 
Measure of SI Parents’ educational achievement  
Measure of SI Perception of health status 
Measure of SI Regular source of care 
Measure of SI Residency 
 A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, 
b = Behavioral beliefs, e = Outcome evaluation, FH = Family history of prostate cancer, RS = Regular source of care, PCB= 







Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 




Measure of C Annual 2012 Household Income 
Measure of C Ethnicity 
Measure of C Family history of prostate cancer 
Measure of C Health Insurance Status 
Measure of C Major field of study 
Measure of C Marital Status 
Measure of C Parents’ educational achievement  
Measure of C Perception of health status 
Measure of C Regular source of care 
Measure of C Residency  
 
 Measure of CA Academic Classification 
Chi-square 
 
Measure of CA Annual 2012 Household Income 
Measure of CA Ethnicity 
Measure of CA Family history of prostate cancer 
Measure of CA Health Insurance Status 
Measure of CA Major/field of study 
Measure of CA Marital Status 
Measure of CA Parents’ educational achievement  
Measure of CA Perception of health status 
Measure of CA Regular source of care 
Measure of CA Residency 
 *A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, b = 
Behavioral beliefs, e = Outcome evaluation, FH = Family history of prostate cancer, RS = Regular source of care, PCB= Prostate 





   
Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 
Objective 1C:  To explore the relationship between attitude (direct and indirect) towards screening for prostate cancer (A), comfortability 
with prostate examinations (C),  social influence (SI), health screening experience (HS), knowledge regarding prostate cancer and 
screening (K),  cues to action (CA) and exercise with demographic/personal factors. 
 Measure of Exercise Academic Classification 
t-test, ANOVA 
 
Measure of Exercise Annual 2012 Household Income 
Measure of Exercise Ethnicity 
Measure of Exercise Family history of prostate cancer 
Measure of Exercise Health Insurance Status 
Measure of Exercise Major Field of study 
Measure of Exercise Marital Status 
Measure of Exercise Parents’ educational achievement  
Measure of Exercise Perception of health status 
Measure of Exercise Regular source of care 
Measure of Exercise Residency 
 
 Measure of HS Academic Classification 
t-test, ANOVA 
 
Measure of HS Annual 2012 Household Income 
Measure of HS Ethnicity 
Measure of HS Family history of prostate cancer 
Measure of HS Health Insurance Status 
Measure of HS Major/field of study 
Measure of HS Marital Status 
Measure of HS Parents’ educational achievement  
Measure of HS Perception of health status 
Measure of HS Regular source of care 
Measure of HS Residency 
* A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, b = 






Table 3.2: Study Objectives, Hypotheses and Corresponding Statistical Tests (Cont’d) 
Objective 1C:  To explore the relationship between attitude (direct and indirect) towards screening for prostate cancer (A), comfortability 
with prostate examinations (C),  social influence (SI), health screening experience (HS), knowledge regarding prostate cancer and screening 
(K),  cues to action (CA) and exercise with demographic/personal factors. 
 Measure of K Academic Classification 
t-test, ANOVA 
 
Measure of K Annual 2012 Household Income 
Measure of K Ethnicity 
Measure of K Family history of prostate cancer 
Measure of K Health Insurance Status 
Measure of K Major Field of study 
Measure of K Marital Status 
Measure of K Parents’ educational achievement  
Measure of K Perception of health status 
Measure of K Regular source of care 
Measure of K Residency 
* A = Attitudes, C = Comfortability, CA= Cues to action, HS= Health screening experience, K= Knowledge, SI= Social influence, b = 







There are several limitations to be noted in this study. The limitations are 
categorized as 1) methodological and 2) statistical.  
 
Methodological Limitations 
The study employed a cross-sectional design and therefore only 
measured the relationship between the variables at a single point in time. Thus, 
future or past relationships may not be easily inferred from the study. The 
sampling frame includes only young black men, thus the results may not be 
generalizable to other men beyond the selected population. Selection bias is also 
another limitation, as participants who will respond to the survey will do so 
voluntarily. Selection bias is an important concern in which there is a difference 
between those who respond and those who do not; however, non-responders will 
not be identifiable due to the anonymous nature of the data collection process. 
As such, the results of this study may not be freely generalized to young black 
men who do not respond to the survey. Because the online survey employs a 
forced-response design, another limitation may be that the online responders 
may give random answers. This effect has been described as reactance 
phenomenon, which manifests when pressure is exerted on individuals to adopt 








 Recruiting participants from a university student database for the web-
based survey may likely produce a pool of participants with very similar 
demographic/personal characteristics (e.g., those with computer access, college 
educated), thus further limiting the generalizability of the study. The measures 
included in the questionnaire to predict the intention of young black men to 
screen for prostate cancer may not account for all the factors related to younger 
males’ willingness to adopt protective health behaviors regarding prostate 
cancer. 
 Finally, the use of survey questions to report self-recorded intentions 
may not accurately represent the likelihood of research participants to engage in 
the actual behaviors (prostate cancer screening). 
 
Statistical Limitations 
Multiple regression analysis assumes normality, homoscedasticity and 
linearity
312
; the proposed model used in the study satisfied these assumptions,  
when evaluated for potential violations. Multicollinearity is another problem that 
could exist with multiple regression; appropriate analyses were conducted to 
examine the presence of multicollinearity between the predictor variables. 
Given the descriptive and exploratory nature of this study, the results 
generated did not conclusively suggest a causal relationship between the 
variables under study. Therefore, only correlational and descriptive statistics 





3.11 SUMMARY  
This chapter outlined the methodological plans for this study. It 
described the procedures that were employed to develop the constructs in the 
survey. Also detailed were the variables used in the study, the objectives, and 
hypotheses tested, as well as the statistical tests used to assess statistical 






CHAPTER FOUR: RESULTS 
This chapter details the results of the study. The theory of reasoned action 
(TRA) was used as the theoretical framework for the study. The first section describes 
the results obtained from the focus group sessions. The second section describes the 
results obtained from the web-based and paper-pencil surveys administered to young 
black men aged between 18 and 40. Descriptive statistics are presented for all study 
variables along with bivariate statistics for all theoretical constructs. In addition, 
internal consistency of multi-item scales based on the TRA and other predictor variables 
are presented. Multivariate analyses were used to examine the variance explained in 
intention to engage in prostate cancer screening and engagement in prostate cancer risk-
reduction behaviors. 
 
4.1 FOCUS GROUP RESULTS 
    Three focus group sessions were conducted with a total of 20 black men aged 
18 to 40 for the purpose of eliciting the salient beliefs black men hold toward prostate 
cancer screening and comfortability with prostate examinations. The first focus group 
was conducted in a local church in Austin, Texas with two men in attendance. The 
second and third focus groups were conducted at The University of Texas at Austin 
with eight and ten men, respectively. Lunch was provided to all of the participants in 
addition to a $20 Visa gift card as incentives. Focus groups were tape recorded and 
participants provided written responses to the questions found on the focus group 





content analyzed by two different investigators to determine the common themes and 
categories regarding young black men’s beliefs toward prostate cancer screening and 
comfortability with prostate examinations. 
The most frequently mentioned beliefs developed from the focus group analysis 
were used in the questionnaire and they represented young black men’s modal beliefs. 
Modal beliefs represent the salient beliefs of the group of interest. 
 
4.1.1 BEHAVIORAL BELIEFS 
A total of 16 behavioral beliefs were identified from the three focus group 
sessions and nine were deemed salient and included in the final questionnaire [See 
Table 4.1]. The two most frequently mentioned behavioral beliefs were “knowing 
whether one has prostate cancer or not” (n = 12) and “unnecessary cost” (n = 12). 
Fishbein’s Theory of Reasoned Action suggests that an individual has five to nine 
beliefs that he or she holds to be salient.
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 Based on this information, only the most 






Table 4.1: Behavioral Belief Items Based on Responses to Questions 1 to 3 from 






What do you believe are the advantages of screening for prostate 
cancer? 
What do you believe are the disadvantages of screening for prostate 
cancer? 
Are there any other factors that come to mind when you think about 
screening for prostate cancer? 
 No.   Items                                                                                           Frequency
a
 
1    Means knowing whether one has prostate cancer or 
not 
12 
2    Leads to unnecessary medical cost 12 
3    Can detect prostate cancer early  10 
4    Means having to eventually undergo the process  7 
5    Leads to invasion of privacy 6 
6    Leads to stigma 5 
7    Gives peace of mind 4 
8    Causes emasculation  2 
9    Is a fearful process  2 
10    Results in more issues 1 
11    Leads to embarrassment   1 
12    Causes too much pain 1 
13    Tests are not always accurate 1 
14    Being able to live longer 1 
15    Being able to treat it early 1 
16    Saves money on the long run  1 
aFrequency refers to the number of times this item was discussed in all three focus groups. Transcription of audio 
tapes did not allow for discerning which participant discussed an item more than once. 
 
4.1.2 COMFORTABILITY WITH PROSTATE EXAMINATIONS 
A total of nine items related to comfortability with prostate examinations were 
identified from the three focus group sessions [See Table 4.2]. The two most frequently 
mentioned beliefs associated with comfortability with prostate examinations were 
“having a male to conduct the examination” (n = 7) and “having a female conduct the 






Table 4.2: Comfortability with Prostate Examinations Items Based on Responses 
to Question 4 from Focus Group Sessions (N = 20) 
Questions 4: 
 
What issues would make prostate examinations comfortable or 
uncomfortable? 
 No.   Items                                                                                          Frequency
a
 
1    Having a male conduct the examination 7 
2    Having a female conduct the examination 7 
3    Including the examination as part of a regular physical 6 
4    The awkwardness of the process 6 
5    Being touched in the sensitive area during the 
examination 
5 
6    Having to go through the examination in general 4 
7    Having someone acting professional conduct the 
examination 
4 
8    Undergoing the examination despite the stigma 
associated with it 
4 
9    The idea of being sedated in order to get through the 
process 
3 
aFrequency refers to the number of times this item was discussed in all three focus groups. Transcription of audio 
tapes did not allow for discerning which participant discussed an item more than once. 
 
4.2 QUESTIONNAIRE PRETEST  
Based on the information obtained from the focus groups and a review of the 
literature on black men and prostate cancer screening, the questionnaire was 
constructed. A pilot test of the survey was completed prior to survey instrument 
distribution in an effort to determine if there were any problems with the questionnaire, 
such as readability, relevance, formatting, and discrepancies between the web-based and 
paper-pencil surveys. The questionnaire was pretested with 15 young black men aged 
18 – 40 years and was further reviewed by the thesis committee members. Pretesters 
were randomly assigned to pretest either the web-based or paper-pencil surveys. 
These respondents were also asked to pay special attention to the following 





unclear or confusing answer choices, and time to complete. All 15 participants 
completed the pilot test, including comments, where applicable, in between eight and 23 
minutes. Based on feedback provided by the committee members and pretesters, several 
changes were made to the questionnaire. The most notable change to the questionnaire 
was the addition of the items assessing prostate cancer risk-reduction behaviors. This 
addition to the survey served as a proxy for current engagement in chemopreventive 
behaviors. Due to the extensive changes made to the original survey, responses from the 
pretesting were excluded in the final version of the survey. 
 
4.3  SURVEY DISTRIBUTION  
Survey data were collected in February 2014 via web-based and paper-pencil 
surveys. The survey introduction email (pre-notification) was sent February 4 – 6, 2014 
to potential participants using mailing lists from black student organizations, radio 
stations, and black community-based organizations. A majority of the responses from 
the paper-pencil surveys were obtained from face-to-face conversations and referrals 
from participants. Regardless of the mode of distribution, cover letters were attached to 
each survey indicating the purpose of the study and the anonymity and confidentiality 
of survey responses. 
A total of 279 surveys were received via the mixed mode of distribution (109 
from web-based survey and 170 from the paper-based survey). Four surveys were 
deleted for the following reasons: three were non-black male participants, and one was 





a sufficient amount of questions on the survey items). Thus, the number of useable 
surveys was 267. Table 4.3 shows all the primary constructs and representative 
questions used in the survey. 
 
Table 4.3: Primary Constructs and Representative Survey Questions 




Intention 3 1a – 1c 
Prostate Cancer Risk-Reduction 
Behavior 
10 2a – 2j  
Direct Attitude 9 10a – 10e 
Indirect Attitude
a
 9 8a – 8i 
9a – 9i 
Subjective Norm 4 7a – 7d 
Comfortability
a
 9 14a – 14i 
Cues to Action 2 11a – 11b  
Exercise  3 4 – 6 
Health Screening Experience  2 12a – 12b 
Knowledge of Prostate Cancer and 
Screening 
14 13a – 13n 
a
Represents items developed from focus group findings. 
 
 
4.4 DATA PREPARATION AND CLEANING  
Data were entered into SAS 9.3 for data preparation, screening, and analysis. Data 
were assessed for normality (evaluating the symmetry and peakedness of the 
distributions) as well as the existence of outliers and the extent of missing data. 
 
 
4.4.1 NON-NORMALITY, OUTLIERS, AND MISSING DATA 
 Skewness and kurtosis values were calculated and plotted. Non-normality was 
defined as having a skew >|2| and kurtosis >|7|.
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 The distributions of all the interval 
level variables did not exceed the skewness and kurtosis thresholds of >|2| and >|7|, 





 Inspection of the z-scores of all continuous interval variables was used to 
identify potential outliers that may change study results. No outliers were identified in 
this dataset. Because there was a low incidence of missed responses (eight responses in 
total), data was analyzed as is, without imputation of missing values. 
Table 4.4: Skewness and Kurtosis Values of Interval-Level Variable 
 
Variable  Skewness Kurtosis 
Age 0.66 -0.98 
Attitude (Direct) -0.62 0.32 
Attitude (Indirect) 1.04 1.26 
Social Influence -0.67 0.10 
Comfortability 0.11 0.49 
Exercise -1.37 1.51 
Health Screening Experience  0.07 -0.73 
Intention -0.64 -0.30 
Knowledge 0.17 -1.03 
Prostate Cancer Risk-Reduction Behavior 0.31 -0.30 
 
4.5 INTERNAL CONSISTENCY 
Reliability estimates of both the direct and indirect measure scales were assessed 
via Cronbach’s alpha, where an acceptable value of internal consistency is α ≥ 0.60 [See 
Table 4.5 below].
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Table 4.5: Reliability Analyses of Direct and Indirect Measure Study Scales 
Scale Number of Items Cronbach 
Alpha 
Direct Measures  
Attitude  5 0.90 
Comfortability with prostate examination (C) 9 0.86 
Intention 3 0.92 
Knowledge (K)
a
 14 0.84 
Prostate cancer risk-reduction behavior (PCB) 10 0.68 
Social influence (SI) 4 0.83 
Exercise 3 0.67 
Indirect Measures 
Attitude 9 0.76 
aKuder-Richardson’s ρ was calculated because the items were dichotomous 
 
4.6 PARTICIPANTS’ DEMOGRAPHIC AND PERSONAL FACTORS 
The demographic and personal factors of the respondents are described below 
[See Tables 4.6– 4.17].  
 
4.6.1 DEMOGRAPHIC FACTORS  
Age 
The mean age of the sample was 26.4±6.7 years (median = 24.00; mode = 20.00), 
with a range of 18 to 40 years.  
 
Ethnicity  
As shown in Table 4.6, African-American men of American origin (N=171) 








 Table 4.6: Frequency Distribution of Ethnicity  
Income  
Table 4.7 details respondents’ annual household income. About 26 percent of 
participants in the study reported having an annual income of ≤$10,000 (26.2%).  
 







Ethnicity  N Percent (%) 
African-American of American origin (born and grew up in 
America) 
171 65.3 
African-American of African origin (born in Africa but 
now American citizen) 
28 10.7 
African-American of Caribbean origin (born in one of the 
Caribbean Islands but now American citizen) 
7 2.7 
African 45 17.2 
Caribbean 5 1.9 
Other
b




aTotal does not equal 267 due to missing responses 
bRepresents those of mixed heritage who identify with being black 
 
 
Annual 2012 Household Income N Percent (%) 
$0 - $10,000 69 26.2 
$10,001 - $20,000      29 11.0 
$20,001 - $30,000 28 10.6 
$30,001 - $40,000 18 6.8 
$40,001 - $50,000 38 14.4 
$50,001 - $60,000 
$60,001 - $70,000 
$70,001 - $80,000 
$80,001 - $90,000 






















Recoded Income Variable 
aTotal does not equal 267 due to missing responses 
 
Residency  
Respondents reported residing mostly in suburban (50.6%) or urban (42.2%) 
areas, respectively [See Table 4.8]. 
Table 4.8: Frequency Distribution of Participants’ Residency 
       
4.6.2 ACADEMIC CHARACTERISTICS 
Education 
Table 4.9 details the highest level of education. About 19 percent of respondents 
reported their highest level of education/current classification as College Freshmen 
(18.9%). In addition, approximately 18 percent were College Seniors (18.2%) and 




Annual 2012 Household Income N Percent (%) 
≤30,000 (“1”) 126 47.9 




Residency N Percent (%) 
Rural 19 7.2 
Suburban     111 42.2 










Table 4.9: Frequency Distribution of Highest Level of Education (Current 
Classification) 
 aTotal does not equal 267 due to missing responses 
 







aTotal does not equal 267 due to missing responses 
 
Parent’s Education  
As depicted in Table 4.10, about 23 percent (22.8%) of respondents reported 
their parents’ highest educational achievement as high school graduate or GED and 21.3 
percent reported parents’ highest educational achievement as postgraduate. This 
measure was collapsed to a single measure by choosing the higher of the father’s or the 
mother’s education to represent the parents’ educational achievement. 
 
Highest Level of Education (Current Classification) N Percent (%) 
Less than High School 6 2.3 
High School Graduate or GED 16 6.1 
Freshman (College) 





Junior (College) 47 17.8 
Senior (College) 48 18.2 
Graduate Student    





Total    264
a
 100.0 
Highest Level of education (current classification) N Percent (%) 
High School Graduate or GED or Less than high school 22 8.3 
Freshman (College) 





Junior (College) 47 17.8 
Senior (College) 48 18.2 
Graduate Student    
















Recoded Parents’ Educational Achievement Variable 
 
Major Field of Study 
The predominant major/field of study was Business (23.4%), followed by Natural 
Sciences (14%), Education (13.6%) and Engineering (12.8%). Table 4.11 more fully 
delineates these academic characteristics.  
  
Parents’ Educational Achievement N Percent (%) 
Less than High School 8 3.0 
High School Graduate or GED 61 22.8 
Freshman (College) 





Junior (College) 14 5.2 
Senior (College) 42 15.7 
Graduate Student    








Total    267 100.0 
Parents’ Educational Achievement Variable N Percent (%) 
High School Graduate or GED or Less than high school 69 25.8 
College Graduate 76 28.5 
Graduate Student    













Table 4.11: Frequency Distribution of Major Field of Study 
 
Recoded Major Field of Study Variable 
aTotal does not equal 267 due to missing responses 
 
 
4.6.3 PERSONAL FACTORS 
Perception of Health 
When asked about their perception of health status, more than half of the 
respondents (52.5%) indicated “Good” [See Table 4.12]. 
  
Major Field of Study N Percent (%) 
Architecture  4 1.5 
Business 62 23.4 
Communication 13 4.9 
Education 36 13.6 


































aTotal does not equal 267 due to missing responses 
 
Major Field of Study  N Percent (%) 
Professional & Applied Sciences 153 58.1 
Humanities 












Table 4.12: Frequency Distribution of Perception of Health Status 





         About 44 percent (43.9%) of the respondents most commonly reported being 
single and not in a relationship [See Table 4.13].  
Table 4.13: Frequency Distribution of Participants’ Marital Status 
   aTotal does not equal 267 due to missing responses 
    
 
Health Insurance Status  
Respondents most commonly (34.7%) reported having private insurance, as 
shown in Table 4.14.  
  
Perception of Health Status N Percent (%) 
Poor 4 1.5 
Fair  40 15.2 
Good 138 52.5 




Marital Status  N Percent (%) 

























Table 4.14: Frequency Distribution of Participants’ Health Insurance Status 
bTotal does not equal 267 due to missing responses 
 
 
Recoded Health Insurance Variable 
aTotal does not equal 267 due to missing responses 
 
Regular Source of Care 
When asked about their regular sources of care, more than half of the 
respondents (58.1%) indicated having a regular source of care.  Of those who answered 
“Yes” to having a regular source of care, twice as many had been seeing their 
physicians for a period of 1 – 5 years (38.7%) as compared to 6 months – less than a 
year (19.4%). [See Table 4.15] 







CHIP (Children’s Health Insurance Plan) 7 2.7 
Medicare 
Private insurance (e.g. BlueCross/Blue 
















Health Insurance Status N Percent (%) 
Private Insurance  90 34.7 
















Table 4.15: Frequency Distribution of Participants’ Regular Source of Care 
 
Table 4.16: Frequency Distribution of Participants’ (Students) Use of Health 
Services 
 
Almost 41 percent (40.8%) of student participants do not make use of Student 
Health Services to obtain healthcare [See Table 4.16].
 
 
Family History of Prostate Cancer  
 
When asked about their family histories of prostate cancer, a majority of the 
respondents (87.6%) indicated having no family history of prostate cancer.  Of those 
who answered “Yes” to positive family history of prostate cancer, approximately 94% 
reported one family member as having had prostate cancer (93.9%) and about six 







Total                 267 100.0 
        
    If Yes, how long have you been seeing your physician?  [N=155] 
 
Less than 6 months 
6 months to less than 1 year 
1 – 5 years 
6 – 10 years 
11 – 15 years 













Total 155 100.0 







Not a college student 71 26.6 





percent (6.1%) reported having two family members with prostate cancer [See Table 
4.17]. 
Table 4.17: Frequency Distribution of Family History of Prostate Cancer 
aTotal does not equal 267 due to one missing response 
 







Total                 266
a
 100.0 
        




Father and Uncle 
Grandfather 




















Total 33 100.0 
 





Two Family Members 2 6.1 





4.7 THEORY OF REASONED ACTION CONSTRUCTS 
The paper-pencil and online-based surveys measured the following components 
of the Theory of Reasoned Action: intention, attitude (A) and social influence (SI).The 
independent variables, A and SI were measured directly; in addition, A was also 
measured using belief-based (indirect) measures.  
 
4.7.1 INTENTION 
Intention, one of the primary dependent variables, was measured with three 
questions using a bipolar semantic differential scale ranging from +3 to -3, with higher 
scores corresponding to increased intention. The individual means for intention 
questions 1 – 3 were 0.91± 1.90; 1.05±1.67 and 1.10±1.65, respectively [See Table 
4.18]. The total intention score was 3.06±4.80 out of a possible score range of -9 to +9 
(i.e., 3 questions rated -3 +3). Based on total scores, participants in the present study 
have a weak positive intention to screen for prostate cancer when it is recommended by 






Table 4.18 Mean and Frequency Distribution of Intention 











































































































































































Score Total 258 3.06
b
 4.80        
Cronbach’s Alpha
c
 0.92         
aTotals do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range -9 to +9  





4.7.2 ATTITUDE (DIRECT AND INDIRECT MEASURES) 
Direct attitude in the study was measured with five questions representative of 
young black men’s overall subjective favorable or unfavorable views toward prostate 
cancer screening when it is recommended by a physician [See Table 4.19]. Each 
question was assessed using a 7-point bipolar semantic differential scale from -3 to +3, 
represented by the anchors: very bad/very good, very harmful/very beneficial, very 
inconvenient/very convenient, very worthless/very valuable, and very useless/very 
useful. Approximately 37 percent of participants viewed prostate cancer screening as 
very good (36.7%) and 30 percent viewed prostate cancer screening as very beneficial 
(30.3%). About 26 percent of the respondents thought prostate cancer screening was 
neither convenient nor inconvenient (26.3%), and approximately 29 percent viewed 
prostate cancer screening as very valuable (28.9%). However, approximately 31 percent 
of participants thought that prostate cancer screening was either useful (30.8%) or very 
useful (30.5%), respectively. The total mean score for attitude (direct) was 6.91±6.08, 
out of a possible range of -15 to +15. Based on this scale total score, participants 
reported a mildly positive attitude toward prostate cancer screening. The attitude scale 





Table 4.19 Mean and Frequency Distribution of Direct Attitude Measure 
























































































































































































































Score Total 263 6.91
b
 6.08        
Cronbach’s Alpha
c
  0.90        
aTotal do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range -15 to +15;  





Indirect attitude was measured with nine items derived from the focus group 
sessions. The first nine questions assessed the behavioral beliefs of young black men 
regarding prostate cancer screening when it is recommended by a physician. The 
response scale was a 7-point bipolar semantic differential scale ranging from -3 
(strongly disagree) to +3 (strongly agree). The second set of nine questions captured 
young black men’s outcome evaluation of prostate cancer screening. Participants 
somewhat agreed that screening for prostate is a process one has to eventually go 
through (mean = 1.04±1.62) and that it gives a peace of mind (mean = 0.93 ±1.53) [See 
Table 4.21]. Participants’ disagreed that prostate cancer screening is an unnecessary 
medical cost (mean = -1.00±1.67) and they neither agreed nor disagreed that prostate 
cancer screening was an invasion of privacy (mean = -0.73±1.79). However, they 
agreed that screening can detect prostate cancer early (mean = 1.20±1.47) [See Table 
4.21]. Participants somewhat agreed that screening for prostate cancer opens them up to 
knowing whether or not they have prostate cancer (mean = 1.37±1.69) and they 
somewhat disagreed that prostate cancer screening causes emasculation (mean = -
0.90±1.78). Participants neither disagreed nor agreed to prostate cancer screening being 
a process that carries a stigma (mean = 0.01±1.65) [See Table 4.20]. 
With regards to participants’ outcome evaluations of prostate cancer screening, 
opening one up to knowing whether one has prostate cancer or not (mean = 1.22±1.52), 
detecting prostate cancer early (mean =1.60±1.55), and giving a peace of mind (mean 
=1.58±1.49), were viewed as good outcomes of prostate cancer screening [See Table 





undergo or having undergone the process (mean = -0.57±1.45), invading privacy (mean 
=-0.74±1.59), screening carrying a stigma (mean = -0.46±1.62), causing emasculation 
(mean = -0.92±1.63) and screening being a fearful process (mean = -0.41±1.54) were 
viewed as neither good nor bad by participants [See Table 4.21]. 
Indirect attitude is determined by the two components of behavioral beliefs and 
outcome evaluations. The results of the multiplicative summation of the behavioral 
beliefs and outcome evaluations are shown in Table 4.22. Since there are nine 
questions, the possible range for the total scores is -81 to +81. The range of scores 
among respondents was -30 to +81. The overall indirect attitude score of 15.45±19.12 
reflects a weak positive attitude towards prostate cancer screening. “Opening me up to 
knowing whether or not I have prostate cancer” was the largest positive contributor to 
overall attitude, with a mean of 3.31±3.73. Attitude subscale items ranged from 0.41 to 






Table 4.20: Mean and Frequency Distribution of Behavioral Beliefs 


















































1.  opens me up to knowing 











































3.  is a process I have or will 
eventually have to go through.  




























5.  can detect prostate cancer 
early. 














6.  is a process that carries a 
stigma. 




























8.  causes emasculation (weakens 
my manhood).  




























Score Total 266 1.93
b
 7.78        
Cronbach’s Alpha
c
 0.66         
aTotals do not equal 267 due to missing responses  
 bThe composite score for the overall scale calculation based on 267 responses, possible scale range -27 to +27 





Table 4.21: Mean and Frequency Distribution of Behavioral Outcome Evaluations 
Q. How good or bad do you feel each of the following outcomes would be if you were to screen for prostate cancer when it is 







































1.  Opening me up to knowing whether or 
not I have prostate cancer is: 




























3.  Having to eventually undergo or having 
undergone the process is: 






































































8.  Causing emasculation (weakening my 
manhood) is: 




























       Score Total 264 1.79
b
 7.89        
  Cronbach’s Alpha
c
 0.74         
aTotals do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range -27 to +27 





Table 4.22: Mean and Range of Behavioral Beliefs x Outcome Evaluations 
(Indirect Attitude) 
                      Score Range
a
 
 Items (∑ bi.ei) N
b
 Mean SD Min Max 
a.  Opening me up to knowing whether or 
not I have prostate cancer  
267 3.31 3.73 -9.00 9.00 
b.  Incurring unnecessary medical cost  265 1.26 3.43 -9.00 9.00 
c.  Having to eventually undergo or having 
undergone the process   
267 1.36 3.34 -9.00 9.00 
d.  Invading my privacy  267 1.02 3.93 -9.00 9.00 
e.  Detecting prostate cancer early  265 3.18 3.62 -9.00 9.00 
f.  The screening carrying a stigma  265 0.41 3.60 -9.00 9.00 
g.  Giving me peace of mind  267 2.73 3.67 -6.00 9.00 
h.  Causing emasculation (weakening my 
manhood)  
267 1.67 3.87 -9.00 9.00 
i.  Screening being a fearful process  266 0.56 3.48 -9.00 9.00 









     
aA total of nine items provide a possible range total of (±3 x ±3) x 9 = -81 to +81  
bTotals do not equal 267 due to missing responses  
cRepresents the total number of valid responses used in calculation of the overall scale  
d Cronbach’s alpha based on 9 items 
 
4.7.3 SOCIAL INFLUENCE (DIRECT MEASURE) 
This was the proxy used for subjective norm in this study. The direct social 
influence in the study was measured with four questions representative of young black 
men’s overall perception of social pressure to undergo prostate cancer screening when it 
is recommended by a physician [See Table 4.23]. Each item was assessed using a 7-
point bipolar semantic differential scale ranging from -3 to +3. Respondents most 
commonly believed that it was somewhat likely (24.1%) that many of their peers will 
screen for prostate cancer and it was definitely true (25.2%) that people whose opinions 
they value would approve of them screening for prostate cancer. Twenty-two percent 





them to screen for prostate cancer; however, approximately 24 percent (23.8%) strongly 
agreed that most people who are important to them would want them to screen for 
prostate cancer. The total mean score for social influence was 2.63 ±5.45, out of a 
possible range of -12 to +12. Based on this total mean score, participants reported a 
weak positive social influence towards prostate cancer screening. The social influence 













































1.  many of my peers will 
screen for prostate cancer. 



































2.  the people in my life whose 
opinion I value would 




























































3.  it is expected of me that I 


















































4.  most people who are 
important to me would want 







































Score Total 265 2.63
b





         
aTotals do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range -12 to +12  





4.8 PROSTATE CANCER RISK-REDUCTION BEHAVIORS 
Prostate cancer risk-reduction behavior was operationalized through 14 items 
from one of the constructs from the Personal Integrative model of Prostate Cancer 
Disparity (PIPCaD) model developed by Odedina et al.
321
 The items in the prostate 
cancer risk-reduction scale assessed the consumption of food and nutrients that have 
been suggested to reduce/increase chances of getting prostate cancer.  
Most of the participants ate fruits (41.6%), vegetables (35.5%), dairy products 
(31.4%), and butter/oil 1-3 times a week. Approximately 37 percent (36.5%) of 
participants consumed meat products 2 or more times a day. In addition, most did not 
use chemoprevention products such as selenium, lycopene, Vitamins A and D, retinoid 
and soy within the last week [See Table 4.24]. The prostate cancer risk-reduction 
behavior scale had a mean of 13.70±5.62 (range of 0 to 40) [See Table 4.25]. The 
summary score on this variable is low with a median of 13. This is because the 
majority of the participants sampled were not taking vitamins/supplements to prevent 
prostate cancer. Internal consistency of the items on the risk-reduction sale was 






Table 4.24: Mean and Frequency Distribution of Risk Reduction Behaviors 
Q. Think about your eating habits within THE LAST WEEK. Counting breakfast, lunch, dinner, snacks and eating out, 
please state how often you ate the stated food or took the stated nutrients: 
Frequency Distribution of Response Choices N (%) 


















































2.  Vegetables (such as greens, vegetable soup, stew, 






















3.  Meat products (such as beef, goat, chicken, pork, 

































































8.  Vitamin A and other retinoid to prevent prostate 
cancer. 






























Score Total 266 13.7
b





       
aTotals do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range 0 to +40 





Table 4.25: Mean Risk-Reduction Behavior Score 




Table 4.27: Frequency Distribution of Participants’ Last Month Exercise 
Variable N
a





 13.00 5.62 0.00 40.00 
aTotals do not equal 267 due to missing responses  
bThe composite score for the overall scale calculation based on 267 responses, possible scale range 0 to +40 
 
 
When asked about their eating habits within the last week, more than half of the 
respondents (55.3%) indicated that meat products made up the biggest portion of their 
meal [See Table 4.26]. 
 
Meal N Percent (%) 













aTotal does not equal 267 due to missing responses 
 
Respondents most commonly (44.3%) indicated they exercised four to six days 
a week within the last month [See Table 4.27]. 
 
Exercise in Last Month N Percent (%) 
None  
1 – 3 days a week 















About forty-six percent (45.8%) of respondents engaged in strenuous exercise, 






Table 4.28: Frequency Distribution of Participants’ Last Month Exercise Level 
 
 
Table 4.29: Frequency Distribution of Participants’ Last Month Exercise Length  
 
 
Table 4.30: Mean Duration and Frequency of Exercise 
 
Exercise Level N Percent (%) 
Did not exercise in the last month 
Mild exercise with minimal effort (such as easy walking, 
bowling, golf) 
Moderate exercise with light perspiration (such as fast walking, 









Strenuous exercise that makes your heart beat rapidly and sweat 





aTotal does not equal 267 due to missing responses 
 
A majority (36.9%) of respondents spent between 40 and 60 minutes each time 
they exercised, within the last month [See Table 4.29]. 
 
Exercise Minute N Percent (%) 
Did not exercise in the last month 
Less than 20 mins 
Between 20 and 39 mins 













aTotal does not equal 267 due to missing responses 
 
 
The exercise scale had a mean of 6.44±3.14 and a median of 7 [See Table 
4.30]. The mean of 6.44 indicates that participants engaged in a somewhat high level, 
duration and intensity of exercise. The scale reliability was acceptable at α=0.86. 
Variable N
a
 Mean SD Median Minimum Maximum 
Exercise Month 264 1.97 1.12 2.00 0.00 3.00 
Exercise Level 264 2.02 1.11 2.00 0.00 3.00 










   
aTotal does not equal 267 due to missing responses 
bThe composite score for the overall scale calculation based on 267 responses, possible scale range +0 to +10 






4.9 ADDITIONAL MODEL PREDICTORS 
4.9.1 PROSTATE CANCER AND SCREENING KNOWLEDGE 
Prostate cancer and screening knowledge was operationalized through 12 items 
from the Knowledge About Prostate Cancer Screening Questionnaire,
15
 and two 
additional items assessing dietary knowledge
321
 and prostate cancer screening 
controversy; making the scale a total of 14 items. The 14 scale items were scored 
according to whether or not study participants answered each correctly. Total 
Knowledge score [See Table 4.31] could range from 0 to 14. The Knowledge of 
Prostate Screening scale had a mean of 5.25±3.81 and a median score of 5.00 [See 
Table 4.33]. On average, men from this sample answered approximately 29 percent of 
the questions correctly. On average, 47 percent of the respondents replied “Don’t 
Know” to the questions. Questions concerning risk factors, screening age guidelines, 
limitations and diet were responded to incorrectly mostly by the sample in the study. 
For example, approximately 49 percent of the participants responded incorrectly that 
younger men were more likely to get prostate cancer than older man (49.1%), and that 
most 80-year-old men do not need a prostate cancer screening (48.7%). Thirty-five 
percent of the participants responded incorrectly to the “true,” “false,” or “don’t know” 
statements that doctors can tell which men may die from prostate cancer and which men 
will not be harmed by prostate cancer (35.2%) and that an abnormal Prostate Specific 
Antigen (PSA) blood test means one has prostate cancer for sure (34.8%). Almost 
thirty-two percent of respondents (31.8%) could not correctly identify that a diet high in 





Knowledge of Prostate Cancer Screening Questionnaire was acceptable (Cronbach α = 
KR20 = 0.84). 
 
Table 4.31: Mean Total Knowledge Scores   
Variable N Mean Median SD Minimum Maximum 
Knowledge 267 5.25
a
 5.00 3.80 0.00 14.00 







Table 4.32: Frequency Distribution of Participants’ Knowledge Regarding Prostate Cancer and Screening 
                                                                                                                                











1.  Men who have several family members (blood relatives) with prostate cancer are 





































































9.  A doctor can tell which men may die from prostate cancer and which men will not 





















































  0.84     





4.9.2 COMFORTABILITY WITH PROSTATE EXAMINATIONS 
Comfortability with prostate examination was measured with nine items derived 
from the focus group sessions. As shown in Table 4.33, positive and negative 
contributors had a mean of 12.70±3.40 and 14.07±4.33, respectively. 
Since there are nine questions, the possible range for the total scores is +9 to +45 
[See Table 4.34]. The overall comfortability score of 26.80±7.19 reflects a neutral 
comfortability towards prostate examinations. The comfortability scale alpha value was 
0.86, which met the acceptable level of 0.6.  
 
Table 4.33 Mean Positive and Negative Contributors to Comfortability with 
Prostate Examinations 
Variable N Mean SD Minimum Maximum 
Positive Contributors  
(Questions 1 – 3, and 7) 
263 12.70 3.40 4.00 20.00 
Negative Contributors 
(Questions 4 – 6 and 8 – 9) 
264 14.07 4.33 5.00 25.00 
Score Total 261
a
 26.77 7.73 9.00 14.00 
aTotal does not equal 267 due to missing responses 
 





Table 4.34: Mean and Frequency Distribution of Participants’ Comfortability with Prostate Examinations 
 
 
                                                                                                                  Frequency Distribution of Response Choices N (%) 
































































3.  including the examination as part 






















4.  the awkwardness of the process 
of the examination. 










5.  being touched in a sensitive area 
during the examination. 










6.  having to go through the process 
of the examination in general. 










7.  having someone who acts 
professional conduct the 
examination. 










8.  undergoing the examination 
despite the stigma associated with 
it. 










9.  the idea of being sedated in order 
to get through the examination. 










Score Total 266  26.80
b





       
aTotals do not equal 267 due to missing responses  
 bThe composite score for the overall scale calculation based on 267 responses, possible scale range +9 to +45 





4.9.3 CUES TO ACTION 
When asked if they have ever had prostate cancer, the majority of the 
respondents (95.5%) indicated having no prior history of prostate cancer. In addition, 
almost 45 percent (44.9%) indicated not knowing someone close to them who has ever 
had prostate cancer [See Table 4.35].  





                                                                   Frequency Distribution of Response Choices N (%) 
 
 
  N Yes No Don’t 
Know 











          Total 267    




4.9.4 HEALTH SCREENING EXPERIENCES 
Health screening experience was measured with two questions using a unipolar 
scale ranging from “Never had one” (0) to “Very Positive” (+5) with health screening 
experiences. The individual means for health screening experiences were 1.19±1.68 
and 2.84±1.85, respectively [See Table 4.36]. The total health screening experience 
Cues to Action N Percent 
“0”(Negative Cues) 206 77.2 
“1”(Positive Cues) 61 22.8 







score was 4.03±2.83 out of a possible score range of 0 to +10. Based on the total 
scores, participants in the present study have negative health screening experience. 
 






                                                                   Frequency Distribution of Response Choices N (%) 
 
 


















































































































































Score Total 267 4.03
a
 2.83       






4.10 CORRELATIONS AMONG TRA CONSTRUCTS AND ADDITIONAL MODEL PREDICTORS 
Table 4.37 shows the Pearson’s correlation among the direct measures of TRA construct and additional predictor 
variables in the model. Attitude (direct), social influence (direct), comfortability, and knowledge were significantly and 
positively correlated with intention at a significance level of p<0.01. 























































































Intention 1.00        
Age  0.09 1.00       
Attitude (Direct) 0.46
**












 1.00    




 0.06 -0.09 1.00   





















Table 4.38 shows the Pearson’s correlation among the indirect measure construct (i.e., focus group derived) with 
intention. Intention was significantly and positively correlated with indirect attitude (r = 0.30, N = 260, p<0.001). 
 


























Intention 1.00  
Attitude (Indirect) 0.30** 1.00 
Note: Pearson’s correlations are significant at ** p < 0.001 
 
Table 4.39 shows the Pearson’s correlations among the direct and indirect measure of TRA constructs. Direct attitude 
was shown to have a significant positive relationship with the indirect measure of attitude (r = 0.50, N = 260, p<0.01). 

















Attitude (Direct)  0.50** 






4.11 CORRELATIONS OF PREDICTOR VARIABLES WITH PROSTATE CANCER RISK-REDUCTION 
BEHAVIORS 
Table 4.40 shows the Pearson’s correlation among the predictor variables and the prostate cancer risk-reduction 
behaviors construct. Knowledge was significantly and positively correlated with risk-reduction behaviors at a significance 
level of p<0.01. 
 













































Risk-Reduction Behavior  1.00     
Age  0.03 1.00    
Cues to Action 0.04 0.25
**
 1.00   
Exercise -0.02 -0.14
**





 0.01 0.00 1.00 






4.12 DESCRIPTIVES OF STUDY SCALE TOTALS 
Table 4.41 provides a summary of the scale total scores calculated for each of the 
variables in the model.  
Tale 4.41: Summary of the Means and Ranges of Study Scales 




Prostate Cancer Risk-Reduction 
Behavior 
266 13.7 5.62 0 to 40 1 to 30 
Intention 258 3.06 4.8 -9 to +9 -9 to +9 
Age  264 26.44 6.67 18 to 40 18 to 40 
Attitude (Direct) 263 6.91 6.08 -15 to +15 -15 to +15 
Attitude (Indirect) 266 15.45 19.12 -81 to +81 -30 to +81 
Social Influence 265 2.63 5.45 -12 to +12 -12 to +12 
Comfortability 266 26.80 7.19 +9 to +45 +9 to +45 
Exercise 264 6.22 3.14 0 to +10 0 to +10 
Health Screening Experience  267 4.03 2.83 0 to +10 0 to +10 
Knowledge 267 5.25 3.80 0 to +14 0 to +13 
 
4.13 DATA SCREENING PRIOR TO ANALYSIS 
Multicollinearity 
Multicollinearity was assessed between the 19 independent variables in order to 
determine if they were correlated with each other. Multicollinearity is described here by 
a tolerance less than 0.1 or a variance inflation factor greater than 10. Collinearity 
diagnostics were performed and the tolerance and variance inflation factor between each 
pair of independent variables was assessed. None of the tolerance values were less than 
0.1, and none of the variation factors were greater than 10. Since multicollinearity was 






Each assumption of multiple regression analysis (i.e., normality of residuals, 
homoscedasticity, linearity, and independence) was checked prior to statistical analyses. 
For each dependent variable, the distributions of the residuals were found to be normal 
based on histograms of the residuals and normal probability plots. The assumption of 
homoscedasticity was assessed for each dependent variable.  Based on the non-curved 
shape of the residual scatter plots of both dependent variables, the assumption of 
linearity of residuals was met. Finally, the assumption of independence of residuals was 
met since participants received individual treatments and responded individually to the 
survey within a short period of time [See Appendices I – K]. 
 
 
4.14 TEST OF HYPOTHESES 
 
 After checking for multicollinearity and violations of assumptions, no rescoring 
or transformation of the data was necessary. The dependent variables did not have 
violations of skewness and kurtosis, and their distributions were approximately normal. 
Data analyses were conducted to determine the results of the study hypotheses [See 
Chapter 3, Table 3.2]; these results were obtained via multiple regression analyses, 
correlation analyses, t-tests, ANOVAs and chi-squares. To develop a more 
parsimonious model, bivariate analyses were done on dependent variables and 
demographic/personal factors. Demographic/personal factors that were not related to 





For the dependent variable, Intention, nine of the 11 demographic/personal 
factors were dropped. The retained demographic/personal factors were health 
insurance status and perception of health. For the dependent variable, Engagement in 
Prostate Cancer Risk-Reduction Behaviors, eight of the 11 demographic/personal 
factors were dropped. The retained demographic/personal factors were academic 
classification, major field of study and residency.  
A summary of each of the hypothesis test results is presented below: 
 
Objective 2A: To explore the predictive ability of age, attitude (direct and indirect) 
towards prostate cancer screening (A), social influence (SI), comfortability with 
prostate examinations (C), cues to action (CA), health screening experience (HS), 
knowledge regarding prostate cancer and prostate cancer screening (K), in 
explaining intention to screen for prostate cancer (I) while controlling for 
demographic/personal factors. 
H1A: A, Age, SI, C, CA, HS, and K will explain a significant amount of variance in 
I while controlling for demographic/personal factors. 
 
With Direct Attitude as a predictor 
The intention to screen for prostate cancer screening regression model was 
significantly different from zero, F=14.86, df=12, 251; p<0.001. Approximately 41 
percent of the variation in intention to screen for prostate cancer (R
2
=0.41) was 





variables, where the adjusted R
2
 was about 39 percent (R
2
=0.38). Therefore, H1A was 
supported [See Table 4.42]. 
 
With Indirect Attitude as a predictor 
The intention to screen for prostate cancer screening regression model was 
significantly different from zero, F=15.21; d.f. =12, 244; p<0.001. Forty-three percent 
of the variation in intention to screen for prostate cancer (R
2
=0.43) was accounted for 
by the 2 demographic/personal factors and 7 independent variables, where the adjusted 
R
2
 was 40 percent (R
2
=0.40). The results of the multiple regression analysis (e.g., 
unstandardized coefficients, standardized coefficients, confidence intervals and p-
values) are shown in Table 4.43. Therefore, H1A was supported. 
 
H2A: Age will be a positive and significant predictor of I while controlling for A, SI, 
C, CA, HS, K, and demographic/personal factors. 
Age was not a significant or positive predictor of intention while controlling for 
other predictor and demographic variables (β=0.02, p=0.67). Therefore, H2A was 

















H3A: A towards screening for prostate cancer will be a positive and significant 
predictor of I while controlling for Age, SI, C, CA, HS, K, and 
demographic/personal factors. 
 
This statistical result suggests that attitude (direct) was a positive and significant 
predictor of intention while controlling for other predictors and demographic variables 
(β=0.20, p<0.01) [See Table 4.42]. The attitude (indirect) was also a significant and 
positive predictor of intention while controlling for other predictors and demographic 
variables (β=0.17, p<0.01) [See Table 4.43]. Therefore, H3A was supported. 
 
H4A: SI will be a positive and significant predictor of I while controlling for Age, 
A, C, CA, HS, K and demographic/personal factors. 
 This hypothesis was accepted (β=0.41, p<0.01). The statistical result suggests 
that, while controlling for other factors, there was a positive significant difference in 
social influence and intention to screen for prostate cancer [See Table 4.42]. 
 
 
H5A: C will be a positive and significant predictor of I while controlling for Age, A, 
SI, CA, HS, K, and demographic/personal factors.  
This hypothesis was rejected (β=0.10, p=0.09). This statistical result suggests 
that comfortability was not a positive and significant predictor of intention while 
controlling for other predictor and demographic variables. Therefore, H5A was rejected 





H6A: CA will be a positive and significant predictor of I while controlling for Age, 
A, SI, C, HS, K, and demographic/personal factors. 
 Cues to action was not a positive and significant predictor of intention while 
controlling for other predictor and demographic variables (β=0.08, p=0.06). Therefore, 
H6A was rejected [See Table 4.42]. 
 
H7A: HS will be a positive and significant predictor of I while controlling for Age, 
A, SI, C, CA, K, and demographic/personal factors. 
 Health screening experience was not a positive and significant predictor of 
intention while controlling for other predictor and demographic variables (β=0.06, 
p=0.28). Therefore, H7A was rejected [See Table 4.42]. 
 
 
H8A: K will be a positive and significant predictor of I while controlling for Age, A, 
SI, C, CA, HS, and demographic/personal factors. 
This hypothesis was accepted (β=0.19, p=0.02). This statistical result suggests 
that knowledge was a positive and significant predictor of intention while controlling 
for other predictor and demographic variables. Therefore, H8A was accepted [See Table 
4.42]. 
Out of all the independent variables, attitude [direct (β=0.20, p<0.01) and 
indirect (β=0.17, p<0.01)], social influence (β=0.41, p<0.01), comfortability (indirect 
model) and knowledge (β=0.19, p=0.02) were significantly related to intention to screen 





coefficients, standardized coefficients, confidence intervals and p-values) are shown in 
Tables 4.42 – 4.43. Eight hypotheses were tested for objective 2A, where four 





























Intercept -1.08 1.45  -3.94 1.78 0.46 
       
Independent Variables       
Age 0.02 0.04 0.02 -0.06 0.08 0.67 
Attitude (Direct) 0.12 0.05 0.20 0.06 0.25 <0.01
**
 
Social Influence  0.36 0.06 0.41 0.26 0.47 <0.01
**
 
Comfortability 0.06 0.04 0.10 -0.01 0.13 0.09 
Cues to Action 1.27 0.58 0.08 -0.08 2.12 0.06 
Health Screening Experience 0.09 0.09 0.06 -0.07 0.26 0.28 





      
Health Insurance Status
b
       
     Private Insurance -0.03 0.59 -0.02 -1.19 1.14 0.97 
     Public Insurance 0.22 0.63 0.00 -1.03 1.46 0.73 
     Not Sure -0.57 1.51 -0.02 -3.55 2.41 0.71 
Perception of Health Status
c
       
     Good  0.49 0.65 0.05 -0.79 1.77 0.45 
     Excellent -1.40 0.69 -0.12 -2.61 0.12 0.07 





aCI = confidence interval of unstandardized coefficients 
bHealth Insurance Status was dummy coded as “private insurance”, “public insurance”, “not sure” with comparator “no insurance/self-pay” 
cPerception of health was dummy coded as “good”, and “excellent”  with comparator “fair” 
*Indicates significance at p < 0.05 






























Intercept -0.27 1.46  -3.15 2.62 0.86 
       
Independent Variables       
Age -0.01 0.04 -0.01 -0.08 0.07 0.86 
Attitude (Indirect) 0.04 0.01 0.17 0.02 0.07 <0.01
**
 
Social Influence  0.41 0.05 0.47 0.31 0.51 <0.01
**
 
Comfortability 0.07 0.04 0.11 0.00 0.14 0.05
*
 
Cues to Action 0.91 0.60 0.08 -0.27 2.10 0.13 
Health Screening Experience 0.03 0.09 0.02 -0.14 0.20 0.76 





      
Health Insurance Status
b
       
     Private Insurance 0.13 0.59 0.01 -1.04 1.30 0.83 
     Public Insurance 0.31 0.63 0.03 -0.93 1.56 0.62 
      Not Sure -2.66 1.61 -0.08 -5.83 0.50 0.10 
Perception of Health Status
c
       
    Good  0.40 0.65 0.04 -0.87 1.68 0.53 
    Excellent -1.32 0.69 -0.13 -2.68 0.03 0.04
*
 





aCI = confidence interval of unstandardized coefficients 
bHealth Insurance Status was dummy coded as “private insurance”, “public insurance”, “not sure” with comparator “no insurance/self-pay” 
cPerception of health was dummy coded as “good”, and “excellent”  with comparator “fair” 
*Indicates significance at p < 0.05 








Objective 3A: To determine if participants’ attitude (direct) towards screening for 
prostate cancer (A)  is related to  age, comfortability with prostate examinations 
(C), cues to action (CA), health screening experience (HS) and knowledge 
regarding prostate cancer and prostate cancer screening (K). 
The attitude (direct) toward prostate cancer screening regression model was 
significantly different from zero, F=9.74; d.f.=5, 258; p<0.01. About 16 percent of the 
variation in attitude (direct) toward prostate cancer screening (R
2
=0.16) was accounted 
for by the 5 independent variables, where the adjusted R
2
 was 14 percent (R
2
=0.14).  
The attitude (indirect) toward prostate cancer screening regression model was 
significantly different from zero, F=4.11; d.f.=5, 251; p<0.01. Approximately eight 
percent of the variation in attitude (indirect) toward prostate cancer screening (R
2
=0.08) 
was accounted for by the 5 independent variables, where the adjusted R
2
 was about six 
percent (R
2
=0.06) [See Table 4.45]. 
 
H9A: There is no difference between A and age. 
This hypothesis was accepted (β=0.06, p=0.30) [See Table 4.44]. This statistical 
result suggests that there is no significant relationship between attitude (direct) and age. 
Furthermore, there was also no significant relationship between attitude (indirect) and 







H10A: There is no difference between A and C. 
This hypothesis was rejected (β=0.38, p<0.01) [See Table 4.44]. This statistical 
result suggests that there is a significant and positive relationship between attitude 
(direct) and comfortability. Furthermore, there was also a significant and positive 
relationship between attitude (indirect) and comfortability (β=0.25, p<0.01) [See Table 
4.45]. Therefore, H10A was rejected. 
 
H11A: There is no difference between A and CA. 
This hypothesis was accepted (β=-0.10, p=0.12) [See Table 4.44]. This statistical 
result suggests that there is no significant relationship between attitude (direct) and cues 
to action. Also, there was no significant relationship between attitude (indirect) and cues 
to action (β=-0.02, p=0.80) [See Table 4.45]. Therefore, H11A was accepted. 
 
H12A: There is no difference between A and HS. 
This hypothesis was accepted (β=-0.06, p=0.36) [See Table 4.44]. This statistical 
result suggests that there is no significant relationship between attitude (direct) and 
health screening experience. Furthermore, there is no significant and positive 
relationship between attitude (indirect) and health screening experience (β=0.06, 








H13A: There is no difference between A and K. 
This hypothesis was accepted (β=0.02, p=0.80) [See Table 4.44]. This statistical 
result suggests that there is no significant relationship between attitude (direct) and 
knowledge. Furthermore, there was also no significant relationship between attitude 
(indirect) and knowledge (β=-0.04, p=0.50) [See Table 4.45]. Therefore, H13A was 
accepted. 
 
Out of all the independent variables, comfortability was positively and 
significantly related to attitude (direct and indirect) towards prostate cancer screening. 
The results of the multiple regression analysis (e.g., unstandardized coefficients, 
standardized coefficients, confidence intervals and p-values) are shown in Table 4.44.  
Five hypotheses were tested for objective 3A, where four hypotheses were 





Table 4.44: Multiple Regression Analysis of Attitude (Direct) toward Prostate Cancer Screening (N=257) 
 
aCI = confidence interval of unstandardized coefficients  
*Indicates significance at p < 0.05 
**Indicates significance at p < 0.01 
 




















Cues to Action 


































F statistic =4.11; df=5, 251, Model p-value <0.01; R
2
=0.08,  Adjusted R
2
=0.06 
aCI = confidence interval of unstandardized coefficients  
*Indicates significance at p < 0.05 





















Cues to Action 











































Objective 4A: To determine if participants’ social influence (SI) is related to age 
and comfortability.  
Bivariate correlations were used to assess the related hypotheses of this 
objective. The results are described in Table 4.46 below.  
 
 
H14A: There is no difference between SI and age. 
There was no significant difference in age and social influence (r =-0.08, p = 
0.18). In other words, the age of participants was not significantly related to social 
influence. Therefore, H14A was accepted.  
 
 
H15A: There is no difference between SI and C. 
Comfortability with prostate examinations was positively and significantly 
related with social influence (r =0.29, p <0.01). Therefore, H15A was rejected.  
 
Two hypotheses were tested for objective 4A, where one hypothesis was 
accepted, and the other was rejected. 
 
Table 4.46: Correlations of Predictor Variables with Social Influence (N=264) 
Social Influence and Predictor Variables Social Influence Age  
 
Comfortability  
Social Influence  1.00   
Age  0.08 1.00  
Comfortability 0.29
**
 -0.02 1.00 






Objective 5A: To determine if participants’ comfortability with prostate 
examinations (C) is related to age and health screening experience (HS). 
Bivariate correlations were used to assess the related hypotheses of this 
objective. The results are described in Table 4.47 below.  
 
H16A: There is no difference between C and age. 
There was no significant difference in age and comfortability with prostate 
examination (r =-0.02, p = 0.813). In other words, the age of participants was not 
significantly related to comfortability with prostate examinations. Therefore, H16A was 
accepted. 
 
H17A: There is no difference between C and HS. 
Health screening experience was positively and significantly related with 
comfortability with prostate examinations (r =0.19, p <0.01). Therefore, H17A was 
rejected. 
Two hypotheses were tested for objective 5A, where one hypothesis was 
accepted, and the other was rejected. 
Table 4.47: Correlations of Predictor Variables with Comfortability with Prostate 
Examination (N=264) 






Comfortability 1.00   
Age  -0.02 1.00  
Health Screening Experience 0.19
**
 0.04 1.00 





Objective 6A: To determine if participants’ cue to action (CA) is related to age. 
H18A: There is no difference between CA and age. 
A t-test was used to assess the relationship between cues to action and age. The 
differences in mean age scores between the two groups (“0” and “1”) were statistically 
significant (t=6.09, d.f.=262, p<0.01) [See Table 4.48]. This means that those with 
negative cues to action were younger compared to those with positive cues to action. 
The hypothesis tested for objective 6A (H18A) was thus rejected. 
Table 4.48: Cues to Action
a
 by Age 
Cues to Action and Predictor 
Variable 
Means for “0” 
(SD) 
(N) 

















aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to knowing 
someone with prostate cancer and “1” representing those who answered “Yes” to having had prostate cancer before or knowing someone close to them 
with prostate cancer. 
bFor t-test equality of means, equal variance assumed (The Levene test for equality of variance: p>0.05) 
 **Asterisk indicates statistical significance at p<0.01 
 
Objective 7A: To determine if participants’ health screening experience (HS) is 
related to age. 
H19A: There is no difference between HS and age. 
Bivariate correlation was used to assess the relationship between health 
screening experience and age. There was no significant difference in age and health 
screening experience (r =0.04, p = 0.53) [See Table 4.49]. The hypothesis tested for 






Table 4.49: Correlations of Age with Health Screening Experience (N=264) 
Health Screening Experience and Age Health Screening Experience Age  
Health Screening Experience 1.00  
Age  0.04 1.00 
 
Objective 8A: To determine if participants’ knowledge regarding prostate cancer 
and screening (K) is related to age, cues to action (CA), health screening 
experience (HS). 
Bivariate correlations were used to assess the hypotheses for this objective. The 
results are described in Table 4.50 below.  
 
H20A: There is no difference between K and age.  
There was no significant difference in knowledge regarding prostate cancer and 
screening and age (r =0.06, p = 0.31). Therefore, H20A was accepted. 
 
 
H21A: There is no difference between K and HS. 
There was no significant difference in knowledge regarding prostate cancer 




H22A: There is no difference between K and CA. 
There was a significant and positive difference in knowledge regarding prostate 
cancer and screening and cues to action (r =0.01, p=0.93). Therefore, H22A was 
accepted. 






Table 4.50: Correlations of Predictor Variables with Knowledge regarding 



















































Knowledge  1.00    
Age 0.06 1.00   
Health Screening Experience -0.10 0.04 1.00   
Cues to Action 0.01 0.25
**
 0.09 1.00 
*Indicates significance at p < 0.05 
**Indicates significance at p < 0.01 
 
Objective 2B: To determine participants' age, cues to action (CA), exercise, 
knowledge regarding prostate cancer and prostate cancer screening (K), prostate 
cancer risk-reduction behavior (PCB) and other demographic/personal factors. 
H1B: Age, CA, Exercise, and K will explain a significant amount of variance in 
PCB while controlling for demographic/personal factors. 
The prostate cancer risk-reduction regression model was significantly different 
from zero, F=1.93; d.f.=14, 237; p=0.02. Approximately 10 percent of the variation in 
prostate cancer risk-reduction behaviors (R
2
=0.10) was accounted for by three 
demographic/personal factors and four independent variables, where the adjusted R
2
 
was ten percent (R
2






H2B: Age will be a positive and significant predictor of PCB while controlling for 
CA, exercise, K, and demographic/personal factors. 
Age was not a significant, positive predictor of prostate cancer risk-reduction 
behavior while controlling for other predictor and demographic variables (β=-0.05, 
p=0.49) [See Table 4.51]. Therefore, H2B was rejected. 
 
H3B: CA will be a positive and significant predictor of PCB while controlling for 
age, exercise, K, and demographic/personal factors. 
Cues to Action was not a significant and positive predictor of prostate cancer 
risk-reduction behavior while controlling for other predictor and demographic variables 
(β=0.04, p=0.57) [See Table 4.51]. Therefore, H3B was rejected. 
 
H4B: Exercise will be a positive and significant predictor of PCB while controlling 
for age, CA, K, and demographic/personal factors. 
Exercise was not a significant and positive predictor of prostate cancer risk-
reduction behavior while controlling for other predictor and demographic variables 









H5B: K will be a positive and significant predictor of PCB while controlling for age, 
exercise, CA, and demographic/personal factors  
Knowledge was a significant, positive predictor of prostate cancer risk-reduction 
behavior while controlling for other predictor and demographic variables (β=0.19, 
p=0.03) [See Table 4.51]. Therefore, H5B was accepted. 
Out of all the independent variables, only knowledge (β=0.19, p=0.03) was 
significantly related to prostate cancer risk-reduction behavior. The results of the 
multiple regression analysis (e.g., unstandardized coefficients, standardized coefficients, 
confidence intervals and p-values) are shown in Tables 4.51. Five hypotheses were 






























Intercept 17.53 2.39  12.81 22.25    <0.01
**
 
       
Independent Variables       
Age -0.04 0.06 -0.05 -0.17 0.08 0.49 
Cues to Action 0.52 0.91 0.04 -1.28 2.31 0.57 
Exercise 0.09 0.12 0.05 -0.14 0.32 0.44 





      
Academic Classification
b
       
    Freshman (College) -2.14 1.49 -0.15 -5.08 0.80 0.15 
    Sophomore (College) -3.52 1.59 -0.21 -6.64 -0.39 0.03
*
 
    Junior (College) -2.59 1.49 -0.18 -5.52 0.34 0.08 
    Senior (College) -2.61 1.51 -0.18 -5.59 0.38 0.09 
    Graduate Student  0.97 1.58 -0.05 -2.24 3.98 0.58 
    Postgraduate -0.37 1.66 -0.02 -3.63 2.89 <0.01
**
 
 Major Field of Study
c
       
     Professional & Applied Science -3.10 0.90 -0.27 -4.88 -1.32   <0.01
**
 





       
         Urban 1.05 0.76 0.09 -0.45 2.55 0.17 
         Rural 2.95 1.45 0.13 0.09 5.81 0.04
*
 





aCI = confidence interval of unstandardized coefficients; bAcademic Classification was dummy coded as  “freshman (college)”, “sophomore  (college)”, “junior (college)”, “senior (college)” , “graduate student”, 
“postgraduate”, with comparator “high school graduate/GED or Less than high school.”; cMajor Field of Study was dummy coded as “professional & applied science”, and “humanities”  with comparator “natural & 





4.15 DEMOGRAPHIC/PERSONAL FACTORS AND PREDICTOR 
VARIABLES 
 The predictor (independent) variables used in the model were assessed to 
determine their relationships with the additional demographic/personal factors: 
academic classification, income, ethnicity, family history, health insurance, major field 
of study, marital status, parent educational achievement, perception of health, regular 
source of care and residency [See Tables 4.52 – 4.57]. 
 
A. Academic Classification 
ANOVA 
To determine if there were any relationships between the independent variables and 
the academic classification of the respondents, one-way analysis of variance (ANOVA) 
and appropriate post-hoc tests were employed [See Tables 4.52 – 4.57]. ANOVAs 
showed statistical significance for direct attitude (F=2.601, d.f.=7, 256, p=0.01), social 
influence (F=2.133, d.f.=7, 256, p=0.041), comfortability (F=2.402 d.f.=7, 256, 
p=0.021) and knowledge (F=6.47, d.f.=7, 256, p<0.00).  
Post hoc analyses via Tukey were used for the direct measure of attitude: the mean 
for those in the sophomore (college) group  (mean=7.657, s.d=5.418) was significantly 
higher than the mean for the less than high school group (mean=-0.500, s.d=7.036, 
p=0.043) [note: range for direct measure of attitude was -15 to +15]; the mean for the 
junior (college) group (mean=7.638, s.d.=4.856) was significantly higher than the mean 





the graduate student group(mean=7.833, s.d=6.131) was significantly higher than the 
mean for the less than high school category (mean=-0.500, s.d=7.036, p=0.040) and the 
mean for the postgraduate group (mean=8.844, s.d=4.840) was significantly higher than 
the mean for the less than high school category (mean=-0.500, s.d=7.036, p=0.011). 
Tukey’s post hoc test for social influence showed that the mean for those in the 
postgraduate group (mean=5.06, s.d=3.792) was significantly higher than the mean for 
the less than high school group (mean=-2.833, s.d=3.189, p=0.024) [note: range for 
social influence was -12 to 12].  
Post hoc analyses for comfortability via Tukey showed that the mean for those 
in junior (college) group (mean = 30.06, s.d.=8.047) was significantly higher than the 
mean for those in the senior (college) group (mean=25.29, s.d.=6.916, p=0.022) [note: 
range for comfortability  was +9 to +45]. 
Post hoc analyses via Games-Howell were used for knowledge: the mean for 
those in the postgraduate  group  (mean=7.875, s.d=4.240) was significantly higher than 
the means for the high school graduate/GED group (mean=3.688, s.d=2.938, p=0.006) 
[note: range for knowledge was 0 to 14], the freshman  (college) group (mean=4.40, 
s.d.=3.88, p=0.009) , the sophomore (college) group (mean=3.514, s.d=2.605, p<0.001) 
and the junior (college) group (mean=4.213, s.d.=3.706). The mean for those in the 
senior (college) category (mean=6.292, s.d.=3.531) was significantly higher than the 
mean for the sophomore (college) group (mean=3.514, s.d=2.605, p=0.012); and the 
mean for the graduate group (mean=6.567, s.d=3.266) was significantly higher than the 






B. Annual Household Income 
In assessing the relationship between the independent variables and annual 
household income, t-tests were utilized. The result from the analysis shows that the 
difference in mean indirect attitude scores between those with an annual household 
income of ≤30,000 (mean =18.72) and those with an annual household income of ≥ 
30,001 (mean =12.48) was statistically significant (mean difference= -6.2437, t=-2.609, 
d.f.=242.633, p=0.010). This negative mean difference indicated that participants with 
an annual household income of ≤30,000 had a more favorable mean than did the 
participants with an annual household income of ≥ 30,001. The results from the analysis 
can be found in Tables 4.52 – 4.57. 
 
C. Ethnicity 
To determine if there were any statistically significant relationships between the 
independent variables and the ethnic background of the respondents, one-way analysis 
of variance (ANOVA) and appropriate post-hoc tests were employed [See Tables 4.51 – 
4.56]. The direct measure of attitude (F=2.847, d.f.=5, 256, p=0.016), health screening 
experience (F=3.473, d.f.=5, 256, p=0.005) and exercise (F=2.978, d.f.=5, 248, 
p=0.012) were statistically significant for ethnicity.  
Tukey’s post hoc tests for the direct measure of attitude indicated that the mean 
for the African-American of American origin group (mean=7.1871, s.d.=5.634) was 
significantly higher than the mean for the African-American of Caribbean origin 





(mean=7.880, s.d.=5.6340) was significantly higher than the mean for the African-
American of Caribbean origin category (mean=-0.429, s.d.=6.803, p=0.033).  
Tukey’s post hoc tests for the health screening experience indicated that the 
mean for the African-American of American origin group (mean=4.193, s.d.=2.670) 
was significantly higher than the mean for the African group (mean=2.644, s.d.=3.068, 
p=0.015) and the mean for the African-American of African origin group (mean=4.679, 
s.d.=3.209) was significantly higher than the mean for the African group (mean=2.644, 
s.d.=3.068, p=0.032). 
For exercise, the mean for the African-American of American origin group 
(mean=7.209, s.d.=2.336) was significantly higher than the mean for the African group 
(mean=5.818, s.d.=2.919, p=0.011). The results from the analysis can be found in 
Tables 4.52 – 4.57. 
 
D. Family History of Prostate Cancer 
In assessing the relationship between the independent variables and family 
history of prostate cancer, t-tests were utilized. The results from the analyses show that 
social influence (*t=2.049, d.f.=257, p=0.041; mean Yes family history = 4.42) was 
significantly higher than the mean of those without a family history of prostate cancer 
(Mean No family history = 2.35) mean difference= 2.068). Therefore, the positive mean 
difference indicated that participants with a family history of prostate cancer had a 






Health screening experience [t=-2.809, d.f.=264, p=0.005; mean Yes family 
history = 5.30; mean No family history = 3.84; mean difference= 1.46)]; knowledge [t=-
2.429, d.f.=264, p=0.016; mean Yes family history (coded “1”) = 6.758; mean No 
family history = 5,05; mean difference= 1.71)]; and exercise [t=2.315, d.f.=256, 
p=0.021; mean Yes family history = 5.939; mean No family history = 7.0; mean 
difference= 1.06)] were all significant. The results from the analysis can be found in 
Tables 4.52 – 4.57. Therefore, the positive mean difference indicated that participants 
with a family history of prostate cancer had a favorable health screening experience 
mean than did the participants with no family history of prostate cancer. 
 
E. Health Insurance Status 
To determine if there were any statistically significant relationships between the 
independent variables and the health insurance of the respondents, one-way analysis of 
variance (ANOVA) and appropriate post-hoc tests were employed [See Tables 4.52 – 
4.57]. The direct measure of attitude (F=5.269 d.f.=3, 255, p=0.002), social influence 
F=9.299, d.f.=3, 255, p=0.00), health screening experience (F=3.322, d.f.=3, 255, 
p=0.02) and knowledge (F=4.068 d.f.=3, 255, p=0.008) were statistically significant for 
health insurance status.  
Tukey’s post hoc tests for the direct measure of attitude indicated that the mean 
for the private insurance group (mean=8.067, s.d.=5.867) was significantly higher than 
the mean for the public insurance category (mean=5.146, s.d.=7.29, p=0.032) and the 





Games-Howell post hoc analysis used for social influence indicated that the 
mean for the private insurance group (mean=3.4778, s.d.=4.465) was significantly 
higher than the mean for the not sure group (mean=-0.0244, s.d.=6.16, p=0.09) and the 
mean for the public insurance group (mean=0.7708, s.d.=5.987, p=0.037). Furthermore, 
the mean for the no insurance/self-pay group (mean=4.275, s.d.=4.698) was 
significantly higher than the mean for the not sure group (mean=-0.0244, s.d.=6.16, 
p<0.01) and the public insurance group (mean=0.7708, s.d.=5.987, p<0.01). 
Tukey’s post hoc tests for health screening experience indicated that the mean 
for the public insurance group (mean=5.063, s.d.=2.427) was significantly higher than 
the mean for the not sure category (mean=3.220, s.d.=2.707, p=0.011).  
Tukey’s post hoc tests for knowledge indicated that the mean for the no 
insurance/self-pay group (mean=6.138, s.d.=3.838) was significantly higher than the 
mean for the not sure category (mean=4.146, s.d.=4.00, p=0.029) and the public 
insurance category (mean=4.313, s.d.=3.22, p=0.038). The results from the analysis can 
be found in Tables 4.52 – 4.57. 
 
 
F. Major Field of Study 
When analyzing the respondents’ major field of study and the independent 
variables, ANOVAs indicated that only knowledge (F=7.183, d.f.=2, 264, p<0.01) was 
statistically significant. Tukey’s post hoc test showed that the mean for the 
natural/healthcare sciences (mean=6.769, s.d.=4.134) was significantly higher than the 





the mean for the humanities (mean=4.894, s.d.=3.649, p=0.024). The results from the 
analysis can be found in Tables 4.52 – 4.57. 
 
G. Marital Status 
Participants’ marital status, analyzed via ANOVAs, showed statistical 
significance for direct attitude (F=4.698, d.f.=5, 256, p<0.001), indirect attitude 
(F=2.980, d.f.=5, 250, p=0.012), health screening experience (F=4.672, d.f.=5, 256, 
p<0.001) and knowledge (F=5.015 d.f.=5, 264, p<0.001) [See Tables 4.52 – 4.57]. Post 
hoc analysis via the Games-Howell was used for the direct measure of attitude; the 
mean for the married group (mean=8.25, s.d.=5.755) was significantly higher than the 
partner/living together group (mean=2.100, s.d.=4.459, p=0.019), and the mean for the 
single, not in a relationship group (mean=7.409, s.d.=6.061) was significantly higher 
than the partner/living together group (mean=2.100, s.d.=4.459, p=0.039).  
Games-Howell used for the indirect measure of attitude showed that the mean 
for the married group (mean=23.05, s.d.=21.274) was significantly higher than the 
single, in a relationship group (mean=11.209, s.d.=14.931, p=0.016).  
Tukey’s post hoc tests for health screening experience indicated that the mean 
for the divorced/separated group (mean=8.167, s.d.=1.472) was significantly higher 
than the single, in a relationship group (mean=3.625, s.d.=2.645, p=0.002) and the 
partner/living together group (mean=3.900, s.d.=1.853, p=0.002).  
The mean for the married group (mean=4.800, s.d.=3.25) was significantly 





and the mean for the partner/living together group (mean=3.900, s.d.=1.853) was 
significantly higher than the mean for the single, in a relationship group (mean=3.625, 
s.d.=2.645, p=0.026). Tukey’s post hoc tests for knowledge indicated that the mean for 
the married group (mean=6.875, s.d.=3.123) was significantly higher than the single, 
not in a relationship group (mean=4.409, s.d.=3.64, p<0.01) and the mean for the 
partner/living together group (mean=8.182, s.d.=3.97) was significantly higher than the 
single, not in a relationship group (mean=4.409, s.d.=3.64, p=0.02). 
 
 
H. Parents’ Educational Achievement 
Of all the independent variables, ANOVAs indicated that none were statistically 
significantly related to parents’ educational achievement. The results can be seen in 
Tables 4.52 – 4.57. 
 
 
I. Perception of Health Status 
Of all the independent variables, ANOVAs indicated that none were statistically 
significantly related to perception of health status. The results can be seen in Tables 
4.52 – 4.57. 
 
J. Regular Source Of Care 
Of all the independent variables, ANOVAs indicated that none were statistically 









Of all the independent variables, ANOVAs indicated that health screening 
experience [F=3.694, d.f.=2, 260, p=0.029] and knowledge [F=9.067, d.f.=2, 260, 
p<0.001] were statistically significantly related to residency. The results can be seen in 
Tables 4.52 – 4.57. Tukey’s post hoc tests for health screening experience indicated that 
the mean for the rural group (mean=5.684, s.d.=3.19) was significantly higher than the 
urban group (mean=3.836, s.d.=2.974, p=0.022) and the suburban group (mean=3.964, 
s.d.=2.559, p=0.039).  Games-Howell test for knowledge showed that the mean for the 
suburban group (mean=6.355, s.d.=4.019) was significantly higher than the mean for 









 Attitude (Direct) Attitude (Indirect) 
Academic Classification *F=2.601, d.f.=7, 256, p=0.01 F=0.84, d.f.=7, 249, p=0.553 
Annual 2012 Household Income t=-1.364, d.f.=257.474, p=0.174 *t=-2.609, d.f.=242.633, p=0.01 
Ethnicity *F=2.847, d.f.=5, 256, p=0.016 F=0.506, d.f.=5, 249, p=0.772 
Family history of prostate cancer  t=-0.159, d.f.=264, p=0.873 t=-1.823, d.f.=257, p=0.07 
Health Insurance Status *F=5.269 d.f.=3, 255, p=0.002 F=1.509,d.f.=3, 258, p=0.213 
Major field of study F=2.017, d.f.=2, 264, p=0.124 F=0.077, d.f.=2, 257, p=0.926 
Marital Status *F=4.698, d.f.=5, 256, p<0.001 *F=2.980, d.f.=5, 250, p=0.012 
Parents’ educational achievement F=1.44, d.f.=8, 258, p=0.18 F=1.729, d.f.=8, 251, p=0.09 
Perception of health status F=0.519, d.f.=3, 259, p=0.669 F=0.061, d.f.=3, 252, p=0.980 
Regular source of care  F=0.788, d.f.=6, 260, p=0.580 F=1.535, d.f.=6, 253, p=0.167 
Residency F=1.878, d.f.=2, 260, p=0.155 F=2.752, d.f.=2, 253, p=0.066 
aNote: results preceded by an asterisk (*) indicates statistical  significance. 




 Social Influence 
Academic Classification *F=2.133, d.f.=7, 256, p=0.041 
Annual 2012 Household Income t=-0.331, d.f.=251.563, p=0.742 
Ethnicity F=1.23, d.f.=5, 256, p=0.295 
Family history of prostate cancer  *t=-2.049, d.f.=257, p=0.041 
Health Insurance Status *F=9.299, d.f.=3, 255, p=0.00 
Major field of study F=0.271, d.f.=2, 257, p=0.763 
Marital Status F=1.123 d.f.=5, 256, p=0.348 
Parents’ educational achievement F=0.753, d.f.=8, 258, p=0.645 
Perception of health status F=0.256, d.f.=3, 259, p=0.857 
Regular source of care  F=0.826, d.f.=6, 260, p=0.550 
Residency F=2.026, d.f.=2, 260, p=0.134 












Academic Classification *F=2.402 d.f.=7, 256, p=0.021 
Annual 2012 Household Income t=-0.029, d.f.=259.908, p=0.977 
Ethnicity F=0.470, d.f.=5, 256, p=0.798 
Family history of prostate cancer  t=0.758, d.f.=264, p=0.449 
Health Insurance Status F=1.722 d.f.=3, 255, p=0.163 
Major field of study F=0.991, d.f.=2, 264, p=0.372 
Marital Status F=1.514, d.f.=5, 256, p=0.186 
Parents’ educational achievement F=0.83, d.f.=8, 258, p=0.60 
Perception of health status F=0.520, d.f.=3, 259, p=0.669 
Regular source of care  F=1.104, d.f.=6, 260, p=0.360 
Residency F=1.114, d.f.=2, 260, p=0.330 
aNote: results preceded by an asterisk (*) indicates statistical  significance. 
 




 Health Screening Experience 
Academic Classification F=1.564, d.f.=7, 256, p=0.146 
Annual 2012 Household Income t=1.910, d.f.=259.604, p=0.057 
Ethnicity *F=3.473, d.f.=5, 256, p=0.005 
Family history of prostate cancer  *t=-2.809, d.f.=264, p=0.005 
Health Insurance Status *F=3.322, d.f.=3, 255, p=0.02 
Major field of study F=2.288, d.f.=2, 264, p=0.103 
Marital Status *F=4.672, d.f.=5, 256, p<0.001 
Parents’ educational achievement F=1.16, d.f.=8, 258, p=0.353 
Perception of health status F=0.53, d.f.=3, 259, p=0.071 
Regular source of care  F=0.958, d.f.=6, 260, p=0.454 
Residency *F=3.694, d.f.=2, 260, p=0.029 












 Knowledge  
Academic Classification *F=6.47, d.f.=7, 256, p<0.00 
Annual 2012 Household Income t=1.570, d.f.=258.009, p=0.118 
Ethnicity F=1.925, d.f.=5, 256, p=0.091 
Family history of prostate cancer  *t=-2.429, d.f.=264, p=0.016 
Health Insurance Status *F=4.068 d.f.=3, 255, p=0.008 
Major field of study *F=7.183, d.f.=2, 264, p<0.01 
Marital Status *F=5.015 d.f.=5, 264, p<0.001 
Parents’ educational achievement F=1.027, d.f.=8, 258, p=0.416 
Perception of health status F=1.502, d.f.=3, 259, p=0.215 
Regular source of care  F=1.679, d.f.=6, 260, p=0.126 
Residency *F=9.067, d.f.=2, 260, p<0.001 
aNote: results preceded by an asterisk (*) indicates statistical  significance. 




 Exercise  
Academic Classification F=1.43, d.f.=7, 248, p=0.192 
Annual 2012 Household Income t=1.039, d.f.=258.009, p=0.118 
Ethnicity *F=2.978, d.f.=5, 248, p=0.012 
Family history of prostate cancer  *t=2.315, d.f.=256, p=0.021 
Health Insurance Status F=0.982 d.f.=3, 249, p=0.402 
Major field of study F =0.915 d.f.=2, 256, p=0.402 
Marital Status F=1.169,  d.f.=5, 248, p=0.325 
Parents’ educational achievement F=0.933, d.f.=8, 250, p=0.489 
Perception of health status F=1.954, d.f.=3, 251, p=0.121 
Regular source of care  F=1.134, d.f.=6, 252, p=0.343 
Residency F=0.121, d.f.=2, 252, p=0.886 






A. Academic Classification  
Pearson’s chi-square analysis was used to assess the relationship between cues to action and participants’ highest 
educational achievement. The chi-square analysis showed a significant relationship between cues to action and education 
levels (χ
2
 = 13.29, n = 264, df = 6, p = 0.04). The majority (20.6%) of participants with negative cues to action were junior 
(college) students, while the majority (29.1%) of those with positive cues to action was senior (college) students [See Table 
4.58]. 
Table 4.58: Chi-Square Test of Cues to Action
a
 by Academic Classification (N
b
=264) 
  High School 
Graduate or GED 


















0 N 19 42 29 42 32 22 22 13.29 6 0.04 
Row % 9.1 20.1 13.9 20.6 15.3 10.5 10.5 
1 N 3 8 6 4 16 8 10 
Row % 5.5 14.5 10.9 7.3 29.1 14.5 18.2 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 
bTotal does not equal 267 due to missing responses 





B. Annual Household Income 
Pearson’s chi-square analysis was used to assess the relationship between cues 
to action and income. The results did not show a significant relationship between cues 
to action and income levels (χ
2
 = 0.76, n = 263, d.f. = 1, p = 0.40) [See Table 4.59]. 
Table 4.59: Chi-Square Test of Cues to Action
a






  ≤$30,000 ≥$30,001 χ
2
-value d.f. p-value 
0 N 101 107 0.76 1 0.40 
Row % 48.6 51.4 
1 N 25 30 
Row % 45.5 54.5 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having 
someone close to them who ever had prostate cancer and “1” represents those with positive prostate cancer history or those who answered “Yes” to 
having someone close to them who ever had prostate cancer 
bIncome was dummy coded as “$≤30,000” and “≤$30,001.”  
cTotal does not equal 267 due to missing responses 







Pearson’s chi-square analysis was used to assess relationship between cues to action and ethnicity. The chi-square analysis 
did not show a significant relationship between cues to action and ethnicity. (χ
2
 = 9.04, n = 262, d.f = 5, p = 0.11). [See Table 
4.60] 







  AAA AFA AC A C Mixed χ
2
-value d.f. p-value 
0 N 130 26 5 39 4 3 9.04 5 0.11 
Row % 62.8 12.6 2.4 18.8 1.9 1.4 
1 N 41 2 2 6 1 3 
Row % 74.5 3.6 3.6 10.9 1.8 5.5 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 
bAAA represents African-American of American origin (born and grew up in America); AFA represents African-American of African origin (born in Africa but now American citizen); AC represents African-
American of Caribbean origin (born in one of the Caribbean Islands but now American citizen), A represents African, C represents Caribbean; Mixed represents those of mixed heritage 




D. Family History of Prostate Cancer 
Results from the Chi-square analysis showed a significant relationship between cues to action and family history of 
prostate cancer (χ
2





had a negative family history of prostate cancer, while the majority (53%) of those with positive cues to action also had a 
negative family history of prostate cancer [See Table 4.61]. 
Table 4.61: Chi-Square Test of Cues to Action
a





  0 1 χ
2
-value d.f. p-value 
0 N 207 4 103.74 1 <0.01
**
 
Row % 98.1 1.9 
1 N 26 29 
Row % 47.3 52.7 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 
b“0” represents those without a family history of prostate cancer; “1” represents those with at least one family history of prostate cancer 
cTotal does not equal 267 due to missing responses 
*Indicates significance at p < 0.05 
 
E. Health Insurance Status 
There was no statistically significant relationship from the Pearson’s chi-square analysis of cues to action and health 
insurance (χ
2
 = 5.48, n = 259, d.f = 3, p = 0.14) [See Table 4.62]. 
Table 4.62: Chi-Square Test of Cues to Action
a
 by Health Insurance Status (N
c
=259) 
  Private Public Not sure No Insurance/Self Pay χ
2
-value d.f. p-value 
0 N 68 42 36 60 5.48 3 0.14 
Row % 33.0 20.4 17.5 29.1 
1 N 22 6 5 20 
Row % 41.5 11.3 9.4 37.7 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 





F. Major Field of Study 
Pearson’s chi-square analysis was used to assess the relationship between cues to action and major field of study. The 
chi-square analysis did not show a significant relationship between cues to action and major field of study (χ
2
 =1.58, n = 267, 
d.f = 2, p = 0.46) [See Table 4.63]. 
Table 4.63: Chi-Square Test of Cues to Action
a
 by Major Field of Study (N
b
=267) 
  Professional & 
Applied Sciences 





-value d.f. p-value 
0 N 123 40 49 1.58 2 0.46 
Row % 58.0 18.9 23.1 
1 N 32 7 18 
Row % 58.2 12.7 29.1 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 





G. Marital Status 
Pearson’s chi-square analysis was used to assess the relationship between cues to action and marital status. The chi-
square analysis showed a significant relationship between cues to action and marital status (χ
2
 = 18.86; n = 262, d.f. = 5, p 
=<0.001). The majority (47%) of participants with negative cues to action were single, not in a relationship. While the 
majority (29.6%) of those with positive cues to action were either single, in a relationship or were single, not in a relationship 
[See Table 4.64]. 
Table 4.64: Chi-Square Test of Cues to Action
a
 by Marital Status (N
c
=262) 
  Single, in a 
relationship 
















34.6 13.9 1.4 47.1 2.9 0.0 
1 N 16 11 3 17 5 2 
Row 
% 
29.6 20.4 5.6 31.5 9.3 3.7 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 
b“1” represents “Single, in a relationship”; “2” represents “Single, not in a relationship/Widowed/Divorced/Separated”; and “3” represents “Married/Partner/Living together”  
cTotal does not equal 267 due to missing responses 







H. Parents’ Educational Achievement 
Pearson’s chi-square analysis was used to assess the relationship between cues to action and parents’ highest 
educational achievement. The chi-square analysis did not show a significant relationship between cues to action and parents’ 
education (χ
2
 = 4.95, n = 267, d.f = 4, p = 0.29) [See Table 4.65]. 
Table 4.65: Chi-Square Test of Cues to Action
a
 by Parents’ Educational Achievement (N
b
=267) 
  High School 
Graduate or GED or 
 Less than High 
School 








-value d.f. p-value 
0 N 56 57 40 42 17 4.95 4 0.29 
Row % 26.4 26.9 18.9 19.8 8.0 
1 N 13 19 6 15 2 
Row % 23.6 34.5 10.9 27.3 3.6 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 
bTotal does not equal 267 due to missing responses 





I. Perception of Health Status 
Results from the Chi-square analysis did not show a significant relationship between cues to action and perception of 
health (χ
2
 = 3.88, n = 263, d.f. = 3, p =0.28) [See Table 4.66]. 
Table 4.66: Chi-Square Test of Cues to Action
a
 by Perception of Health (N
b
=263) 
  Poor Fair Good Excellent χ
2
-value d.f. p-value 
0 N 3 29 116 61 3.88 3 0.28 
Row % 1.4 13.9 55.5 29.2 
1 N 1 11 22 20 
Row % 1.9 20.4 40.7 37.0 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 





J. Regular Source of Care 
Results from the Chi-square analysis did not show a significant relationship between cues to action and regular source 
of care (χ
2
 = 1.56, n = 267, d.f. = 1, p =0.14) [See Table 4.67]. 
Table 4.67: Chi-Square Test of Cues to Action
a
 by Regular Source of Care (N
b
=267) 
  No Yes χ
2
-value d.f. p-value 
0 N 93 119 1.56 1 0.14 
Row % 43.9 56.1 
1 N 19 36 
Row % 34.5 65.5 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having someone close to them who ever had prostate cancer and “1” 
represents those with positive prostate cancer history or those who answered “Yes” to having someone close to them who ever had prostate cancer 






Results from the Chi-square analysis did not show a significant relationship 
between cues to action and residency (χ
2
 = 4.64, n = 263, d.f. = 2, p =0.10) [See Table 
4.68]. 
 
Table 4.68: Chi-Square Test of Cues to Action
a
 by Residency (N
b
=263) 
  Urban Suburban Rural χ
2
-value d.f. p-value 
0 N 114 82 14 4.65 2 0.10 
Row % 54.3 39.0 6.7 
1 N 20 28 5 
Row % 37.7 52.8 9.4 
 
 
aCues to action was collapsed into two categories: “0” represents those with negative prostate cancer history and those who answered “No” to having 
someone close to them who ever had prostate cancer and “1” represents those with positive prostate cancer history or those who answered “Yes” to 
having someone close to them who ever had prostate cancer 





4.16 SUMMARY OF TESTS OF HYPOTHESES  
Table 4.69 shows the summary of the hypotheses test results. Sixteen of the 27 hypotheses (59%) were supported via 
direct measures, and four of the six hypotheses (66.7%) were supported using indirect measures. One (H11A) out of the six 
hypotheses (17%) yielded different results when comparing the direct and indirect measures In total, 20 out of 33 hypotheses 
were supported (61%) were supported – which included both the direct and indirect measures [See Table 4.69]. 
Table 4.69: Summary of Hypotheses Test Results 
Hypotheses Direct Measures Indirect Measures 
For the dependent variable – Intention  
H1A: Age, A, SI, C, CA, HS, and K will explain a significant amount of variance 
in I while controlling for demographic/personal factors. 
Supported N/A 
H2A: Age will be a positive and significant predictor of I while controlling for A, 
SI, C, CA, HS, K, and demographic/personal factors. 
Not Supported N/A 
H3A: A towards screening for prostate cancer will be a positive and significant 
predictor of I while controlling for Age, SI, C, CA, HS, K, and 
demographic/personal factors. 
Supported Supported 
H4A: SI will be a positive and significant predictor of I while controlling for Age, 
A, C, CA, HS, K and demographic/personal factors. 
Supported N/A 
H5A: C will be a positive and significant predictor of I while controlling for Age, 
A, SI, CA, HS, K, and demographic/personal factors. 
Not Supported N/A 
H6A: CA will be a positive and significant predictor of I while controlling for Age, 
A, SI , C, HS, K, and demographic/personal factors. 
Not Supported N/A 
H7A: HS will be a positive and significant predictor of I while controlling for Age, 
A, SI, C, CA, K, and demographic/personal factors. 
Not Supported N/A 
H8A: K will be a positive and significant predictor of I while controlling for Age, 






Table 4.69: Summary of Hypotheses Test Results (Continued) 
H9A: There is no difference between A and age. Supported Supported 
H10A: There is no difference between A and C. Not Supported Not Supported 
H11A: There is no difference between A and CA. Supported Supported 
H12A: There is no difference between A and HS. Supported Supported 
H13A: There is no difference between A and K Supported Supported 
H14A: There is no difference between SI and age. Supported N/A 
H15A: There is no difference between SI and C. Not Supported N/A 
H16A: There is no difference between C and age. Supported N/A 
H17A: There is no difference between C and HS. Not Supported N/A 
H18A: There is no difference between CA and age. Not Supported N/A 
H19A: There is no difference between HS and age Supported N/A 
H20A: There is no difference between K and age. Supported N/A 
H21A: There is no difference between K and HS. Supported N/A 
H22A: There is no difference between K and CA. Supported N/A 
 
For the dependent variable – Prostate Cancer Risk-Reduction Behavior 
H1B: Age, CA, Exercise, and K will explain a significant amount of variance in 
PCB while controlling for demographic/personal factors. 
Supported N/A 
H2B: Age will be a positive and significant predictor of PCB while controlling for 
CA, Exercise, K, and demographic/personal factors. 
Not Supported N/A 
H3B: CA will be a positive and significant predictor of PCB while controlling for 
age, exercise, K, and demographic/personal factors. 
Not Supported N/A 
H4B: Exercise will be a positive and significant predictor of PCB while 
controlling for age, CA, K and demographic/personal factors. 
Not Supported N/A 
H5B: K will be a positive and significant predictor of PCB while controlling for 










Figure 4.1: Conceptual Model Showing Significant Relationships with Intention 
a
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CHAPTER FIVE: DISCUSSION AND CONCLUSION 
 This study investigated the predictive ability of selected constructs from the 
theory of reasoned action (TRA) and additional predictors in understanding young black 
males’ intentions to screen for prostate cancer. In addition, factors affecting young 
black males’ current engagement in prostate cancer risk-reduction behaviors were 
examined. The study also examined the roles of participants’ demographic and personal 
factors on attitude (direct and indirect), social influence, exercise, comfortability, cues 
to action, health screening experience and knowledge. 
 This chapter provides a discussion of the study results. The first section 
discusses the results of the hypotheses of the study, evaluation of the study model, and 
possible explanations for the findings. The second section discusses the implications 
and directions for future research. The final section addresses the main limitations of the 
study and conclusions. 
 
5.1 DISCUSSION  
A discussion of the survey results are described in the following subsections. These 
include: intention to engage in prostate cancer screening, current engagement in prostate 









5.1.1 Intention To Screen For Prostate Cancer 
The overall mean intention score was somewhat low, suggesting that 
respondents had weak positive intentions toward screening for prostate cancer when it is 
recommended by a physician. Studies have shown that intention to undergo prostate 
cancer screening is higher if it is recommended by a doctor than if it is self-
initiated;
179,333,334
 perhaps the weak but positive intention to engage in prostate cancer 
screening observed in this study might be reflective of the potential impact of expert 
advice as an important component of health behavior
179
 and might therefore offer at 
least tangential evidence of the impact of physicians on cancer screening behaviors.
334
 
In the literature, intention has been shown to be a valid precursor and proxy for 
behavior; there is good correspondence between measures of an individual’s intention 
and their subsequent behavior.
261,303,335,336
 A systematic review by Eccles et al.
337
 
showed that on average, intention explained about 28 percent (range 15 – 40%) of the 
variance in subsequent behavior. Therefore, black men’s engagement in prostate cancer 
screening when it is recommended by a physician can be increased by targeting their 
intentions and the predictors of intentions.  
In this study, after controlling for demographic/personal factors, participants’ 
attitude (direct and indirect), social influence, comfortability (indirect) and knowledge 








5.1.1.1 Evaluation of the Study Model of Intention  
The hypothesis that the model would predict a significant amount of variance in 
intention to screen for prostate cancer was supported by the data. Using direct and 
indirect measures, the combination of attitude, social influence, comfortability (indirect 
model) and knowledge explained 41.0 and 43.0 percent of the variance in intention to 
screen for prostate cancer, respectively. Comparatively, Berglund, Nilsson & Nordin
179
 
conducted a study on men’s intentions to screen for prostate cancer when it is 
recommended by a physician and found that attitude, subjective norms and perceived 
behavioral control (all significant at p<0.05) explained 47 percent of the variance in 
intention.  
In the literature, the most significant predictors of intentions and behaviors 
were social influence and beliefs about capabilities and consequences.
338
 Upon 
reviewing the results of this study in comparison to others, social influence emerges as 
the strongest predictors of men’s intention to screen for prostate cancer. Men perhaps 
may feel more pressure from their peers, or family members to perform specific 
behaviors. This might explain why social influence was a strong predictor of black 
men’s intention to screen for prostate cancer in the current study as well. Moreover, 
studies have shown that black men regard friends and family as credible informal 
sources of health information and as sources of encouragement to adopt healthy 









5.1.1.2 Demographic and Personal Factors Associated with Intention 
Of the two demographic/personal factors included in the regression model, only 
perception of health status was significant with intention (direct model) to screen for 
prostate cancer. Compared to those who have a fair perception of health status, those 
who reported excellent health status were less likely to intend to engage in prostate 
cancer screening. This is contrary to findings from other studies examining 
demographic variables associated with intention to undergo prostate cancer 
screening.
12,339,340
 Eisen et al.
341
 observed that physical health problems significantly 
impact the likelihood of undergoing prostate cancer screening, suggesting that good 
health may be an index for engaging in preventive health practices. 
 In our study, fair health status was significantly and positively associated with 
intention to undergo prostate cancer screening. It could be that having some health 
problems (as suggestive in the cases of those with fair perceptions of health) could serve 
as a cue of some sort that could increase participation in future health screenings such 
as prostate cancer screening. Additionally, since most of the participants in our study 
were young, it was not surprising to see that those in excellent health had lower 
intentions to screen for prostate cancer, especially given that studies have shown black 
men who perceive their health to be excellent feel invincible and might be less likely to 










5.1.2 Participants’ Attitude Toward Prostate Cancer Screening 
In this study, it was hypothesized and supported that attitude would be 
significantly related to intention. Thus, an understanding of the factors affecting 
participants’ attitude could provide insight into how to increase prostate cancer 
screening participation among black men when it is recommended by a physician. 
Overall participants’ attitudes were positive which may indicate that young black men 
recognized the value of screening for prostate cancer when it is recommended by a 
physician. Other studies of black men also reported favorable attitudes toward screening 
for prostate cancer.
133,147,196
 Gelfand, Parzuchowski, Cort, and Powell
147
 conducted a 
study of Michigan black men between the ages of 40 and 70 (N=613). The majority of 
the participants (60%) strongly agreed that prostate cancer screening was important and 
would detect prostate cancer early. Several studies have also shown attitude toward 
prostate cancer screening to be a significant predictor of intention to engage in 
one,
147,254
 which is consistent with the current findings. 
 
5.1.2.1 Primary Drivers of Attitude 
The strongest positive beliefs driving attitude towards prostate cancer screening 
were opening one up to knowing whether one has prostate cancer or not, detecting 
prostate cancer early, and giving one peace of mind. Conversely, the more negative 
behavioral beliefs were screening being an unnecessary medical cost, invading of one’s 





 The most influential attitudinal beliefs (the product of behavioral beliefs and 
behavioral outcome) were: 1) opening one up to knowing whether one has prostate 
cancer or not and 2) detecting prostate cancer early. The literature is rich in examples of 
the benefits of prostate cancer screening.
342-344
 Undoubtedly, the most frequent benefit 
described is knowing whether one has prostate cancer or not,
75,146,344,345
 which is 
consistent with the present findings. In addition to knowing whether one has prostate 
cancer or not, detecting prostate cancer early was a strong positive attitudinal belief. 
Cancers detected early have survival rates of nearly 100% and these survival rates 
decrease significantly when the diagnosis comes at a later stage.
346
 Thus, focusing on 
beliefs such as these could be very productive in efforts to increase favorable attitudes 
toward prostate cancer screening in young black men.  
 
5.1.2.2 Factors Associated with Attitude 
In both the direct and indirect measures models, comfortability with prostate 
examinations was a positive and significant predictor of attitude toward prostate cancer 
screening. In the indirect measure model, health screening experiences was positively 
associated with attitude. 
Regarding comfortability, it is logical to assume that a higher comfortability 
with prostate examinations would be related to a more favorable attitude towards 
prostate cancer screening. Health screening experiences was also a positive and 
significant predictor of attitude towards prostate screening. Studies have not generally 





comfortability and health screening experiences. Future research is needed to more fully 
elucidate these relationships and their potential impact on screening intentions. 
 
5.1.2.3 Demographic and Personal Factors Associated with Attitude 
 Study results indicated that those that were sophomore (college), junior 
(college), graduate and postgraduate students had a more favorable attitude (direct 
measure) than those in the less than high school group. Thus, higher education 
positively influences attitudes. These findings are consistent with prior studies that 
examined the relationship between attitude and educational levels; where it was found 
that those with a lower educational level are more likely to have a less favorable attitude 
toward prostate cancer screening.
11,347
 
As for income, it was surprising to see that those in the lower annual income 
group (≤30,000) had more favorable attitudes than those in the higher income group (≥ 
30,001). This is in contrast to what is commonly obtained in the literature where those 
with a higher income are more likely to perceive prostate cancer screening in a positive 
light (have favorable attitude) as compared to those with a lower income 
11,13
 Our 
study’s contradictory findings might be because a majority of the participants were 
younger (less than 40 years) compared to other literature findings. However, more 
research is needed to further understand how income might play a role in attitude 





African-American men of American origin and African men held more 
favorable attitudes toward prostate cancer screening than did African-American men of 
Caribbean origin.  
Those with private health insurance had more favorable attitudes (direct) than 
those with public insurance and those in the not sure category. Previous studies 
described the likelihood of those with health insurance as having a more favorable 
attitude toward prostate cancer screening. 
143,160,253,348
 It is therefore logical to think that 
having private insurance might remove some of the hassles associated with healthcare 
access and thereby affect black men’s decision regarding prostate cancer screening. 
 Regarding marital status, those who were married had a more favorable attitude 
(direct) towards prostate cancer screening than those in the partner/living together and 
those in the married group had a favorable attitude (indirect) than those in the single/in 
a relationship group. These findings are consistent with previous studies that show the 
increased likelihood of married men having more favorable attitude towards prostate 
cancer screening than unmarried men.
28,349
 
These aforementioned demographic/personal factors (academic classification, 
annual household income, ethnicity, health insurance and marital status) can be used to 
target black men’s attitude toward screening and perhaps positively impact their future 









5.1.3 Participants’ Social Influence towards Prostate Cancer Screening 
Overall, participants’ social influence scores were low but positive. Social 
influence was statistically significantly related to intentions, which suggests that the 
views of important others might carry much weight in black men’s intention to screen 
for prostate cancer. This finding has mixed consistency with what is obtainable in the 
literature. While some studies in black men have shown social influence to be 





 For example, in a study by Weinrich et al.,
5
 social influence was the 
strongest predictor associated with intention to screen for prostate cancer. Similar 
findings were reported in another study by Woods, Montgomery, Herring, Garnder, & 
Stokols,
52
 where it was reported that black men were likely to undergo screening when 
they are positively engaged by friends, family members and physicians. In addition to 




To some extent, social influence may aid the decision-making processes 
associated with prostate cancer screening. This study examined social influence to the 
extent that significant referents are actively involved in prostate cancer screening; 
suggesting that perhaps, intention to screen for prostate cancer is impacted by those 
with whom participants consider relevant enough to impact their decision making 






5.1.3.1 Primary Drivers of Social Influence 
The overall mean of social influence was low. Overall, participants agreed that 
the people in their lives whose opinion they value would approve of them screening for 
prostate cancer. Participants also agreed that most people who are important to them 
will want them to screen for prostate cancer. The importance of “significant others,” 
especially in blacks, is well documented.
33,52,351,352
 Findings from the literature show 
that black men often defer to these significant others when making healthcare decisions. 
Conversely, the lowest mean from the items on the social influence measure was 
from the belief that many of ones’ peers will screen for prostate cancer when it is 
recommended by a physician, suggesting that many participants thought it was neither 
likely nor unlikely that many of their peers will screen for prostate cancer. The majority 
of the participants were young men, and therefore it is likely that their peers are not 
thinking about prostate cancer screening at early ages. 
 
5.1.3.2 Factors Associated with Social Influence  
Social influence was positively associated with comfortability with prostate 
examinations. More research findings are needed to further understand how 
comfortability might play a role in social influence. Based on this study finding, 
comfortability with prostate examination should be considered in designing 
interventions aimed at enhancing social influence regarding prostate cancer screening, 






5.1.3.3 Demographic and Personal Factors Associated with Social Influence 
Study results indicated that those in the postgraduate group had significantly 
higher social influence than those in the less than high school category. The differences 
in social influence, may illustrate an educational level difference among participants 
regarding prostate cancer screening. Prior studies have not yet focused much attention 
on the relationship between educational level and social influence toward prostate 
cancer screening, but this relationship could be examined in future  research in this area. 
Regarding family history, those with a positive family history had a significantly 
higher social influence when compared to those without a positive family history of 
prostate cancer. Perhaps, a positive family history makes important others more salient 
in their decision-making regarding prostate cancer screening.  
There was a significant difference in social influence scores between those in the 
private insurance group and public insurance group. This suggests that having private 
insurance might make one more salient in decisions regarding prostate cancer screening. 
Recognizing the significant demographic and personal factors (academic 
classification, family history, and health insurance) can lead to creating effective 
policies directed toward improving social influence among young black men intending 
to screen for prostate cancer.  
 
5.1.4 Participants’ Comfortability with Prostate Examinations 
 Overall, participants exhibited a neutral comfortability towards prostate 





that participants were neither comfortable nor uncomfortable with prostate 
examinations. Findings from the literature have shown that black men generally show 
discomfort toward prostate examinations.
33,34,159,163,353
 There is much anxiety associated 
with prostate examinations and studies have shown that younger black males have 
expressed fear and disapproval regarding prostate examinations.
163
 As hypothesized in 
this study, comfortability was positively and significantly associated with intention to 
screen for prostate cancer in the indirect model. 
 
5.1.4.1 Primary Drivers of Comfortability 
The strongest contributor to comfortability was when screening is conducted by 
someone who acts in a professional manner. Given how serious and fearful black men 
are regarding prostate examination,
6,116,159,160,354
 it was not surprising to see that 
professionalism exhibited on the part of the examiner was a major driver of 
comfortability. Furthermore, in this study, prostate examination conducted by a female 
was the second highest driver of comfortability. Studies have shown that a sense of 
vulnerability and defenselessness associated with positioning during examination may 
interfere with both the physical and psychological distress associated with the 
examination.
34,139
 Therefore, it is logical to think that black men might feel more 
comfortable in the presence of the opposite sex while undergoing such a “vulnerable” 
examination. This finding is in contrary to what is in the literature, especially among 
men over the age of 40. In a study by Heaton et al.,
355
 126 men were surveyed on their 





expressed a specific preference for a male examiner and 62 percent gave no preference; 
none expressed a preference for a female examiner. This is consistent with findings 
from other studies.
32,356
 Given that studies have examined beliefs regarding prostate 
examination in older men, where it has been shown that these men prefer male 
examiners; it would appear that there is something different about younger men that 
drives their preference for female examiners. 
 
5.1.4.2 Factors Associated with Comfortability  
This study found that health screening experience was a positive and significant 
predictor of comfortability with prostate examination. This is consistent with findings 
from the literature.
147,163
 In this study, health screening experience was operationalized 
as experiences encountered during prostate cancer screening and other “invasive” 
procedures. Gelfand, Parzuchowdki, Cort & Powell
147
 surveyed 613 black men between 
the ages of 40 and 70 regarding their comfortability regarding digital rectal 
examinations. They found that having a past and favorable rectal examination was 
positively significant with comfortability with prostate examinations. It would appear 
that being exposed to some form of “invasive” procedures and having favorable 
experiences during such procedures will be positively and significantly associated with 
comfortability with prostate examinations. 
Unlike girls and women in the United States, the importance of regular physical 
exams is not instilled in men. Courtenay
357
 suggested that the greater use of the 





also be taught to boys and men. A classic example is how women are taught at a 
younger age that physical exams involves genital examinations.
358
 The same cannot be 
said of men who do not have the same social upbringing; not until much later in life 
when rectal examinations need to be done on a regular basis.
358
 Perhaps, if men were 
exposed early on to these examinations, they may see them less as a threat to their 
masculinity when the time comes.
358
 
For successful improvement of men’s comfortability with prostate examinations, 
past health screening experiences should be considered. 
 
5.1.4.3 Demographic and Personal Factors Associated with Comfortability 
 College junior participants had significantly higher comfortability as compared 
to college senior participants. This indicates that college junior students were more 
comfortable with prostate examinations compared to their college senior counterparts. It 
can be speculated that junior students, who are likely to be younger, may not view 
prostate examination with so much discomfort compared to senior college participants, 
who are likely to be older. Although, there are likely many interrelating factors that 
might be responsible for these findings.  
 
5.1.5 Participants’ Knowledge of Prostate Cancer and Screening 
 Responses on knowledge items in this survey showed a general lack of 
knowledge regarding prostate cancer and screening, which is consistent with findings in 





prostate cancer and screening when compared to Caucasians.
15,354,359
 The mean score 
was a 5.25 out of a possible score of 14. 
Knowledge was a significant predictor of both intention to screen for prostate 
cancer and engagement in prostate cancer risk-reduction behaviors. There was a 
statistically significant positive association between knowledge and prostate cancer 
intention. While some studies assessing prostate cancer and screening knowledge have 
not done so with the aim of assessing its association with intention to screen,
160,354,360-362
 
other studies have shown that knowledge regarding prostate cancer screening is a 
predictor of screening intentions.
16,166,253,254,363,364
 Findings from this study support the 
notion that improving knowledge regarding prostate cancer and screening is warranted 
in young black men and that improved knowledge may positively influence screening 
rates when recommended. 
 Results from this study are also comparative with commonly held beliefs from 
literature
14,354
 that knowledge contributes to positive health behaviors (e.g., risk 
reduction). Although knowledge was operationalized differently in the studies by 
Winterich et al.
347
and Weinrich et al., 
14 
the domains used in these studies and ours are 
similar. 
 
5.1.5.1 Factors Associated with Knowledge 
Age, cues to action and health screening experiences were all positive and 
significant predictors of knowledge regarding prostate cancer and screening. 





findings from a study by Agho and Lewis
253
 where age (40 – 70 years) was a negative 
and significant predictor of knowledge. 
Cues to action and health screening experiences were significant in predicting 
knowledge in this study but have not been the subject of previous investigations in the 
area.  Thus, more research is needed to further establish these relationships. These 
aforementioned cognitive-behavioral factors may be targeted to improve black men’s 
knowledge of prostate cancer and screening and their subsequent engagement in 
prostate cancer screening when recommended. 
 
5.1.5.2 Demographic and Personal Factors Associated with Knowledge 
The postgraduate group had higher knowledge means than those in the lower 
education group. Increasing education level has been significantly associated with 
increased knowledge regarding prostate cancer and screening.
295,365
 These findings from 
the literature are consistent with our study findings.  
Regarding family history, those with a positive family history had a significantly 
higher knowledge mean when compared to those without a positive family history of 
prostate cancer, which is consistent with previous findings that link higher knowledge 
levels to positive family history of prostate cancer.
361,366,367
  
There was a significant difference in knowledge scores between those in the no 
insurance/self-pay group and public insurance group and not sure category. Participants 
in the natural & healthcare sciences had significantly higher knowledge scores than 





speculated that pursuing a degree related to natural & healthcare sciences (where one is 
exposed to disease conditions such as prostate cancer) increases one’s knowledge of or 
at least interest in prostate cancer. Furthermore, those in a relationship (married or 
partner/living together) had significantly higher scores than those who were single/not 
in a relationship, which is also consistent with findings in the literature.
15,368
 
A better understanding of these specific demographic and personal factors that 
affect knowledge of prostate cancer and screening can be areas of opportunity to 
educators and policy makers.  
 
5.1.6 Factors Associated With Cues To Action 
In this study, age was significantly and negatively associated with cues to action. 
Those with negative cues to action were younger compared to those with positive cues 
to action. It appears that younger men are not exposed to cues or triggers associated 
with prostate cancer screening. This is inconsistent with findings in the literature,
369
 
where age has been shown to be a positive and significant predictor toward prostate 
cancer screening. Of course, the inconsistency in our study findings could be due to 
participants from our study being younger compared to other studies. Not many studies 
have conceptualized the relationships between age and cues to actions regarding 








5.1.7 Participants’ Engagement in Prostate Cancer Risk-Reduction Behavior 
The overall mean of prostate cancer risk-reduction behavior was low, with a 
median of 13.0.  This is because most of the respondents were not taking vitamins and 
supplements to prevent prostate cancer. This is not surprising given that the age range 
of the respondents in the study was less than 40 years and it is not expected that they 
would be using prostate cancer supplements at such age. Most of the men ate fruits, 
butter/oil, vegetables, and dairy products 1 – 3 times a week. However, most of the 
respondents consumed meat products 2 or more times a day. These findings are 




5.1.7.1 Evaluation of the Study Model of Prostate Cancer Risk-Reduction Behavior 
The overall model accounted for 10 percent of the variance in engagement in 
prostate cancer risk-reduction behavior. Knowledge was found to be the only predictor 
that was positively and statistically significant with engagement in prostate cancer risk-
reduction behavior. It is therefore important that targeted, culturally effective 
interventions aimed at black men to encourage engagement in risk-reduction behaviors 
be developed using their knowledge regarding prostate cancer and screening. 
Our study findings regarding prostate cancer risk-reduction behaviors and 
knowledge are consistent with findings among older black men.
321
 A cross-sectional 
study by Odedina et al.
321
 assessed the effect of knowledge on prostate cancer risk-
reduction behavior in 2,648 black men aged between 40 and 70 years. Their study 





prostate cancer risk-reduction behavior (β= 0.25, P<0.01). Thus, knowledge is 
important to engaging in risk reduction behavior across the life course in black men. 
 
5.1.7.2 Demographic and Personal Factors Associated with Risk-Reduction 
Behavior 
The three demographic/personal factors (academic classification, major field of 
study and residency) included in the regression model were significant with intention to 
screen for prostate cancer. Regarding academic classification, compared to those in less 
than high school/High school graduate or GED category, engagement in risk-reduction 
behavior reduces with increasing educational levels. Although studies have not yet 
shown a direct relationship between educational levels and engagement in preventive 
behaviors, other findings have shown that highly educated people tend to be more 
proactive about their health than those with low education levels.
168
 Our own study 
findings contradict these reports. More studies are needed to clearly understand the role 
of education on preventive behaviors. 
Compared to those in the natural/healthcare sciences, those in humanities and 
professional/applied sciences have significantly lower levels of engagement in 
preventive behaviors. It can therefore be speculated that those in the natural/healthcare 
science field may be more proactive about their health due to their knowledge about 
healthy behaviors. However, there are likely many interrelating factors affecting this 
result. Therefore, educational efforts should attend to the knowledge needs of non-





With regards to residency, engagement in preventive behaviors was positively 
associated with residing in rural areas compared to those residing in suburban areas. 
Paradoxically, rural residents are usually less advantaged than their suburban/urban 
counterparts due to limitations set by geographical, economic and cultural barriers 
which in turn limits access to health care.
228,229
 Perhaps this dynamic is different in 
young black men and warrants further study. 
A better understanding of these specific demographic and personal factors that 
affect engagement in prostate cancer risk-reduction behavior can be areas of 
opportunity for educators and policy makers.  
 
5.1.8 Participants’ Knowledge of Prostate Cancer and Screening 
Similar in the intention model, knowledge of prostate cancer and screening was 
significantly and positively associated with engagement in prostate cancer risk-
reduction behavior. This suggests the potential impact of improving knowledge in this 
population of black men. Knowledge of prostate cancer and screening is critical in 
predicting young black men’s intention to screen for prostate cancer and engage in 
prostate cancer risk-reduction behaviors. 
 
5.1.9 Implications for Healthcare Research 
There are several implications for healthcare research and education within 
community settings. Prostate cancer screening still remains the best available method of 





have been shown to have the lowest participation rates in prostate cancer screening and 
higher incident rates of prostate cancer, compared to men of other ethnicities. It is 
therefore important that interventions in the form of tailor-made educational programs 
are developed for black men. These educational programs must take into consideration 
a variety of health values and appropriate social influences that are relevant to black 
men.  
 To encourage prostate cancer screening and prostate cancer engagement in risk-
reduction behaviors, healthcare researchers must also be aware of the relevant 
cognitive-behavioral factors that may impact prostate cancer screening and engagement 
in risk-reduction behaviors among black men. This recognition factor is important and 
should be adequately reflected in ways that ensure that interventions regarding prostate 
cancer screening are properly developed and delivered. The results from this study are 
of special importance to healthcare workers who serve young black men. 
 
5.1.10 Suggestions for Future Research 
This study identified some of the salient issues and factors related to young 
black males’ intentions to screen for prostate cancer and their engagement in prostate 
cancer risk-reduction behavior. It is essential that black males be provided with an array 
of options with respect to becoming more aware of prostate cancer and means to 
preventing it. Adequate information has the potential for increasing knowledge and 
awareness of prostate cancer and its risk factors, while education provides an avenue for 





men’s decision is a key step in advancing the appropriate use of prostate cancer 
screening as well as engagement in prostate cancer risk-reduction behavior.  
Several opportunities exist for future research in the area of prostate cancer 
screening and engagement in prostate cancer risk-reduction behavior. Some questions 
from these study findings are implications for future research and they include: a) What 
additional factors influence intentions to screen for prostate cancer or engagement in 
risk-reduction behaviors? b) To what extent does perceived behavioral control toward 
prostate cancer screening affect intention to screen for prostate cancer in young black 
men? c) How do the factors explored in this study vary by other races/ethnicities? d) 
Are there other environmental and cognitive-behavioral factors that play significant 
roles in encouraging or discouraging prostate cancer screening? 
As this study focused on the intention to screen for prostate cancer, future 
studies are needed to examine actual behavior. Current and future studies will 
ultimately affect the ongoing debate between policy, advocacy and utilization of 
prostate cancer screening in the years to come.  
In addition, studies suggest that men who engage in preventive behaviors 
(screening) in early years are more likely to be committed to these behaviors in their 
later adult years. When this is coupled with other healthy lifestyle behaviors such as 
engaging in regular exercise, maintaining ideal body weight, using supplements, 
increasing intake of fruits and vegetables, men can adopt healthy preventative 
advantages over several diseases, including prostate cancer. Although engaging in early 





choices may help to at least reduce prostate cancer incidence rates among black men 
and improve their overall quality of life. Future research can help by delineating the 
most effective strategies for encouraging the uptake of preventative health behaviors in 
the younger adult years of black men. 
 
5.2 STUDY LIMITATIONS 
Findings from this study should be interpreted in light of several limitations as 
discussed below. First, the study design used was a cross-sectional one and the findings 
provide a one-time scenario only. Therefore, causality cannot be inferred from the 
structural relationships as these relationships may change over a period of time. 
Second, self-report measures of both the paper-pencil and web-based surveys were 
used, which are susceptible to inaccurate responses. Furthermore, given the anonymous 
nature of this study, participants’ responses could not be verified. Participants’ 
responses could have been influenced by response bias, social desirability, poor recall 
or acquiescence factors related to expected behavior.
370,371
. It is possible that some 
participants provided socially desirable responses to question regarding attitude, social 
influence, cues to action and intentions. Responses such as these make it difficult to 
interpret study findings especially if participants overestimate their behaviors. For 
example, in this study 12 black men reported having a positive personal history of 
prostate cancer even though studies have shown that prostate cancer rate is 1 in 10,000 
in men under age 40.
88






Third, the survey length may have been discouraging to some responders. The 
paper-pencil survey was 9 pages long and consisted of 87 items. It is likely that some 
respondents may have found the items in the survey instrument to be too long and as 
such affected the way they responded. Furthermore, because the online survey employs 
a forced-response design, another limitation may be that the online responders may give 
random answers. This effect has been described as reactance phenomenon, which 
manifests when pressure is exerted on individuals to adopt specific views or attitudes 
and as a result, exhibit directly contradicting norms.
331
 
Finally, there was no time frame specified for the measure of intention so it is 
possible that the intention scores may have been inflated, which may reduce the 
accuracy of the predictive ability of intention in future behavior. Nonetheless, this might 
not be an immediate threat to the validity of the study findings because this study did 
not investigate the relationship between intention and behavior.  
 
5.3 CONCLUSION 
In conclusion, this study described the intention of young black males (ages 18 – 
40 years) to screen for prostate cancer and their engagement in prostate cancer risk-
reduction behaviors and delineated the factors related to both intention and prostate 
cancer risk-reduction behavior. The study concludes the following regarding black men 
aged between 18 and 40 years: 
Young black males had a weak positive intention to screen for prostate cancer 





intention to screen for prostate cancer was useful; the direct model explained 41 percent 
while the indirect model accounted for 43 percent of the variance in intention. The 
constructs – attitude (direct and indirect), social influence, comfortability (indirect) and 
knowledge – were significant determinants of intention to screen for prostate cancer 
with social influence being the strongest predictor, followed by attitude and knowledge. 
The levels of these predictors varied by demographic and personal variables.  
Young black males’ engagement in prostate cancer risk-reduction behavior was 
low. The model used to predict this behavior explained 10 percent of the variance in 
behavior. The construct – knowledge – was the only significant determinants of 
engagement in prostate cancer risk-reduction behavior. Knowledge varied by 
demographic/personal factors. 
To our knowledge, this is the first study to incorporate a theoretical model to 
investigate young black men’s intention to screen for prostate cancer and their 
engagement in prostate cancer risk-reduction behavior. As such, significant direct and 
indirect model predictors relating to intention to screen for prostate cancer and 
engagement in prostate cancer risk-reduction behavior have been identified. A more 
thorough understanding of these significant predictors [attitude, social influence and 
knowledge (relating to intention to screen for prostate cancer); as well as knowledge 
(relating to engagement in prostate cancer risk-reduction behavior)] will allow 
researchers, educators, healthcare professionals, patients, and policy makers to adopt 
relevant strategies and allocate resources to enable young black men to screen for 





cancer risk-reduction behavior. Reducing the disparity gaps in prostate cancer and 
solving the problem of low participation rates in prostate cancer screening and risk-


















Appendix A: Focus Group Recruitment Details 
 
Black Men and Prostate cancer! 




Photo from http://trialx.com/curetalk/2013/01/prostate-cancer-and-baldness-in-men-linked/ 
Purpose: To explore and understand the 
determinants of Black men’s intention to screen 
for prostate cancer. 
Compensation: $20 VISA gift card 
Contact:tmadedipe@utexas.edu  
Contact: Motolani Ogunsanya  
512-471-2374 or email tmadedipe@utexas.edu 
 
 
WHO: Black American men 
(Ages 18 – 40) 
WHAT: Focus group study 
(1 hour) 
WHEN: June – July 2013 
 







Focus Group- Recruitment/Initial Email Script 
Study Title: Attitudes and Behavioral Intentions Toward Prostate Cancer 
Screening Among Black Men Aged 18 to 40 Years  
Dear ________________________________ (Participant Name),  
My name is Motolani Ogunsanya from the University of Texas at Austin College of 
Pharmacy (UT-COP), and I am conducting a research study to understand the 
determinants of Black men's intention to screen for prostate cancer.  This research is 
very exciting and has the potential to shed light on the factors that would encourage or 
prevent you from participating in prostate cancer screening.  The information obtained 
from this focus group will be used to develop a survey that will be administered to a 
larger group of Black men. 
This research can only be successful with the generous help of people like you.   
Because you are a Black male, between the ages of 18 and 40, we would formally like 
to ask for your participation in this most important research.  If you are interested, 
please read the information below and respond to this email by providing the 
information requested.    
Requirements for participation: 
1. Participation in approximately a 1-hour focus group that will be held at UT-COP 
and Huston Tilloston University, during convenient times to accommodate 
weekend and evening schedules.   Specific details will be provided before the 
meeting.   
2. All records will be confidential, and study records will be stored securely.  
Reponses will only be reported in aggregate form and results can in no way be 
linked to you.   Specific details regarding confidentiality, data tracking, and 
reporting will be provided in the study-related consent forms, which will be 
provided before data are collected. 
 
Benefits for participation:  
You will receive no direct benefit from participating in this study; however, 
society, in particular other black men, may benefit from the knowledge gathered in 
the focus group.  There is also the possibility of enhancing your knowledge of 
prostate cancer screening.  The information gathered from this study will increase 
our understanding of the factors influencing Black men's intentions to screen for 
prostate cancer.  Ultimately, we hope that this information will serve as a basis for 
the development of educational programs for patients, health-care providers and 
policy makers as well as a baseline for future research.   
Compensation 





If you have any questions, please do not hesitate to contact me (Carolyn Brown) by 
phone at 512.471.2374 or tmadedipe@utexas.edu. Also, if you have questions about 
your rights or are dissatisfied at any time with any part of this study, you can contact, 
anonymously if you wish, the Institutional Review Board by phone at (512) 471-8871 
or email at orsc@uts.cc.utexas.edu. Thank you in advance for your time and 
consideration.  We hope to hear from you soon.  Note: You can reply to this email.   
 
If you are interested in participating in this most important research project, please 





Best Contact Phone Number: _______________________________ 
 
What is the best time to participate in a focus group (Please place an X by your 
responses)? 
 
Time of week 
Weekend ______ 
Weekday ______ 
Both weekend and weekday______ 
 
Time of day 
Evening______ 
Day______ 








The University of Texas at Austin 
College of Pharmacy 







Appendix B: Focus Group Consent Forms 
 
IRB USE ONLY 
Study Number: 2013-02-0134 
Approval Date: 10-15-2013 
Expires:       
 
Consent for Participation in Research  
Title: Attitudes and Behavioral Intentions Toward Prostate Cancer Screening Among Black 
Men Aged 18 to 40 Years  
Principal Investigator: Motolani E. Ogunsanya 
Phone Number: 512-775-8720  
 
Introduction 
The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study.  The person performing the research will 
answer any of your questions.  Read the information below and ask any questions you might 
have before deciding whether or not to take part. If you decide to be involved in this study, this 
form will be used to record your consent. 
Purpose of the Study 
You have been asked to participate in a research study about prostate screening intentions 
among Black males. The purpose of this study is to get a better understanding of the advantages 
and disadvantages of screening for prostate cancer according to your views as a black man.  
What will you to be asked to do? 
If you agree to participate in this study, you will be asked to: 
1. Discuss your beliefs regarding prostate cancer screening; and 
2. Participate in a focus group discussion with 6-10 Black men; and 
3. Respect and protect the confidentiality of the other participants in this focus group. 
 
Total estimated time to participate in the study is 1 to 1.5 hours. The study will include thirty 
participants and your participation will be audio recorded. 
What are the risks involved in this study? 
Loss of confidentiality - The researchers will protect the confidentiality of all participants in this 
focus group by using pseudonyms when transcribing data from the discussion. The digital 
recordings will be kept locked in the principal investigator's office. After they have been 
transcribed, the digital recordings will be destroyed. The research may involve risks that are 
unanticipated. Because all study personnel will be trained, there is little potential for physical, 





It is unlikely that the counseling, questionnaires, or interviews will lead to any potential legal, 
social, or psychological problems. 
If you wish to discuss the information above or any other risks you may experience, you many 
ask questions now, or call the Principal Investigator contact phone number listed at the top of 
the page.  
What are the possible benefits of this study? 
You will receive no direct benefit from participating in this study; however, society may benefit 
from the knowledge gathered in the focus group. There is the possibility of enhancing your 
knowledge of prostate cancer screening.  
 
Do you have to participate? 
No, your participation is voluntary. You may decide not to participate at all or, if you start the 
study, you may withdraw at any time. Withdrawal or refusing to participate will not affect your 
relationship with The University of Texas at Austin, Huston Tillotson University, or your 
church in anyway.  
Compensation 
You will receive a $20.00 Visa gift card for your participation upon completion of the focus 
group.  
 
Confidentiality or Privacy Protections 
 The records of the data will be stored securely and kept confidential. 
 
Audio/video recordings will be made include the following statements: 
If you choose to participate in this study, you will be audio recorded.  Any audio recordings 
will be stored securely and only the research team will have access to the recordings.  Once the 
recordings have been transcribed, they will be erased. This study is confidential and 
pseudonyms will be associated with data collected from the focus group session. All audio 
recordings will be void of any personally identifying information or marks by using 
pseudonyms for each study participant prior to the start of audio recording. Any publications 
resulting from this study will exclude any information that will make it possible to identify any 
person in the study. Throughout the study, the researchers will notify you of new information 
that may become available and that might affect your decision to remain in the study. The data 
collected from this study will be destroyed at the completion of the study. 
Whom to contact with questions about the study?   
Prior, during or after your participation you can contact: Motolani Ogunsanya at 512-775-8720 or 
send an email to tmadedipe@utexas.edu. The study has been reviewed and approved by The 






Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you can contact, 




If you agree to participate please sign and return the consent form to designated research 
assistant. You will receive a copy of this form. 
 
Signature   
You have been informed about this study’s purpose, procedures, possible benefits and risks, and 
you have received a copy of this form. You have been given the opportunity to ask questions 
before you sign, and you have been told that you can ask other questions at any time. You 
voluntarily agree to participate in this study.  By signing this form, you are not waiving any of 
your legal rights. 
______________________________ 
Printed Name  
_________________________________    _________________ 
Signature Date 
As a representative of this study, I have explained the purpose, procedures, benefits, and the 
risks involved in this research study. 
 
_________________________________      
Print Name of Person obtaining consent      
_________________________________    _________________
  








Appendix C: Focus Group Moderator Guide 
Hello, my name is Motolani Ogunsanya and I will be the moderator for this focus group session.  
The purpose of this focus group session is to talk with you about your beliefs regarding prostate 
cancer screening, such factors that would encourage or prevent you from participating in 
prostate cancer screening.  The information obtained from this focus group will be used to 
develop a survey that will be administered to a larger group of Black American men. 
This session will be audio recorded.  However, no names will be used for any portion of the 
larger study.  Fake names will be used instead of your real names once I begin recording.  Here 
are the name cards to place in front of you; these will be used to identify each of you from this 
point forward.  Information obtained from this focus group session will not be associated with 
any specific focus group participant.  The purpose of the audio recording during the focus group 
session ensures that all the important information is captured and available for inclusion in the 
final questionnaire.  The audio tapes will be stored in a locked file cabinet and will be used only 
by research personnel.  This session is expected to last about an hour and you have the right to 
stop participating at any time. 
Confidentiality is important and any publication or presentations derived from this discussion 
will not identify any individual in any way.  Also whatever is discussed in this room will not be 
shared with anyone not associated with the research study. 
 
Here is a copy of the consent form that you may read and sign.   
Group Rules 
As the session moderator, I will ask the questions and keep everyone on track.  I will keep track 
of time, and therefore, I may need to interrupt the discussion to move forward in the interest of 
time.  It is important that everyone feels comfortable and at ease during the discussion.  There is 
no right or wrong answer to any of the questions.  You are encouraged to speak freely about the 
issues discussed as everyone’s input is valuable to the discussion.   
The moderator will give participants a few minutes to write down answers to each 
question below and then discuss them as a group.  Participants will be a given a sheet of 
paper to record their response. 
General Question 










2. What do you believe are the advantages of screening for prostate cancer? 
3. What do you believe are the disadvantages of screening for prostate cancer? 
 
The moderator will probe participants regarding factors that could hinder or facilitate 
screening for prostate cancer.  The participants will be given a few minutes to write down 
their answers to the questions below. 
 
Probe: Take a moment to jot down your experience with any physicals that included 
being touched in places where you were not comfortable with? Tell me more about 
that experience. 
Probe: Do you think that being exposed early to these kinds of “physicals” might 
make it easier for Black American men to be more comfortable with prostate 
examination when the time comes? 
4. Are there any other factors that come to mind when you think about screening for prostate 
cancer? 
 
The moderator will probe for details regarding responses when appropriate to facilitate 
further discussion.  The written answers will be collected after each series of questions and 
each time participants will be reminded to omit their names or any other personally 
identifiable markers. 
Conclusion - We have covered the desired topics today.  Do you have anything that you 
want to add with respect to what we talked about? Any final observations or comments? If 










Appendix D: Survey Recruitment Materials 
Know Events Recruitment (For recruiting Black male participants at UT Austin) 
Black men sought to partake in internet survey about prostate cancer screening 
Description: Black men (aged between 18 – 40 years) are sought to participate in an 
internet survey designed to examine the intention of Black men to screen for prostate 
cancer when it is recommended by a physician. It is estimated that it will take 
approximately 20 minutes of your time to complete the questionnaire. If interested, 
click on the following link: http://goo.gl/nZVBnZ  
Contact email: tmadedipe@utexas.edu  
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Photo from http://trialx.com/curetalk/2013/01/prostate-cancer-and-baldness-in-men-linked/  
WHO: Black men   (Ages 18 – 40) 
 
WHAT: Web-based Survey Research 
(Approximately 20 mins) 
 
 
Purpose: To understand factors that 
influence black men’s intentions to 
screen for prostate cancer. 
Compensation: $10 HEB Gift Card 
 
Visit http://goo.gl/nZVBnZ 
to complete the survey 
Contact email: tmadedipe@utexas.edu  
 
Scan this QR 
code with your 
cell phone to 
access the survey. 
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Example:  Email/Phone/Face to Face Scripts for Recruitment via Student 
Organizations (e.g., UT Black Fraternities and the African American Culture 
Committee)  
Title: UT Austin Researcher Seeks Black men (aged 18-40) to participate in survey  
Hello, 
My name is ________________ from the University of Texas at Austin College of 
Pharmacy (UT-COP), and I am conducting a research study to understand the 
determinants of Black men's intention to screen for prostate cancer. This research is 
very exciting and has the potential to shed light on the factors that would encourage or 
prevent young men from participating in prostate cancer screening when recommended 
by their doctor. Your participation in the study will contribute to a better understanding 
of what factors help drive your intentions to screen for prostate cancer. 
Eligible participants must be of African American/Black race/ethnicity, male and 
between the ages of 18 and 40 years. This entails filling out a survey, it is estimated that 
this will take 20 minutes of your time.  
Do you have any questions at this time? If you have any questions (or additional 
questions) in the future, please don’t hesitate to contact us at the phone number or email 
provided below. 
The link to the survey is below: http://goo.gl/nZVBnZ  
Thanks for your time and have a great day! 
  
 
 240  
  
Example: Email/Phone/Face to Face Script for Communication with Key 
Administrators at Local Universities/Colleges, Churches and Surrounding 
Community 
Title: UT Austin Researcher Seeks Black men (aged 18-40) to participate in a 
survey research 
Hello, 
My name is Motolani Ogunsanya from the University of Texas at Austin College of 
Pharmacy (UT-COP), and I am conducting a research study to understand the 
determinants of black men's intention to screen for prostate cancer. This research is very 
exciting and has the potential to shed light on the factors that would encourage or 
prevent young men from participating in prostate cancer screening when recommended 
by their doctor. Your participation in the study will contribute to a better understanding 
of what factors help drive your intentions to screen for prostate cancer. 
Eligible participants must be of African American/Black race/ethnicity, male and 
between the ages of 18 and 40. This entails filling out a survey, it is estimated that this 
will take 20 minutes of your time.  
Do you have any questions at this time? If you have any questions (or additional 
questions) in the future, please don’t hesitate to contact us at the phone number or email 
provided below. 
The link to the survey is below: http://goo.gl/nZVBnZ  
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Prostate Cancer Prevention and Early Detection Decisions Among Black Males 
Less than 40 Years 
 
Consent to Participate in Internet Research 
 
You are invited to participate in a research study, entitled “Prostate Cancer Prevention 
and Early Detection Decisions Among Black Males Less than 40 Years.” The study is 
being conducted by Motolani Ogunsanya, B.Pharm, College of Pharmacy and Carolyn 
Brown, PhD, College of Pharmacy of The University of Texas at Austin, Mail Code 
A1930, University of Texas at Austin, 1 University Station, Austin, Texas, 78712-0120, 
512-775-8720, tmadedipe@utexas.edu       
 
The purpose of this research study is designed to help us understand your intentions to 
screen for prostate cancer when it is recommended for you by a physician. Your 
participation in the study will contribute to a better understanding of what factors help 
drive your intentions to screen for prostate cancer. You are free to contact the 
investigator at the above address and phone number to discuss the study. You must be 
between the ages of 18 and 40 years old to participate. If you agree to participate:   
 It is estimated that it will take approximately 20 minutes of your time to 
complete the questionnaire.      
 
Risks/Benefits/Confidentiality of Data  
Risks to participants are considered minimal. There will be no costs for participating, 
nor will you benefit from participating. A limited number of research team members 
will have access to the data during data collection. Identifying information will be 
stripped from the final dataset.  
 
Participation or Withdrawal  
Your participation in this study is voluntary. You may decline to answer any question 
and you have the right to withdraw from participation at any time. Withdrawal will not 
affect your relationship with The University of Texas in anyway. If you do not want to 
participate either simply stop participating or close the browser window. If you agree to 
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participate, please click on the survey link below, otherwise use the X at the upper right 
corner to close this window and disconnect.   
To complete the survey, please go to the following URL: http://goo.gl/nZVBnZ 
You are asked to complete this survey within one week. If you do not want to receive 
any more reminders, you may email us at tmadedipe@utexas.edu. 
Contact  
If you have any questions about the study or need to update your email address contact 
the researcher Motolani Ogunsanya at 512-775-8720 or send an email to 
tmadedipe@utexas.edu. This study has been reviewed by The University of Texas at 
Austin Institutional Review Board and the study number is [STUDY NUMBER].      
Questions about your rights as a research participant If you have questions about your 
rights or are dissatisfied at any time with any part of this study, you can contact, 
anonymously if you wish, the Institutional Review Board by phone at (512) 471-8871 
or email at orsc@uts.cc.utexas.edu         
Thank you.      
Please print a copy of this document for your records. 
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Q1 Section I. Intention to Engage in Prostate Cancer Screening - Question 1a - 1c    
 
Instructions: Please check the answer that corresponds to your level of intention to screen for 
prostate cancer if recommended by your physician, using the scales listed below.    
1. When it is recommended by my physician. . . 
        
a. I intend to get 




















b. I will try to get 




















c. I plan to get screened 
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Q2 Section II. Engagement in preventative (risk-reduction) behaviors - Question 2a - 6      
This section of the survey is about your views and actions regarding prostate cancer prevention 
and early detection. Please note that prostate cancer prevention behavior focuses on activities 
that have been suggested to decrease chances for getting prostate cancer, such as eating right, 
taking supplements and exercising.      
 
Instructions: Please check the answer that corresponds to your choice using the scales listed 
below.                   
 
2. Think about your eating habits within THE LAST WEEK. Counting breakfast, lunch, 
dinner, snacks and eating out, please state how often you took the stated food or took the 
stated nutrients:    
 Never (1) 1 - 3 times a 
WEEK 
 (2) 






2 or more 
times a 
DAY (5) 
a. Fruit (fresh, canned or juice but 
not sodas). (1) 
          
b. Vegetables (such as greens, 
vegetable soup, stew, green salad, 
string beans, peas, corn, broccoli). 
(2) 
          
c. Meat products (such as beef, 
goat, chicken, pork, steaks, roasts, 
ribs, hamburgers, ground beef, 
hotdog, sausage).  (3) 
          
d. Dairy products (such as milk, 
cheese, eggs). (4) 
          
e. Butter or oil on food or in 
cooking. (5) 
          
f. Selenium to prevent prostate 
cancer. (6) 
          
g. Lycopene to prevent prostate 
cancer. (7) 
          
h. Vitamin A and other retinoid to 
prevent prostate cancer. (8) 
          
i. Vitamin D to prevent prostate 
cancer. (9) 
          
j. Soy to prevent prostate cancer. 
(10) 
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3. In most cases when you eat, which of the following makes up the     biggest portion of your 
meal? 
 Meat Products 
 Vegetables 
 Fruits 
 Starch or Carbohydrates 
 
The next set of questions is about the frequency and average duration of any exercise you do 
each week in THE LAST MONTH. Please count only the exercise that you did in your free 
time. Do not count exercises due to your job or housework.   
4.  In the last month, how often did you exercise? 
 Everyday 
 4 - 6 days a week 
 1 - 3 days a  week 
 None 
 
5.  When you exercise, which of the following type do you usually do? 
 Did not exercise in the last month 
 Strenuous exercise that makes your heart beat rapidly and sweat (such as running, jogging, 
vigorous swimming) 
 Moderate exercise with light perspiration (such as fast walking, tennis, easy bicycling, easy 
swimming, dancing) 
 Mild exercise with minimal effort (such as easy walking, bowling, golf) 
 
6. On the average, about how many minutes do you spend each time     you exercise? 
 More than 60 mins 
 Between 40 and 60 mins 
 Between 20 and 39 mins 
 Less than 20 mins 
 Did not exercise in the last month 
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Q3 Section III. Social Influences - Question 7a - 7d     
 
Instructions: Next, we are interested in what groups or individuals would influence your 
intention to screen for prostate cancer, if recommended by your physician. Please check the 
answer that corresponds to your choice using the scales listed below.         
 
7. When it is recommended by my physician. . .  
        
        
a. many of my 























b. the people in 
my life whose 
opinion I value 
would approve of 
























c. it is expected of 
me that I should 






















d. most people 
who are important 
to me would want 
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Section IV. Attitudes Toward Prostate Cancer Screening - Question 8a - 8i    Next, we would 
like to determine your attitudes about screening for prostate cancer. The list below represents 
possible outcomes of screening for prostate cancer when your physician recommends it.     
 
Instructions: Please indicate your level of agreement or disagreement by checking the answer 
that corresponds with your choice for each statement. There is no right or wrong answers.     
         













a. opens me up 
to knowing 
whether or not I 
have prostate 
cancer. (1) 
              




              
c. is a process I 
have or will 
eventually have 
to go through.  
(3) 
              
d. is an invasion 
of privacy. (4) 
              
e. can detect 
prostate cancer 
early. (5) 
              
f. is a process 
that carries a 
stigma. (6) 
              
g. gives a peace 
of mind. (8) 





              
i. is a fearful 
process. (10) 
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Section IV. Attitudes Toward Prostate Cancer Screening - Question 9a - 9i     
 
Even though you may not agree or disagree with the outcomes listed, how good or bad do you 
feel each of the following outcomes will be when your physician recommends prostate cancer 
screening.      
 
Instructions: Please check the answer that corresponds to your choice using the scales listed 
below.            
 
9. How good or bad do you feel each of the following outcomes would be if you were to 
screen for prostate cancer when it is recommended by your physician? 
 Very 
Bad (1) 
(2) (3) Neither 
Good nor 
Bad (4) 
(5) (6) Very 
Good (7) 
a. Opening me up to 
knowing whether or not I 
have prostate cancer is: 
(1) 
              
b. Incurring unnecessary 
medical cost is: (2) 
              
c. Having to eventually 
undergo or having 
undergone the process 
is:   (3) 
              
d. Invading my privacy is: 
(4) 
              
e. Detecting prostate 
cancer early is: (5) 
              
f. The screening being 
stigmatized is: (6) 
              
g. Giving me peace of 
mind is: (8) 
              
h. Causing emasculation 
(weakening my manhood) 
is: (9) 
              
i. Screening being a 
fearful process is: (10) 
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Section IV. Attitudes Toward Prostate Cancer Screening - Question 10a - 10e    
Next, we would like to know how you feel about screening for prostate cancer when it is 
recommended by your physician. Please complete the following statement based on each of 
the following adjectives:     
 
Instructions: Please check the answer that corresponds to your choice using the scales 
listed below.   
10. Overall, I think that getting screened for prostate cancer when my physician 
recommends it is…  
        





 Neither Good 

















































 Valuable  
(7) 





 Neither Useful 









Section V. Cues to Action and Health Screening Experiences - Question 11 – 12 
The next section deals with some of your experiences with prostate cancer as well as other 
health screening experiences.     
 
Instructions: Please check the answer that corresponds to your choice using the scales 
listed below.          
11 a. Have you ever had prostate 
cancer? 
b. Has someone close to you ever had prostate cancer? 





    
          
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12.  Health Screening Experiences 

















            
b. How has your 
experience with 
sport physicals 
been (“turn and 
cough”)? 
            
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Section VI. Knowledge Regarding Prostate Cancer and Screening - Question 13a - 13n      
 
The next section deals with your knowledge regarding prostate cancer and prostate cancer 
screening. For the purposes of this survey:  *Prostate-specific antigen (PSA): A prostate-
specific antigen (PSA) test measures the amount of prostate-specific antigen in the blood. PSA 
is released into a man’s blood by his prostate gland. Healthy men have low amounts of PSA in 
the blood.    










a. Men who have several family members (blood relatives) 
with prostate cancer are more likely to get prostate cancer. 
(1) 
      
b. A man can have prostate cancer and have no problems 
or symptoms. (2) 
      
c. Younger men are more likely to get prostate cancer than 
older men. (3) 
      
d. Frequent pain often in your lower back could be a sign 
of prostate cancer. (4) 
      
e. Most 80-year old men do not need a prostate cancer 
screening. (5) 
      
f. Some treatments for prostate cancer can make it harder 
for men to control their urine. (6) 
      
g. Some treatments for prostate cancer can cause problems 
with a man&#39;s ability to have sex. (7) 
      
h. Some treatments for prostate cancer can stop a man 
from ever driving a car again. (8) 
      
i. A doctor can tell which men may die from prostate 
cancer and which men will not be harmed by prostate 
cancer. (9) 
      
j. An abnormal Prostate Specific Antigen (PSA) blood test 
means I have cancer for sure. (10) 
      
k. I can have cancer and have a normal PSA test. (11)       
l. Prostate cancer may grow slowly in men. (12)       
m. A diet high in fat will decrease the chance of getting 
prostate cancer. (13) 
      
n. The tests for prostate cancer screening are not always 
accurate. (14) 
      
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Section VII. Comfortability with Prostate Examinations- Question 14a – 14i    
Next, we would like to determine how comfortable you are or would be with the following issues or 
situations that may be associated with prostate examinations.     
Instructions: Please check the answer that corresponds to your choice using the scales listed below.    
14. How comfortable are you with: 
 Very 
Uncomfortable 
Uncomfortable Neutral Comfortable Very 
Comfortable 
a. having a male  
conduct the 
examination. 
          
b. having a female 
conduct the 
examination. 
          
c. including the 
examination as part 
of a regular 
physical. 
          
d. the awkwardness 
of the process of 
the examination. 
          
e. being touched in 
a sensitive area 
during the 
examination. 
          
f. having to go 
through the process 
of the examination 
in general. 
          





          
h. undergoing the 
examination 
despite the stigma 
associated with it. 
          
i. the idea of being 
sedated in order to 
get through the 
examination. 
          
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Section VIII. Demographic Characteristics – Questions 15 – 30 
 
Now, we would like to know a little about you so we can better understand your responses.   
Instructions: Please check the answer that corresponds to your choice using the scales listed 
below or write in your response where appropriate.   
 
15. In what year where you born?     19_____   (please type a two-digit number below) 
16. Which of the following income categories best describes your total annual 2012 
household income before taxes? 
 $0 - $10,000 
 $10,001 - $20,000 
 $20,001 - $30,000 
 $30,001 - $40,000 
 $40,001 - $50,000 
 $50,001 - $60,000 
 $60,001 - $70,000 
 $70,001 - $80,000 
 $80,001 - $90,000 
 $90,001 - $100,000 
 $100,000+ 
 
17. Which of the following best describes your ethnic background? 
 African-American of American origin (born and grew up in America) 
 African-American of African origin (born in Africa but now American citizen) 




 Other (Please Specify) ____________________ 
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19.  What is your highest level of education (current classification)? 
 Less than High School 
 High School Graduate or GED 
 Freshman (College) 
 Sophomore (College) 
 Junior (College) 
 Senior (College) 
 Graduate Student 
 Postgraduate (e.g., MS, JD, MD, PhD) 
 Other (Please Specify) ____________________ 
 






 Fine Arts 
 Law 
 Liberal Arts 
 Natural Sciences 
 Pharmacy 
 Public Affairs 
 Social Work 




21.  Which of the following best describes your marital status? 
 Single, in a relationship 




 Partner/Living together 
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22. What is your mother’s highest level of education? 
 Less than High School 
 High School Graduate or GED 
 Freshman (College) 
 Sophomore (College) 
 Junior (College) 
 Senior (College) 
 Graduate Student 
 Postgraduate (e.g., MS, JD, MD, PhD) 
 Other (Please Specify) ____________________ 
 
23. What is your father’s highest level of education? 
 Less than High School 
 High School Graduate or GED 
 Freshman (College) 
 Sophomore (College) 
 Junior (College) 
 Senior (College) 
 Graduate Student 
 Postgraduate (e.g., MS, JD, MD, PhD) 
 Other (Please Specify) ____________________ 
 
24. What type of health insurance do you have (Check all that apply)? 
 Medicaid 
 Private Insurance (e.g. BlueCross/BlueShield, Humana) 
 CHIP (Children&#39;s Health Insurance Plan) 
 Medicare 
 No Insurance/Self-pay 
 Not Sure 
 Other (Please Specify) ____________________ 
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26.  How long have you been seeing your regular or primary care physician? 
 Less than 6 months 
 6 months to less than 1 year 
 1 - 5 years 
 6 - 10 years 
 11 - 15 years 
 More than 15 years 
 




 Not a college student 
 
28. Have any of your male blood relatives ever had prostate cancer? 
 Yes 
 No 
 Don't Know 
 
29. Which of your male blood relatives had prostate cancer? 
30. How would you rate your overall health? 
 Poor Fair Good Excellent 
Perception of 
health status 
        
Comments/Summary 
 
If you have any comments or suggestions regarding prostate cancer or prostate cancer 
screening, please provide them in the box provided below:  If you would like to receive an 
aggregate summary of the results, please email Tolani Ogunsanya at tmadedipe@utexas.edu 
with “Results summary” in the subject line.       
 
THANK YOU FOR YOUR PARTICIPATION!     
Additional Resources:  Prostate Cancer Informed Decision Making Video for Patients: 
http://goo.gl/a45qGO  
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Appendix F: Follow Up Email to Web-based survey 
About one week ago, you were invited to participate in an online survey, entitled 
“Prostate Cancer Prevention and Early Detection Decisions among Black Males Less 
than 40 Years Old.” The purpose of this research study is designed to help us 
understand your intentions to screen for prostate cancer when it is recommended for 
you by a physician. If you have already completed the questionnaire, please accept our 
sincere thanks. 
If you have not yet completed the questionnaire, we kindly ask for your assistance by 
completing it as soon as possible. Your opinions and perspectives are very important to 
us. If you agree to participate, please click on the survey link below, otherwise use the 
X at the upper right corner to close this window and disconnect. 
Please go to the following URL to complete the survey: http://goo.gl/nZVBnZ 
Your participation in the study will contribute to a better understanding of what factors 
help drive your intentions to screen for prostate cancer .We estimate that it will take 
about 10 minutes of your time to complete the questionnaire. You are free to contact the 
investigators at the address, phone number, or email listed below to discuss the survey. 
Only aggregate responses will be reported, and the results can be in no way linked to 
you. 
This study has been reviewed and approved by The University of Texas at Austin 
Institutional Review Board. If you have questions about your rights as a study 
participant, or are dissatisfied at any time with any aspect of this study, you may contact 
- anonymously, if you wish - the Institutional Review Board by phone at (512) 471-
8871 or email at orsc@uts.cc.utexas.edu. 
IRB Approval Number: 2013-02-0134 
Thank you again in advance for your time and cooperation in participating in this 
important study. 
Investigators: Motolani Ogunsanya, B.Pharm, Division of Pharmacy,  and Carolyn 
Brown, PhD, College of Pharmacy of The University of Texas at Austin, Mail Code 
A1930, University of Texas at Austin, 2409 University Avenue, Austin, Texas, 78712-
0120, 512-471-6892, 512-775-8720, tmadedipe@utexas.edu  
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Appendix G: Paper-Pencil Survey Booklet 
 
Prostate Cancer Prevention and Early Detection Decisions Among 
Black Males Less than 40 Years     
Consent to Participate in Research 
You are invited to participate in a research study, entitled “Prostate Cancer Prevention and Early 
Detection Decisions Among Black Males Less than 40 Years.” The study is being conducted by 
Motolani Ogunsanya, B.Pharm, College of Pharmacy and Carolyn Brown, PhD, College of 
Pharmacy of The University of Texas at Austin, Mail Code A1930, University of Texas at Austin, 1 
University Station, Austin, Texas, 78712-0120, 512-775-8720, tmadedipe@utexas.edu  
 
The purpose of this research study is designed to help us understand black men’s intentions to 
screen for prostate cancer when it is recommended by their physician. Your participation in the 
study will contribute to a better understanding of what factors drive your intentions to screen for 
prostate cancer. You are free to contact the investigator at the above address and phone number to 
discuss the study. You must be between the ages of 18 and 40 years old to participate.  
If you agree to participate: 
 It is estimated that it will take approximately 20 minutes of your time to complete the 
questionnaire. 
 
Risks/Benefits/Confidentiality of Data 
Risks to participants are considered minimal. There will be no costs for participating, nor will you 
benefit from participating. A limited number of research team members will have access to the data 
during data collection. Identifying information will be stripped from the final dataset. 
 
Participation or Withdrawal 
Your participation in this study is voluntary. You may decline to answer any question and you have 
the right to withdraw from participation at any time. Withdrawal will not affect your relationship 
with The University of Texas in anyway. If you do not want to participate, you may stop at this 
time. If you agree to participate, please kindly fill out the survey. 
 
Contacts 
If you have any questions about the study or need to update your email address contact the 
researcher Motolani Ogunsanya at 512-775-8720 or send an email to tmadedipe@utexas.edu. This 
study has been reviewed by The University of Texas at Austin Institutional Review Board and the 
study number is [STUDY NUMBER]. 
  
Questions about your rights as a research participant 
If you have questions about your rights or are dissatisfied at any time with any part of this study, 
you can contact, anonymously if you wish, the Institutional Review Board by phone at (512) 471-
8871 or email at orsc@uts.cc.utexas.edu.  
 
 
Thank you.    
Please keep a copy of this document for your records. 
  
Throughout the study, prostate examinations will be referred to as digital rectal exam (DRE)*. 
*Digital rectal exam (DRE): A digital (finger) rectal examination is done to check for problems with organs 
or other structures in the pelvis and lower belly. During the examination, the doctor gently puts a lubricated, 
gloved finger of one hand into the rectum. He or she may use the other hand to press on the lower belly or 
pelvic area. 
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Section I. Intention to Engage In Prostate Cancer Screening – Question 1a-1c   
Instructions: Please check the answer that corresponds to your level of intention to screen 
for prostate cancer if recommended by your physician, using the scales listed below. 
1. When it is recommended by my physician. . .    
a. I intend to get 
screened for 
prostate cancer. 
 Extremely   Unlikely   Somewhat   Neither Likely     Somewhat      Likely     Extremely 
Unlikely                          Unlikely        Nor Unlikely          Likely                               Likely 
                                                                                                                     
b. I will try to get 
screened for 
prostate cancer. 
 Definitely     False           Probably    Neither True        Probably       True        Definitely 
False                                  False            Nor False               True                               True 
                                                                                                                    
c. I plan to get 
screened for 
prostate cancer 
 Strongly   Disagree        Somewhat     Neither Agree   Somewhat     Agree     Strongly 
Disagree                           Disagree        Nor Disagree        Agree                           Agree 
                                                                                                                    
  
Section II. Engagement in preventative (risk-reduction) behaviors - Question 2 - 6    
This section of the survey is about your views and actions regarding prostate cancer 
prevention and early detection. Please note that prostate cancer prevention behavior 
focuses on activities that have been suggested to decrease chances for getting prostate 
cancer, such as eating right, taking supplements and exercising.  
Instructions: Please check the answer that corresponds to your choice using the scales 
listed below. 
2.   Think about your eating habits within THE LAST WEEK. Counting 
breakfast, lunch, dinner, snacks and eating out, please state how often you 
ate the stated food or took the stated nutrients: 
 Never 1 – 3          
times a 
WEEK 





2 or more 
times a 
DAY 
a. Fruit (fresh, canned or juice but not 
sodas). 
                               
b. Vegetables (such as greens, vegetable 
soup, stew, green salad, string beans, 
peas, corn, broccoli). 
                               
c. Meat products (such as beef, goat, 
chicken, pork, steaks, roasts, ribs, 
hamburgers, ground beef, hotdog, 
sausage). 
                               
d. Dairy products (such as milk, cheese, 
eggs). 
                               
e. Butter or oil on food or in cooking.                                
f. Selenium to prevent prostate cancer.                                
g. Lycopene to prevent prostate cancer.                                
h. Vitamin A and other retinoid to 
prevent prostate cancer. 
                               
i. Vitamin D to prevent prostate cancer.                                
j. Soy to prevent prostate cancer.                                
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Section II. Engagement in preventative (risk-reduction) behaviors - Question 2 - 6 
(cont’d)  
3. In most cases when you eat, which of the following makes up the biggest portion of 
your meal?  
 Meat products   Vegetables         Fruits                     Starch 
or Carbohydrates  
 
The next set of questions is about the frequency and average duration of any exercise 
you do each week in THE LAST MONTH. Please count only the exercise that you did 
in your free time. Do not count exercises due to your job or housework. 
 
4. In the last month, how often did you exercise? 
 Everyday   4 – 6 days a week   1 – 3 days a week  None 
   
5. When you exercise, which of the following type do you usually do? 
   Strenuous exercise that makes your heart beat rapidly and sweat (such as running,   
jogging, vigorous swimming) 
   Moderate exercise with light perspiration (such as fast walking, tennis, easy 
bicycling, easy swimming, dancing) 
   Mild exercise with minimal effort (such as easy walking, bowling, golf) 
   Did not exercise in the last month 
 
6. On the average, about how many minutes do you spend each time you exercise? 
 More than 60 mins  Between 40 and 60 mins      Between 20 and 39 mins 
 Less than 20 mins  Did not exercise in the last month 
 
Section III. Social Influences – Questions 7a - 7d 
Instructions: Next, we are interested in what groups or individuals would influence your 
intention to screen for prostate cancer, if recommended by your physician. Please check the 
answer that corresponds to your choice using the scales listed below. 
 
7. When it is recommended by my physician. . .    
a. many of my peers 
will screen for 
prostate cancer. 
 Extremely   Unlikely   Somewhat   Neither Likely     Somewhat      Likely     Extremely 
Unlikely                          Unlikely        Nor Unlikely          Likely                               Likely 
                                                                                                                     
b. the people in my life 
whose opinion I 
value would approve 





Definitely     False           Probably    Neither True        Probably       True        Definitely 
False                                  False            Nor False               True                               True 
                                                                                                                    
c. I plan to get screened 
for prostate cancer 
 Strongly   Disagree        Somewhat     Neither Agree   Somewhat     Agree        Strongly 
Disagree                           Disagree        Nor Disagree        Agree                           Agree 
                                                                                                                    
d. it is expected of me 
that I should screen 
for prostate cancer. 
 Strongly   Disagree        Somewhat     Neither Agree   Somewhat     Agree        Strongly 
Disagree                           Disagree        Nor Disagree        Agree                           Agree 
                                                                                                            
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Section IV. Attitudes Toward Prostate Cancer Screening – Questions 8a - 8i 
Next, we would like to determine your attitudes about screening for prostate cancer. The list 
below represents possible outcomes of screening for prostate cancer when your physician 
recommends it.  
 
Instructions: Please indicate your level of agreement or disagreement by checking the 
answer that corresponds with your choice for each statement. There is no right or wrong 
answers. 
8.  Screening for prostate cancer… 
              Strongly  Disagree  Somewhat  Neither Agree  Somewhat   Agree  Strongly  
                 Disagree                   Disagree     Nor Disagree     Agree                   Agree             
a. opens me up to knowing 
whether or not I have prostate 
cancer. 
       
b. is an unnecessary medical 
cost. 
       
c. is a process I have or will 
eventually have to go through.  
       
d. is an invasion of privacy.        
e. can detect prostate cancer 
early. 
       
f. is a process that carries a 
stigma. 
       
g. gives a peace of mind.        
h. causes emasculation (weakens 
my manhood).  
       
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Section IV. Attitudes Toward Prostate Cancer Screening - Question 9a- 9i 
Even though you may not agree or disagree with the outcomes listed, how good or bad do 
you feel each of the following outcomes will be when your physician recommends 
prostate cancer screening.  
Instructions: Please check the answer that corresponds to your choice using the scales 
listed below. 
9.   How good or bad do you feel each of the following outcomes would be if you were to screen for 
prostate cancer when it is recommended by your physician? 
 Very      Bad   Somewhat Neither Bad  Somewhat  Good     Very 
Bad                        Bad         Nor Good      Good                     Good 
a. Opening me up to knowing 
whether or not I have prostate 
cancer is: 
       
b. Incurring unnecessary medical 
cost is: 
       
c. Having to eventually undergo or 
having undergone the process 
is: 
       
d. Invading my privacy is:        
e. Detecting prostate cancer early 
is: 
       
f. The screening carrying a stigma 
is: 
       
g. Giving me peace of mind is:        
h. Causing emasculation 
(weakening my manhood) is: 
       
i. Screening being a fearful 
process is: 
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Section IV. Attitudes Toward Prostate Cancer Screening - Question 10a – 10e 
Next, we would like to know how you feel about screening for prostate cancer when it is recommended by your physician. 
Please complete the following statement based on each of the following adjectives: 
Instructions: Please check the answer that corresponds to your choice using the scales below. 
10. Overall, I think that getting screened for prostate cancer when my physician recommends it 
is… 
 a.    Very                    Bad              Somewhat        Neither Good       Somewhat             Good                   Very                                        
Bad                                           Bad                      Nor Bad               Good                                               Good 
                                                                                                                                                                
 b.    Very                Harmful       Somewhat        Neither Beneficial   Somewhat          Beneficial               Very                        
 Harmful                              Harmful             Nor Harmful        Beneficial                                   Beneficial   
                                                                                                                                                              
 c.    Very            Inconvenient    Somewhat    Neither Convenient  Somewhat        Convenient             Very 
 Inconvenient                      Inconvenient    Nor Inconvenient     Convenient                               Convenient    
                                                                                                                                                              
 d.     Very             Worthless        Somewhat        Neither Valuable   Somewhat         Valuable              Very   
Worthless                              Worthless          Nor Worthless        Valuable                                      Valuable   
                                                                                                                                                                
 e.  Very               Useless            Somewhat        Neither Useful     Somewhat              Useful                Very  
Useless                                     Useless               Nor Useless            Useful                                         Useful   
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Section V. Cues to Action and Health Screening experiences - Question 11 – 12 
The next section deals with your experiences with prostate cancer, if any, as well as other health screening experiences.  
Instructions: Please check the answer that corresponds to your choice using the scales listed below. 
11. Cues to Action 
a. Have you ever had prostate cancer? Yes 
 
                       No 
                         
b. Has someone close to you ever had prostate cancer? Yes                No          Don’t 
Know 
                                  
 
12. Health Screening Experience 
                                                                      Never           Very        Positive   Neither Positive  Negative     Very 
                                                                      Had One    Positive                       Nor Negative                       Negative 
 
a. How has your experience with 
prostate cancer screening been? 
                                                                                
  
b. How has your experience with 
sport physicals been (“turn and 
cough”)? 
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Section VI. Knowledge Regarding Prostate Cancer and Screening – Question 13a – 13n 
The next section deals with your knowledge regarding prostate cancer and prostate cancer 
screening. For the purposes of this survey: 
*Prostate-specific antigen (PSA): A prostate-specific antigen (PSA) test measures the amount of 
prostate-specific antigen in the blood. PSA is released into a man's blood by his prostate gland. 
Healthy men have low amounts of PSA in the blood.  
 
Instructions: Please check the answer that corresponds to your choice using the scales listed 
below. 






a.  Men who have several family members (blood relatives) with 
prostate cancer are more likely to get prostate cancer. 
   
b.  A man can have prostate cancer and have no problems or 
symptoms. 
   
c.  Younger men are more likely to get prostate cancer than older 
men.  
   
d.  Frequent pain often in your lower back could be a sign of prostate 
cancer. 
   
e.  Most 80-year old men do not need a prostate cancer screening.     
f.  Some treatments for prostate cancer can make it harder for men to 
control their urine.  
   
g.  Some treatments for prostate cancer can cause problems with a 
man's ability to have sex.  
   
h.  Some treatments for prostate cancer can stop a man from ever 
driving a car again. 
   
i.  A doctor can tell which men may die from prostate cancer and 
which men will not be harmed by prostate cancer. 
   
j.  An abnormal Prostate Specific Antigen (PSA) blood test means I 
have cancer for sure.  
   
k.  I can have cancer and have a normal PSA test.     
l.  Prostate cancer may grow slowly in men.     
m.  A diet high in fat will decrease the chance of getting prostate 
cancer. 
   
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Section VII. Comfortability with Prostate Examinations - Question 14a – 14i 
Next, we would like to determine how comfortable you are or would be with the following 
issues or situations that may be associated with prostate examinations.   
Instructions: Please check the answer that corresponds to your choice using the scales 
listed below. 
14.  How comfortable are you 
with: 
   
                                                          Very              Uncomfortable    Neutral    Comfortable       Very      
                                                             Uncomfortable                                                                     Comfortable                                                                                                                                    
a. having a male conduct the 
examination 
     
b. having a female conduct the 
examination. 
     
c. including the examination as 
part of a regular physical. 
     
d. the awkwardness of the 
process of the examination. 
     
e. being touched in a sensitive 
area during the examination. 
 -    
f. having to go through the 
process of the examination in 
general. 
     
g. having someone who acts 
professional conduct the 
examination. 
     
h. undergoing the examination 
despite the stigma associated 
with it. 
     
i. the idea of being sedated in 
order to get through the 
examination. 
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Section VIII. Demographic Characteristics – Questions 15 – 30 
Now, we would like to know a little about you so we can better understand your responses. 
Instructions: Please check the answer that corresponds to your choice using the scales listed below 
or write in your response where appropriate.  
15. In what year were born?      19_____   (please use a two digit number) 
 
16. Which of the following income categories best describes your total annual 2012 household 
income before taxes? 
 $0 - $10,000           $10,001 - $20,000     $20,001 - $30,000      $30,001 - $40,000 
 $40,001 - $50,000     $50, 001 - $60,000      $60, 001 - $70,000      $70, 001 - $80,000 
 $80, 001 - $90,000  $90, 001 - $100,000  $100,001+ 
    
17. Which of the following best describes your ethnic background? 
 African-American of American origin (born and grew up in America)   
 African-American of African origin (born in Africa but now American citizen) 
 African-American of Caribbean origin (born in one of the Caribbean Islands but now 
American citizen) 
 African  
 Caribbean   
 Other (Please Specify) ____________________ 
 
18. Which of the following best describes the geographic residence where you grew up? 
 Urban    Suburban    Rural 
 
19. What is your highest level of education (current classification)? 
 Less than High School               High School Graduate or GED   Freshman (College) 
 Sophomore (College)                  Junior (College)   Senior (College) 
 Graduate Student                        Postgraduate (e.g., MS, JD, MD, PhD)   
 Other (Please Specify) ____________________ 
 
20. If currently enrolled in/completed college, what is/was your major field of study 
 Architecture   Business Communication  Education 
 Engineering   Fine Arts Law   Liberal Arts 
 Natural Sciences  Nursing Pharmacy  Public Affairs 
 Social Work   Medicine Other (Please Specify) _________________ 
 
21. Which of the following best describes your marital status? 
 Single, in a relationship                 Married     Divorced/Separated  
 Single, not in a relationship  Partner/Living together   Widowed  
 
22. What is your mother’s highest level of education? 
 Less than High School      High School Graduate or GED   Freshman (College)  
 Sophomore (College)        Junior (College)           Senior (College) 
 Graduate Student                Postgraduate (e.g., MS, JD, MD, PhD)   
 Other (Please Specify) ____________________  
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Section VIII. Demographic Characteristics – Questions 15 – 30 (cont’d) 
23. What is your father’s highest level of education? 
 Less than High School   High School Graduate or GED  Freshman (College)  
 Sophomore (College)          Junior (College)   Senior (College) 
 Graduate Student                   Postgraduate (e.g., MS, JD, MD, PhD) 
 Other (Please Specify) ____________________ 
 
24. What type of health insurance do you have? (Check all that apply) 
 Medicaid                                                             No insurance/Self-pay  
 CHIP (Children’s Health Insurance Plan)     Medicare          
 Private insurance (e.g. BlueCross/Blue Shield, Humana)   Not sure 
 Other (Please Specify) ____________________ 
 
25. Do you currently have a regular or primary care physician? 
 Yes       




26. How long have you been seeing your regular or primary care physician? 
 Less than 6 months   6 months to less than 1 year   1 – 5 years 
 6 – 10 years   11 – 15 years        More than 15 years 
 
27. If you are a college student, do you typically use Student Health Services to obtain 
healthcare? 
 Yes       
 No  
 Not a college student 
 
28. Have any of your male blood relatives ever had prostate cancer? 
 Yes       
 No 
 Don’t Know 
 
 




30. How would you rate your overall health? 
 Poor   
 Fair    
 Good   
 Excellent 
If “No” or “Don’t Know”, 
skip question 29 and proceed 
to question 30 
If “No” skip question 26 and 




If you have any comments or suggestions regarding prostate cancer or prostate cancer 




















If you would like to receive an aggregate summary of the results, please email Motolani 
Ogunsanya at tmadedipe@utexas.edu with “Results summary” in the subject line. 
 
Please fold the questionnaire in half and submit it to the researcher. 
 








Appendix H: Survey Cover Letters 
 
Prostate Cancer Prevention and Early Detection Decisions among 
Black Males Less than 40 Years Old  
 
You are invited to participate in a research study, entitled “Prostate Cancer Prevention and 
Early Detection Decisions Among Black Males Less than 40 Years Old.” The study is being 
conducted by Motolani Ogunsanya, B.Pharm, College of Pharmacy and Carolyn Brown, PhD, 
College of Pharmacy of The University of Texas at Austin, Mail Code A1930, University of 
Texas at Austin, 1 University Station, Austin, Texas, 78712-0120, 512-775-8720, 
tmadedipe@utexas.edu  
 
The purpose of this research study is to help us understand black men’s intentions to screen for 
prostate cancer when it is recommended by their physician. Your participation in the study will 
contribute to a better understanding of what factors drive your intentions to screen for prostate 
cancer. You are free to contact the investigator at the above address and phone number to 
discuss the study. You must be between the ages of 18 and 40 years old to participate.  
If you agree to participate: 
 It is estimated that it will take approximately 20 minutes of your time to complete 
the questionnaire. 
 
Risks/Benefits/Confidentiality of Data 
Risks to participants are considered minimal. There will be no costs for participating, nor will 
you benefit from participating. A limited number of research team members will have access to 
the data during data collection. Identifying information will be stripped from the final dataset. 
 
Participation or Withdrawal 
Your participation in this study is voluntary. You may decline to answer any question and you 
have the right to withdraw from participation at any time. Withdrawal will not affect your 
relationship with The University of Texas in anyway. If you do not want to participate, you may 
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Questions about your rights as a research participant 
If you have questions about your rights or are dissatisfied at any time with any part of this 
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(512) 471-8871 or email at orsc@uts.cc.utexas.edu.  
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for prostate cancer when it is recommended for you by a physician. Your participation in the 
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screen for prostate cancer. You are free to contact the investigator at the above address and 
phone number to discuss the study.  You must be between the ages of 18 and 40 years old to 
participate.  
If you agree to participate: 
 It is estimated that it will take approximately 20 minutes of your time to complete the 
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Risks/Benefits/Confidentiality of Data 
Risks to participants are considered minimal. There will be no costs for participating, nor will 
you benefit from participating. A limited number of research team members will have access to 
the data during data collection. Identifying information will be stripped from the final dataset. 
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This study has been reviewed by The University of Texas at Austin Institutional Review Board 
and the study number is [STUDY NUMBER]. 
  
Questions about your rights as a research participant 
If you have questions about your rights or are dissatisfied at any time with any part of this 
study, you can contact, anonymously if you wish, the Institutional Review Board by phone at 
(512) 471-8871 or email at orsc@uts.cc.utexas.edu.  
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Figure I.1: Histogram of Standardized Residuals from Regression of Direct 




Figure I.2: Histogram of Standardized Residuals from Regression of Indirect 
















Figure I.3: Histogram of Standardized Residuals Regression of Prostate Cancer Risk-


















Figure J.1: Normal P-Plot of Regression of Standardized Residuals of 
Direct Measures of TRA Construct and Other Independent Variables 
Figure J.2: Normal P-Plot of Regression of Standardized Residuals of 





















Figure K.1: Scatterplot of Residuals from Regression of Direct Measures of TRA 
Construct and Other Independent Variables 
Figure K.2: Scatterplot of Residuals from Regression of Indirect Measures of TRA 






Figure K.3: Scatterplot of Residuals from Regression of Prostate Cancer Risk-Reduction 
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